No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4qv8L, 1.0000, 0.00, 1.000, 222, 222, YCP BETA5-C52F MUTANT
2, 4qv8Z, 0.9999, 0.01, 1.000, 222, 222, YCP BETA5-C52F MUTANT
3, 4qv1Z, 0.9999, 0.05, 1.000, 222, 222, YCP BETA5-M45A MUTANT
4, 4qv1L, 0.9999, 0.06, 1.000, 222, 222, YCP BETA5-M45A MUTANT
5, 4r00Z, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
6, 4r00L, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
7, 4qv7Z, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-A50V MUTANT
8, 4qv7L, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-A50V MUTANT
9, 4qv5Z, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-M45I MUTANT
10, 4qv5L, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-M45I MUTANT
11, 4qv4Z, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-M45T MUTANT
12, 4qv4L, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-M45T MUTANT
13, 4qv3Z, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-M45V MUTANT
14, 4qv3L, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-M45V MUTANT
15, 4qv0Z, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT
16, 4qv0L, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT
17, 4quyZ, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49S-MUTANT
18, 4quyL, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49S-MUTANT
19, 5fgaZ, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
20, 5fgaL, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
21, 5fg7L, 0.9997, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T1A MUTANT
22, 5d0wZ, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT
23, 5d0wL, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT
24, 5czaZ, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT
25, 5czaL, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT
26, 5cz6Z, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
27, 5cz6L, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
28, 4y9yZ, 0.9997, 0.08, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT
29, 4y9yL, 0.9997, 0.08, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT
30, 4qzzZ, 0.9997, 0.08, 1.000, 222, 222, YCP IN COMPLEX WITH OMURALIDE
31, 4qzzL, 0.9997, 0.08, 1.000, 222, 222, YCP IN COMPLEX WITH OMURALIDE
32, 4quxZ, 0.9997, 0.09, 1.000, 222, 222, YCP BETA5-A49T-MUTANT
33, 4quxL, 0.9997, 0.09, 1.000, 222, 222, YCP BETA5-A49T-MUTANT
34, 5fg9Z, 0.9996, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
35, 5fg9L, 0.9996, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
36, 5fg7Z, 0.9996, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T1A MUTANT
37, 5cz7Z, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
38, 5cz7L, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
39, 5cgfZ, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT
40, 5cgfL, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT
41, 5bxlZ, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT
42, 5bxlL, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT
43, 4ya4Z, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT
44, 4ya4L, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT
45, 4y8rZ, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT
46, 4y8rL, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT
47, 4qvyZ, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
48, 4qvyL, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
49, 4qv9Z, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-C63F MUTANT
50, 4qv9L, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-C63F MUTANT
51, 5l5aZ, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
52, 5l5aL, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
53, 4z1lZ, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
54, 4z1lL, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
55, 4ya1Z, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT
56, 4ya1L, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT
57, 4y8mZ, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
58, 4y8mL, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
59, 4rurZ, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
60, 4rurL, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
61, 5l5bZ, 0.9994, 0.13, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
62, 5l5bL, 0.9994, 0.13, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
63, 5bouZ, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
64, 5bouL, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
65, 4y6vZ, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
66, 4y6vL, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
67, 4r17Z, 0.9994, 0.13, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
68, 4r17L, 0.9994, 0.13, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
69, 4qvwZ, 0.9994, 0.13, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
70, 4qvwL, 0.9994, 0.13, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
71, 6gopZ, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
72, 6gopL, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
73, 5m2bZ, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
74, 5m2bL, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
75, 5laiZ, 0.9993, 0.14, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
76, 5laiL, 0.9993, 0.14, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
77, 5l6cZ, 0.9993, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
78, 5l6cL, 0.9993, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
79, 5l67Z, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
80, 5l67L, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
81, 5l5rZ, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
82, 5l5rL, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
83, 5l5eZ, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
84, 5l5eL, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
85, 4y8nZ, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
86, 4y8nL, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
87, 4y69Z, 0.9993, 0.15, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
88, 4y69L, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
89, 4qw0Z, 0.9993, 0.15, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
90, 4qw0L, 0.9993, 0.15, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
91, 4qvlZ, 0.9993, 0.14, 1.000, 222, 222, YCP IN COMPLEX WITH BORTEZOMIB
92, 4qvlL, 0.9993, 0.14, 1.000, 222, 222, YCP IN COMPLEX WITH BORTEZOMIB
93, 5lajZ, 0.9992, 0.15, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
94, 5lajL, 0.9992, 0.15, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
95, 5l6bZ, 0.9992, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
96, 5l6bL, 0.9992, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
97, 5l5fZ, 0.9992, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
98, 5l5fL, 0.9992, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
99, 4ya5Z, 0.9992, 0.15, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
100, 4ya5L, 0.9992, 0.15, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
101, 4qv6Z, 0.9992, 0.15, 1.000, 222, 222, YCP BETA5-A49V MUTANT
102, 4qv6L, 0.9992, 0.15, 1.000, 222, 222, YCP BETA5-A49V MUTANT
103, 5l6aZ, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
104, 5l6aL, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
105, 5l65Z, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
106, 5l65L, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
107, 5l5dZ, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
108, 5l5dL, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
109, 5fghZ, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
110, 5fghL, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
111, 5cz4Z, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
112, 5cz4L, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
113, 4y8uZ, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
114, 4y8uL, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
115, 4r18Z, 0.9991, 0.16, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
116, 4r18L, 0.9991, 0.16, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
117, 5bxnZ, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
118, 5bxnL, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
119, 4y8tZ, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
120, 4y8tL, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
121, 4y6aZ, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
122, 4y6aL, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
123, 4qwuZ, 0.9990, 0.17, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
124, 4qwuL, 0.9990, 0.17, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
125, 5l5wZ, 0.9989, 0.18, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
126, 5l5wL, 0.9989, 0.18, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
127, 5d0xZ, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
128, 5d0xL, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
129, 4ya0Z, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
130, 4ya0L, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
131, 5l68Z, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
132, 5l68L, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
133, 5l66Z, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
134, 5l66L, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
135, 5l5zZ, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
136, 5l5zL, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
137, 5l5pZ, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
138, 5l5pL, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
139, 5l5oZ, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
140, 5l5oL, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
141, 5l5iZ, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
142, 5l5iL, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
143, 4ya3Z, 0.9988, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
144, 4ya3L, 0.9988, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
145, 4qw1Z, 0.9988, 0.19, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
146, 4qw1L, 0.9988, 0.19, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
147, 4qvmZ, 0.9988, 0.19, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
148, 5lttZ, 0.9987, 0.19, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
149, 5lttL, 0.9987, 0.19, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
150, 5l64Z, 0.9987, 0.20, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
151, 5l64L, 0.9987, 0.20, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
152, 4qvvZ, 0.9987, 0.20, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
153, 4qvvL, 0.9987, 0.20, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
154, 4qvmL, 0.9987, 0.19, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
155, 5d0tZ, 0.9986, 0.20, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
156, 5d0tL, 0.9986, 0.20, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
157, 5l5uL, 0.9985, 0.21, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
158, 5l5tZ, 0.9985, 0.21, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
159, 4qw3Z, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
160, 4qw3L, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
161, 4qvpZ, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
162, 4qvpL, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
163, 3gpwZ, 0.9985, 0.21, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
164, 3gpwL, 0.9985, 0.22, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
165, 2fakZ, 0.9985, 0.21, 1.000, 222, 222, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
166, 2fakL, 0.9985, 0.21, 1.000, 222, 222, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
167, 5l69Z, 0.9984, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
168, 5l69L, 0.9984, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
169, 5l5uZ, 0.9984, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
170, 5l5tL, 0.9984, 0.21, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
171, 4lqiZ, 0.9984, 0.22, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
172, 4lqiL, 0.9984, 0.22, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
173, 5l5hZ, 0.9983, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
174, 5l5hL, 0.9983, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
175, 4q1sL, 0.9983, 0.22, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
176, 3hyeZ, 0.9983, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
177, 3hyeL, 0.9983, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
178, 1ryp1, 0.9983, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
179, 5l63Z, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
180, 5l63L, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
181, 5l62Z, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
182, 5l62L, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
183, 5l5vZ, 0.9982, 0.23, 0.977, 222, 222,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
184, 5l5vL, 0.9982, 0.23, 0.977, 222, 222,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
185, 5l5qZ, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
186, 5l5qL, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
187, 4qvnZ, 0.9982, 0.23, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
188, 4qvnL, 0.9982, 0.23, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
189, 4eu2M, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
190, 4eu21, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
191, 3tddZ, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
192, 3tddL, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
193, 3gptZ, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
194, 3gptL, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
195, 5l5xZ, 0.9981, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
196, 4q1sZ, 0.9981, 0.24, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
197, 4j70Z, 0.9981, 0.24, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
198, 4j70L, 0.9981, 0.24, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
199, 2gplZ, 0.9981, 0.24, 1.000, 222, 222, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
200, 2gplL, 0.9981, 0.24, 1.000, 222, 222, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
201, 1rypM, 0.9981, 0.24, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
202, 5l61Z, 0.9980, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
203, 5l61L, 0.9980, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
204, 5l5xL, 0.9980, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
205, 5l5sZ, 0.9980, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
206, 5l5sL, 0.9980, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
207, 5l60Z, 0.9979, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
208, 5l60L, 0.9979, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
209, 3un8Z, 0.9979, 0.25, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
210, 3un8L, 0.9979, 0.25, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
211, 3shjZ, 0.9979, 0.25, 1.000, 222, 222, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
212, 3shjL, 0.9979, 0.25, 1.000, 222, 222, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
213, 4qvqZ, 0.9978, 0.26, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
214, 4qvqL, 0.9978, 0.26, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
215, 5dkiZ, 0.9976, 0.27, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
216, 5dkiL, 0.9976, 0.27, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
217, 4x6zM, 0.9976, 0.27, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
218, 5nifM, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
219, 5nif1, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
220, 4zzg1, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
221, 4inrZ, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
222, 3e47Z, 0.9975, 0.27, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
223, 3e47L, 0.9975, 0.27, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
224, 1g0uZ, 0.9975, 0.27, 1.000, 222, 222, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
225, 5dkjZ, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
226, 5dkjL, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
227, 4zzgM, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
228, 4inrL, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
229, 1g0uL, 0.9974, 0.28, 1.000, 222, 222, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
230, 4x6z1, 0.9973, 0.29, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
231, 3wxr1, 0.9972, 0.29, 1.000, 222, 222, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
232, 3dy3Z, 0.9972, 0.29, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
233, 3dy3L, 0.9972, 0.29, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
234, 3oevZ, 0.9970, 0.30, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
235, 3dy4Z, 0.9970, 0.30, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
236, 3dy4L, 0.9970, 0.30, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
237, 4r02Z, 0.9969, 0.31, 1.000, 222, 222, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
238, 4jt0Z, 0.9969, 0.31, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
239, 4jt0L, 0.9969, 0.31, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
240, 3nzjZ, 0.9969, 0.31, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
241, 5l5yZ, 0.9968, 0.31, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
242, 5l5yL, 0.9968, 0.31, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
243, 5fgfZ, 0.9968, 0.32, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
244, 5fgfL, 0.9968, 0.32, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
245, 3wxrM, 0.9968, 0.31, 1.000, 222, 222, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
246, 3nzjL, 0.9968, 0.31, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
247, 5l5jZ, 0.9966, 0.32, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
248, 5l5jL, 0.9966, 0.32, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
249, 3mg4L, 0.9965, 0.33, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
250, 5fgdZ, 0.9964, 0.34, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
251, 5fgdL, 0.9964, 0.34, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
252, 4r02L, 0.9964, 0.34, 1.000, 222, 222, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
253, 3oevL, 0.9964, 0.34, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
254, 3mg4Z, 0.9962, 0.35, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
255, 4y8kZ, 0.9960, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
256, 4inuZ, 0.9960, 0.35, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
257, 4intZ, 0.9960, 0.35, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
258, 4intL, 0.9960, 0.35, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
259, 4y8kL, 0.9959, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
260, 5fgeZ, 0.9958, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
261, 5fgeL, 0.9958, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
262, 4inuL, 0.9958, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
263, 4jsqZ, 0.9957, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
264, 4jsqL, 0.9957, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
265, 4fzcZ, 0.9957, 0.36, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
266, 4fzcL, 0.9957, 0.37, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
267, 3okjL, 0.9957, 0.36, 1.000, 222, 222, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
268, 3oeuZ, 0.9957, 0.36, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
269, 3mg7Z, 0.9956, 0.37, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
270, 4jsuZ, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
271, 4jsuL, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
272, 3un4Z, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
273, 3un4L, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
274, 4fzgZ, 0.9954, 0.38, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
275, 4fzgL, 0.9954, 0.38, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
276, 5fhsZ, 0.9952, 0.39, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
277, 5fhsL, 0.9951, 0.39, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
278, 3oeuL, 0.9949, 0.40, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
279, 3gpjZ, 0.9948, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
280, 3gpjL, 0.9948, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
281, 4no1Z, 0.9947, 0.41, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
282, 4no1L, 0.9947, 0.41, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
283, 3bdmZ, 0.9947, 0.41, 1.000, 222, 222, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
284, 3bdmL, 0.9947, 0.41, 1.000, 222, 222, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
285, 2f16Z, 0.9947, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
286, 2f16L, 0.9947, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
287, 3nzxZ, 0.9946, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
288, 3mg0Z, 0.9946, 0.41, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
289, 5cghZ, 0.9945, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
290, 5cghL, 0.9945, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
291, 3nzxL, 0.9945, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
292, 1z7qM, 0.9945, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
293, 4qwrZ, 0.9944, 0.42, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
294, 4qwrL, 0.9944, 0.42, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
295, 1z7qa, 0.9944, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
296, 4y7xZ, 0.9943, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
297, 4y7xL, 0.9943, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
298, 5d0vZ, 0.9942, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
299, 5cz9Z, 0.9942, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
300, 5cz9L, 0.9942, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
301, 4v7oUA, 0.9942, 0.42, 1.000, 222, 222, 
302, 4v7oM, 0.9942, 0.43, 1.000, 222, 222, 
303, 4v7oAA, 0.9942, 0.42, 1.000, 222, 222, 
304, 4qlsZ, 0.9942, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
305, 4qlsL, 0.9942, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
306, 5fggZ, 0.9941, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
307, 5d0vL, 0.9941, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
308, 4v7oIB, 0.9941, 0.43, 1.000, 222, 222, 
309, 4no8Z, 0.9941, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
310, 4no8L, 0.9941, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
311, 3mg0L, 0.9941, 0.43, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
312, 5fggL, 0.9940, 0.44, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
313, 4ltcZ, 0.9940, 0.43, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
314, 3sdkZ, 0.9940, 0.43, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
315, 3nzwZ, 0.9940, 0.43, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
316, 3nzwL, 0.9939, 0.43, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
317, 4y8sZ, 0.9938, 0.44, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
318, 4y8sL, 0.9938, 0.44, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
319, 3mg6Z, 0.9938, 0.44, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
320, 5fgiZ, 0.9937, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
321, 5fgiL, 0.9937, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
322, 3mg7L, 0.9937, 0.44, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
323, 5cggZ, 0.9936, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
324, 5cggL, 0.9936, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
325, 4qzwZ, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
326, 4qzwL, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
327, 4qwjZ, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
328, 4qwjL, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
329, 4ltcL, 0.9936, 0.45, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
330, 4qwkZ, 0.9935, 0.45, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
331, 4qwkL, 0.9935, 0.45, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
332, 4qlvZ, 0.9935, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
333, 4qlvL, 0.9935, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
334, 4g4sM, 0.9935, 0.45, 1.000, 222, 222, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
335, 4qwsZ, 0.9934, 0.46, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
336, 4qbyZ, 0.9934, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
337, 4qbyL, 0.9934, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
338, 4gk7Z, 0.9934, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
339, 4gk7L, 0.9934, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
340, 3sdkL, 0.9934, 0.46, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
341, 5d0sZ, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
342, 5d0sL, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
343, 5cz5Z, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
344, 4y8qZ, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
345, 4y8qL, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
346, 4qwsL, 0.9933, 0.46, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
347, 4qwiZ, 0.9933, 0.46, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
348, 4qwiL, 0.9933, 0.46, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
349, 5d0zZ, 0.9932, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
350, 5d0zL, 0.9932, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
351, 5cz5L, 0.9932, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
352, 4qluZ, 0.9932, 0.46, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
353, 4qw7Z, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
354, 4qw7L, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
355, 4qw5Z, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
356, 4qw5L, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
357, 4qluL, 0.9931, 0.46, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
358, 5l54Z, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
359, 5l54L, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
360, 5jhsZ, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
361, 5jhsL, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
362, 5jhrZ, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
363, 5jhrL, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
364, 5cz8Z, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
365, 4qwgZ, 0.9930, 0.47, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
366, 4qwgL, 0.9930, 0.47, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
367, 5cz8L, 0.9929, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
368, 3mg8Z, 0.9929, 0.47, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
369, 4ya2L, 0.9928, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
370, 4y82Z, 0.9928, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
371, 4y82L, 0.9928, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
372, 4qz6Z, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
373, 4qz6L, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
374, 4qwlZ, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
375, 4qwlL, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
376, 4qw6Z, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
377, 4qw6L, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
378, 3mg6L, 0.9928, 0.48, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
379, 4ya2Z, 0.9927, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
380, 4y81Z, 0.9927, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
381, 4y81L, 0.9927, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
382, 3sdiZ, 0.9927, 0.48, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
383, 4y78Z, 0.9926, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
384, 5ahjZ, 0.9925, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
385, 5ahjL, 0.9925, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
386, 4y78L, 0.9925, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
387, 4qwfZ, 0.9925, 0.49, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
388, 4qwfL, 0.9925, 0.49, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
389, 1fntM, 0.9925, 0.48, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
390, 4y8pZ, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
391, 4y8pL, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
392, 4y8lL, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
393, 4y6zZ, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
394, 4y6zL, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
395, 4qw4L, 0.9924, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH CARFILZOMIB
396, 4no6Z, 0.9924, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
397, 2zcyZ, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
398, 1fnta, 0.9924, 0.49, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
399, 4y8lZ, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
400, 4y77Z, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
401, 4y77L, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
402, 4qw4Z, 0.9923, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH CARFILZOMIB
403, 4no6L, 0.9923, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
404, 3sdiL, 0.9923, 0.49, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
405, 2zcyL, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
406, 4y80L, 0.9922, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
407, 4y7yZ, 0.9922, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
408, 4y7yL, 0.9922, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
409, 4ya9Z, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
410, 4ya9L, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
411, 4y80Z, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
412, 4y7wZ, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
413, 4y7wL, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
414, 4y75Z, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
415, 4y75L, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
416, 4no9Z, 0.9921, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
417, 4no9L, 0.9921, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
418, 3mg8L, 0.9921, 0.50, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
419, 4ya7Z, 0.9920, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
420, 4ya7L, 0.9920, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
421, 4qltZ, 0.9920, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
422, 4qltL, 0.9920, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
423, 4y9zZ, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
424, 4y9zL, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
425, 4y70Z, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
426, 4y70L, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
427, 4qz5Z, 0.9919, 0.51, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
428, 4qz5L, 0.9919, 0.51, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
429, 5l55Z, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
430, 5l55L, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
431, 5l52Z, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
432, 5l52L, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
433, 4y8hZ, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
434, 4y8oZ, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
435, 4y8oL, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
436, 4y8jZ, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
437, 4y8jL, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
438, 4y8iL, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
439, 4y8hL, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
440, 4y74Z, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
441, 4y74L, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
442, 4qz3Z, 0.9917, 0.51, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
443, 4qz3L, 0.9917, 0.51, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
444, 4y8iZ, 0.9916, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
445, 4y8gZ, 0.9916, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
446, 4y8gL, 0.9916, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
447, 4qzxZ, 0.9916, 0.51, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
448, 4qzxL, 0.9916, 0.51, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
449, 1g65Z, 0.9916, 0.51, 1.000, 222, 222, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
450, 1g65L, 0.9916, 0.52, 1.000, 222, 222, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
451, 4y84Z, 0.9915, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
452, 4y84L, 0.9915, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
453, 4nnnZ, 0.9915, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH MG132
454, 4nnnL, 0.9915, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH MG132
455, 4qz7Z, 0.9914, 0.52, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
456, 4qz7L, 0.9914, 0.52, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
457, 4nnwZ, 0.9914, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
458, 4nnwL, 0.9914, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
459, 3d29L, 0.9914, 0.52, 1.000, 222, 222, PROTEASOME INHIBITION BY FELLUTAMIDE B
460, 4hnpZ, 0.9913, 0.53, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
461, 3d29Z, 0.9913, 0.52, 1.000, 222, 222, PROTEASOME INHIBITION BY FELLUTAMIDE B
462, 5cgiZ, 0.9912, 0.53, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
463, 5cgiL, 0.9912, 0.53, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
464, 4hnpL, 0.9912, 0.53, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
465, 3okjZ, 0.9912, 0.36, 1.000, 221, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
466, 4qz0Z, 0.9911, 0.53, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
467, 4qz0L, 0.9911, 0.53, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
468, 4qxjZ, 0.9910, 0.53, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
469, 4qxjL, 0.9910, 0.53, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
470, 4qwxZ, 0.9910, 0.54, 1.000, 222, 222, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
471, 4qwxL, 0.9910, 0.54, 1.000, 222, 222, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
472, 1jd2L, 0.9910, 0.53, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
473, 1jd2S, 0.9908, 0.54, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
474, 4qz4Z, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
475, 4qz4L, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
476, 4qz2Z, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
477, 4qz2L, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
478, 4qz1Z, 0.9905, 0.55, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
479, 4qz1L, 0.9905, 0.55, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
480, 4hrcZ, 0.9905, 0.55, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
481, 4qlqZ, 0.9902, 0.56, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
482, 4qlqL, 0.9902, 0.56, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
483, 4hrcL, 0.9902, 0.56, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
484, 4hrdZ, 0.9897, 0.57, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
485, 4hrdL, 0.9895, 0.58, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
486, 5mp96, 0.9884, 0.60, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S1)
487, 3jcpA, 0.9876, 0.62, 1.000, 222, 222, 
488, 3jcpH, 0.9875, 0.63, 1.000, 222, 222, 
489, 5mp9m, 0.9872, 0.63, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S1)
490, 5mpa6, 0.9843, 0.70, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
491, 5mpam, 0.9834, 0.73, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
492, 3jcoH, 0.9834, 0.72, 1.000, 222, 222, 
493, 3jcoA, 0.9833, 0.73, 1.000, 222, 222, 
494, 5mpcM, 0.9762, 0.88, 1.000, 222, 222, 
495, 5mpcAA, 0.9714, 0.97, 1.000, 222, 222, 
496, 5wvkM, 0.9699, 0.99, 1.000, 222, 222, 
497, 5wvkF, 0.9687, 1.02, 1.000, 222, 222, 
498, 4cr26, 0.9667, 1.08, 1.000, 222, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
499, 5mpbAA, 0.9629, 1.13, 1.000, 222, 222, 
500, 5mpbM, 0.9620, 1.13, 1.000, 222, 222, 
501, 5a5b6, 0.9603, 1.18, 1.000, 222, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
502, 4cr36, 0.9603, 1.18, 1.000, 222, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
503, 4cr46, 0.9581, 1.25, 1.000, 222, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
504, 5wviRA, 0.9433, 1.34, 0.964, 222, 221, 
505, 5gjrSA, 0.9422, 0.78, 0.484, 213, 213, 
506, 4r3oM, 0.9422, 0.78, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME
507, 4r3o1, 0.9422, 0.79, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME
508, 5gjrEA, 0.9421, 0.78, 0.484, 213, 213, 
509, 6avoX, 0.9416, 0.79, 0.484, 213, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
510, 6avoS, 0.9416, 0.79, 0.484, 213, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
511, 5wviJA, 0.9416, 1.43, 1.000, 222, 222, 
512, 3une2, 0.9415, 0.80, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
513, 3uneL, 0.9414, 0.80, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
514, 5le5L, 0.9413, 0.80, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
515, 5le5Z, 0.9409, 0.81, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
516, 3uneZ, 0.9407, 0.81, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
517, 5lexL, 0.9406, 0.82, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
518, 5lf1L, 0.9402, 0.82, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
519, 5gjqf, 0.9401, 0.82, 0.484, 213, 213, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
520, 1iruM, 0.9401, 0.83, 0.484, 213, 213, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
521, 1iru1, 0.9401, 0.83, 0.484, 213, 213, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
522, 5leyL, 0.9400, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
523, 5gjqt, 0.9400, 0.83, 0.484, 213, 213, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
524, 4r67o, 0.9400, 0.83, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
525, 4r67M, 0.9400, 0.82, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
526, 4r671, 0.9400, 0.83, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
527, 5lf1Z, 0.9399, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
528, 4r67a, 0.9399, 0.83, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
529, 5lf6L, 0.9398, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
530, 5lf4L, 0.9398, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
531, 5lf7L, 0.9397, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
532, 5lexZ, 0.9397, 0.84, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
533, 3unen, 0.9397, 0.84, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
534, 5lf4Z, 0.9396, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
535, 5lf3L, 0.9396, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
536, 5lf7Z, 0.9393, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
537, 5leyZ, 0.9393, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
538, 5lf6Z, 0.9392, 0.85, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
539, 5lf3Z, 0.9391, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
540, 5lf0L, 0.9390, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
541, 5lezL, 0.9390, 0.85, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
542, 5l4gV, 0.9390, 0.85, 0.484, 213, 213, 
543, 3unbZ, 0.9390, 0.84, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
544, 3unb2, 0.9388, 0.84, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
545, 5lf0Z, 0.9387, 0.85, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
546, 3unbL, 0.9385, 0.86, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
547, 5vfqLA, 0.9383, 0.86, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
548, 3unbn, 0.9383, 0.86, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
549, 5vfpKA, 0.9382, 0.86, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
550, 5vfos, 0.9382, 0.86, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
551, 5lezZ, 0.9382, 0.87, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
552, 5vfqM, 0.9380, 0.86, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
553, 5vfpM, 0.9376, 2.15, 0.201, 215, 204, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
554, 3unhZ, 0.9375, 0.87, 0.484, 213, 213, MOUSE 20S IMMUNOPROTEASOME
555, 3unhL, 0.9375, 0.89, 0.469, 213, 213, MOUSE 20S IMMUNOPROTEASOME
556, 5vfoS, 0.9373, 0.89, 0.469, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
557, 5vfuRA, 0.9372, 0.88, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
558, 5vfsM, 0.9372, 0.87, 0.484, 213, 213, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
559, 5vfts, 0.9371, 0.88, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
560, 5vfsLA, 0.9370, 2.13, 0.201, 215, 204, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
561, 5vfrS, 0.9370, 0.88, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
562, 5l4gH, 0.9368, 0.88, 0.484, 213, 213, 
563, 5vfrs, 0.9366, 0.88, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
564, 3unfZ, 0.9361, 0.90, 0.484, 213, 213, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
565, 3unfL, 0.9361, 0.89, 0.484, 213, 213, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
566, 5vfuDA, 0.9360, 0.91, 0.469, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
567, 5vftS, 0.9360, 0.91, 0.469, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
568, 5t0cKB, 0.9350, 0.91, 0.484, 213, 213, 
569, 5t0cEA, 0.9350, 0.91, 0.484, 213, 213, 
570, 5t0gS, 0.9307, 0.92, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
571, 5m32Z, 0.9305, 0.92, 0.484, 213, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
572, 5m32L, 0.9305, 1.00, 0.484, 213, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
573, 5t0hS, 0.9159, 1.02, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
574, 5t0jS, 0.9155, 1.02, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, 5t0iS, 0.9101, 1.24, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
576, 5ln36, 0.8902, 1.25, 0.484, 213, 213, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
577, 5fmgM, 0.8633, 1.35, 0.484, 213, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
578, 5fmga, 0.8633, 1.57, 0.481, 213, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
579, 5l63W, 0.8491, 1.13, 0.377, 199, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
580, 5l63I, 0.8491, 1.13, 0.377, 199, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
581, 5l5yW, 0.8490, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
582, 5l5yI, 0.8490, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
583, 5l6aW, 0.8489, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
584, 5l6aI, 0.8489, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
585, 5l64W, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
586, 5l64I, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
587, 5l62W, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
588, 5l62I, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
589, 5l61W, 0.8488, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
590, 5l61I, 0.8488, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
591, 5l60W, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
592, 5l60I, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
593, 5l5xW, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
594, 5l5xI, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
595, 5l5oW, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
596, 5l5oI, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
597, 5m2bI, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
598, 5l5zW, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
599, 5l5pW, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
600, 5l5pI, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
601, 4hnpW, 0.8486, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
602, 5m2bW, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
603, 5l66W, 0.8485, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
604, 5l66I, 0.8485, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
605, 5l5zI, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
606, 5l5uW, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
607, 5fggW, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
608, 5fggI, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
609, 5l6cW, 0.8484, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
610, 5l6cI, 0.8484, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
611, 5l69W, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
612, 5l69I, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
613, 5l67W, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
614, 5l67I, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
615, 5l5uI, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
616, 5l5tW, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
617, 5l5tI, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
618, 5l5jW, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
619, 5l5jI, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
620, 5l5hW, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
621, 5l5hI, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
622, 5l5dI, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
623, 5l5bI, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
624, 4inuW, 0.8484, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
625, 5l5wW, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
626, 5l5wI, 0.8483, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
627, 5l5rI, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
628, 5l5dW, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
629, 5l5bW, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
630, 5fgfW, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
631, 5fgfI, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
632, 5fgeW, 0.8483, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
633, 5fgeI, 0.8483, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
634, 5ahjW, 0.8483, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
635, 5l68W, 0.8482, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
636, 5l68I, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
637, 5l65W, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
638, 5l65I, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
639, 5l5vW, 0.8482, 1.70, 0.229, 204, 201,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
640, 5l5vI, 0.8482, 1.70, 0.229, 204, 201,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
641, 5l5rW, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
642, 5l5qW, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
643, 5l5qI, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
644, 5fgdW, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
645, 5fgdI, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
646, 5ahjI, 0.8482, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
647, 4qvnW, 0.8482, 1.68, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
648, 4qvnI, 0.8482, 1.69, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
649, 4inuI, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
650, 5lttW, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
651, 5l5sW, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
652, 5l5sI, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
653, 5l5fW, 0.8481, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
654, 5l5fI, 0.8481, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
655, 5cggW, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
656, 5cggI, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
657, 5lttI, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
658, 5l6bW, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
659, 5l6bI, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
660, 5jhrW, 0.8480, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
661, 5jhrI, 0.8480, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
662, 4inrW, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
663, 4inrI, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
664, 5l5eI, 0.8479, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
665, 4y8gW, 0.8479, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
666, 4y8gI, 0.8479, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
667, 4hrdW, 0.8479, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
668, 4hnpI, 0.8479, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
669, 3tddW, 0.8479, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
670, 3tddI, 0.8479, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
671, 5l5iW, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
672, 5l5iI, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
673, 5l5eW, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
674, 5d0vW, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
675, 5cz9W, 0.8478, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
676, 5cz9I, 0.8478, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
677, 5bxnW, 0.8478, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
678, 5bxnI, 0.8478, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
679, 4qwfW, 0.8478, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
680, 4qwfI, 0.8478, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
681, 4qw6W, 0.8478, 1.68, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
682, 4jsqW, 0.8478, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
683, 4jsqI, 0.8478, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
684, 4intW, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
685, 2f16W, 0.8478, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
686, 2f16I, 0.8478, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
687, 5l55W, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
688, 5l55I, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
689, 5jhsW, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
690, 5jhsI, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
691, 5fhsW, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
692, 5fhsI, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
693, 5dkjW, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
694, 5d0zW, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
695, 5d0zI, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
696, 5d0vI, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
697, 5bouI, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
698, 4ya4I, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT
699, 4qw7W, 0.8477, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
700, 4qw7I, 0.8477, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
701, 4qw6I, 0.8477, 1.68, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
702, 4j70W, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
703, 4intI, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
704, 3mg0W, 0.8477, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
705, 3mg0I, 0.8477, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
706, 3hyeW, 0.8477, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
707, 3hyeI, 0.8477, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
708, 1g65W, 0.8477, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
709, 5dkjI, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
710, 5d0sW, 0.8476, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
711, 5d0sI, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
712, 5cghW, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
713, 5cghI, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
714, 5bouW, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
715, 4ya4W, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT
716, 4ya2W, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
717, 4ya2I, 0.8476, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
718, 4y8tW, 0.8476, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
719, 4y8tI, 0.8476, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
720, 4y8hW, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
721, 4y8hI, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
722, 4qzzW, 0.8476, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH OMURALIDE
723, 4qzzI, 0.8476, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH OMURALIDE
724, 4j70I, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
725, 5l5aW, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
726, 5l5aI, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
727, 5czaW, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT
728, 5czaI, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT
729, 4ya9W, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
730, 4ya9I, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
731, 4ya1W, 0.8475, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT
732, 4ya1I, 0.8475, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT
733, 4r02W, 0.8475, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
734, 4qvpW, 0.8475, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
735, 4qvpI, 0.8475, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
736, 4jt0W, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
737, 4jt0I, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
738, 4hrcI, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
739, 3gptW, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
740, 3gptI, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
741, 3gpjW, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
742, 3gpjI, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
743, 1jd2P, 0.8475, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
744, 1jd2I, 0.8475, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
745, 1g65I, 0.8475, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
746, 5l52W, 0.8474, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
747, 5l52I, 0.8474, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
748, 5fgiI, 0.8474, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
749, 5d0wW, 0.8474, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT
750, 5d0wI, 0.8474, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT
751, 5cz6W, 0.8474, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
752, 5bxlW, 0.8474, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT
753, 4y8kW, 0.8474, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
754, 4y8kI, 0.8474, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
755, 4r17W, 0.8474, 1.69, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
756, 4r17I, 0.8474, 1.69, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
757, 4qz0W, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
758, 4qvyW, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
759, 4qvyI, 0.8474, 1.69, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
760, 4qvqW, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
761, 4qvqI, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
762, 4qvlW, 0.8474, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH BORTEZOMIB
763, 4qvlI, 0.8474, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH BORTEZOMIB
764, 4qv5W, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT
765, 4qv5I, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT
766, 4qlqW, 0.8474, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
767, 4qlqI, 0.8474, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
768, 3gpwW, 0.8474, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
769, 2fakW, 0.8474, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
770, 5fgiW, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
771, 5cz7W, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
772, 5cz7I, 0.8473, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
773, 5cz6I, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
774, 4y8mW, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
775, 4y8mI, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
776, 4y75W, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
777, 4y75I, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
778, 4y6aW, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
779, 4y6aI, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
780, 4r18I, 0.8473, 1.70, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
781, 4qz7W, 0.8473, 1.70, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
782, 4qz7I, 0.8473, 1.71, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
783, 4qz0I, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
784, 4qwlW, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
785, 4qwlI, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
786, 4qw5W, 0.8473, 1.70, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
787, 4qw5I, 0.8473, 1.70, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
788, 4jsuW, 0.8473, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
789, 4jsuI, 0.8473, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
790, 3un8W, 0.8473, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
791, 3un4W, 0.8473, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
792, 3gpwI, 0.8473, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
793, 2fakI, 0.8473, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
794, 5laiW, 0.8472, 1.70, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
795, 5laiI, 0.8472, 1.70, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
796, 5fgaI, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
797, 5d0tW, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
798, 5d0tI, 0.8472, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
799, 5bxlI, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT
800, 4y8sW, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
801, 4y8sI, 0.8472, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
802, 4y84W, 0.8472, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
803, 4y84I, 0.8472, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
804, 4r18W, 0.8472, 1.69, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
805, 4qwrW, 0.8472, 1.69, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
806, 4qv6W, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-A49V MUTANT
807, 4qv6I, 0.8472, 1.69, 0.229, 204, 201, YCP BETA5-A49V MUTANT
808, 4qv4W, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45T MUTANT
809, 4qv4I, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45T MUTANT
810, 4qv1W, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45A MUTANT
811, 4qv1I, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45A MUTANT
812, 4no8W, 0.8472, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
813, 4nnwW, 0.8472, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
814, 4nnwI, 0.8472, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
815, 4hrdI, 0.8472, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
816, 3un8I, 0.8472, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
817, 3un4I, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
818, 3mg4W, 0.8472, 1.72, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
819, 3d29I, 0.8472, 1.70, 0.229, 204, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
820, 5fgaW, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
821, 5fg7W, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T1A MUTANT
822, 5fg7I, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T1A MUTANT
823, 5cgiW, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
824, 5cgiI, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
825, 4ya7W, 0.8471, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
826, 4ya7I, 0.8471, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
827, 4y8pW, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
828, 4y8pI, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
829, 4y77W, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
830, 4y74W, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
831, 4qz6W, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
832, 4qz6I, 0.8471, 1.69, 0.229, 204, 201, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
833, 4qz4W, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
834, 4qz4I, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
835, 4qwxW, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
836, 4qwxI, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
837, 4qwuW, 0.8471, 1.69, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
838, 4qwuI, 0.8471, 1.69, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
839, 4qwrI, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
840, 4qw1W, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
841, 4qw1I, 0.8471, 1.69, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
842, 4qw0W, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
843, 4qvwW, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
844, 4qvwI, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
845, 4qv7W, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A50V MUTANT
846, 4qv7I, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A50V MUTANT
847, 4quyI, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-A49S-MUTANT
848, 4no8I, 0.8471, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
849, 4no1W, 0.8471, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
850, 4no1I, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
851, 4nnnW, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH MG132
852, 4nnnI, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH MG132
853, 3d29W, 0.8471, 1.70, 0.229, 204, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
854, 3bdmW, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
855, 3bdmI, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
856, 5fg9W, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
857, 5fg9I, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
858, 5cgfW, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT
859, 5cgfI, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT
860, 4y8rW, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT
861, 4y8rI, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT
862, 4y77I, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
863, 4y74I, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
864, 4y6vW, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
865, 4y6vI, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
866, 4qw4W, 0.8470, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH CARFILZOMIB
867, 4qw4I, 0.8470, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH CARFILZOMIB
868, 4qw0I, 0.8470, 1.69, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
869, 4qv9W, 0.8470, 1.69, 0.229, 204, 201, YCP BETA5-C63F MUTANT
870, 4qv9I, 0.8470, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT
871, 4qv3W, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-M45V MUTANT
872, 4qv3I, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-M45V MUTANT
873, 4quyW, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-A49S-MUTANT
874, 4quxW, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-A49T-MUTANT
875, 4quxI, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-A49T-MUTANT
876, 4lqiW, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
877, 4lqiI, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
878, 4fzgW, 0.8470, 1.71, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
879, 4fzgI, 0.8470, 1.71, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
880, 4eu2X, 0.8470, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
881, 3mg7I, 0.8470, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
882, 3mg4I, 0.8470, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
883, 1rypJ, 0.8470, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
884, 6gopW, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
885, 6gopI, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
886, 5fghW, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
887, 5fghI, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
888, 5cz5W, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
889, 5cz5I, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
890, 4z1lW, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
891, 4z1lI, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
892, 4y9yW, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT
893, 4y9yI, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT
894, 4y8uW, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
895, 4y8nW, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
896, 4y8nI, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
897, 4y7xW, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
898, 4y7xI, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
899, 4rurW, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
900, 4rurI, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
901, 4r00W, 0.8469, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
902, 4r00I, 0.8469, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
903, 4qv8W, 0.8469, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT
904, 4qv8I, 0.8469, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT
905, 4qv0W, 0.8469, 1.71, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT
906, 4qv0I, 0.8469, 1.71, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT
907, 4q1sW, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
908, 3nzjW, 0.8469, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
909, 3nzjI, 0.8469, 1.73, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
910, 3mg7W, 0.8469, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
911, 3e47W, 0.8469, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
912, 3e47I, 0.8469, 1.73, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
913, 3dy4W, 0.8469, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
914, 3dy4I, 0.8469, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
915, 2gplW, 0.8469, 1.71, 0.229, 204, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
916, 2gplI, 0.8469, 1.71, 0.229, 204, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
917, 1rypX, 0.8469, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
918, 5lajW, 0.8468, 1.70, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
919, 5lajI, 0.8468, 1.70, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
920, 4y8uI, 0.8468, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
921, 4y6zW, 0.8468, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
922, 4y6zI, 0.8468, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
923, 4qzwW, 0.8468, 1.69, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
924, 4qzwI, 0.8468, 1.69, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
925, 4qz3W, 0.8468, 1.70, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
926, 4qz3I, 0.8468, 1.70, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
927, 4ltcW, 0.8468, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
928, 4y9zW, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
929, 4y9zI, 0.8467, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
930, 4y82W, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
931, 4y69W, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
932, 4y69I, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
933, 4qwsW, 0.8467, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
934, 4qwgW, 0.8467, 1.70, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
935, 4qvmW, 0.8467, 1.69, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
936, 4qvmI, 0.8467, 1.69, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
937, 4qlsW, 0.8467, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
938, 4qlsI, 0.8467, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
939, 4eu2J, 0.8467, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
940, 2zcyI, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
941, 1g0uW, 0.8467, 1.72, 0.229, 204, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
942, 5dkiW, 0.8466, 1.73, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
943, 5dkiI, 0.8466, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
944, 5cz8W, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
945, 5cz8I, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
946, 4ya5W, 0.8466, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
947, 4ya5I, 0.8466, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
948, 4y8lI, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
949, 4y82I, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
950, 4qz2W, 0.8466, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
951, 4qz2I, 0.8466, 1.70, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
952, 4qwsI, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
953, 4qwkW, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
954, 4qwkI, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
955, 4qwgI, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
956, 4ltcI, 0.8466, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
957, 4hrcW, 0.8466, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
958, 4fzcW, 0.8466, 1.73, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
959, 4fzcI, 0.8466, 1.72, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
960, 3okjW, 0.8466, 1.72, 0.229, 204, 201, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
961, 3okjI, 0.8466, 1.72, 0.229, 204, 201, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
962, 3mg8W, 0.8466, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
963, 2zcyW, 0.8466, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
964, 5d0xW, 0.8465, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
965, 5d0xI, 0.8465, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
966, 4y8lW, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
967, 4y70W, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
968, 4y70I, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
969, 4qz5W, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
970, 4qz5I, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
971, 4qwiW, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
972, 4qwiI, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
973, 4qluW, 0.8465, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
974, 4qluI, 0.8465, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
975, 4no9W, 0.8465, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
976, 4no9I, 0.8465, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
977, 3oevW, 0.8465, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
978, 3nzwW, 0.8465, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
979, 3mg6I, 0.8465, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
980, 5l54W, 0.8464, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
981, 4y8jW, 0.8464, 1.73, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
982, 4y8jI, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
983, 4y80W, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
984, 4y80I, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
985, 4y7wW, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
986, 4qzxW, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
987, 4qzxI, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
988, 4qz1W, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
989, 4qz1I, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
990, 3sdiW, 0.8464, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
991, 3oevI, 0.8464, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
992, 3oeuW, 0.8464, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
993, 3nzxW, 0.8464, 1.73, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
994, 3nzxI, 0.8464, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
995, 3nzwI, 0.8464, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
996, 1g0uI, 0.8464, 1.71, 0.229, 204, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
997, 5l54I, 0.8463, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
998, 4y8qI, 0.8463, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
999, 4y7wI, 0.8463, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1000, 3sdkI, 0.8463, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1001, 3sdiI, 0.8463, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1002, 3mg8I, 0.8463, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1003, 3mg6W, 0.8463, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1004, 3dy3W, 0.8463, 1.73, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1005, 3dy3I, 0.8463, 1.73, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1006, 4y8qW, 0.8462, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1007, 4r02I, 0.8462, 1.72, 0.229, 204, 201, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1008, 4no6W, 0.8462, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1009, 4no6I, 0.8462, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1010, 4y81W, 0.8461, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1011, 4y81I, 0.8461, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1012, 4y7yW, 0.8461, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1013, 4y7yI, 0.8461, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1014, 4qw3W, 0.8461, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1015, 4qw3I, 0.8461, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1016, 4qltW, 0.8461, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1017, 4qltI, 0.8461, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1018, 4gk7W, 0.8461, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1019, 4gk7I, 0.8461, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1020, 3oeuI, 0.8461, 1.72, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1021, 1z7qX, 0.8461, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1022, 5cz4W, 0.8460, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1023, 5cz4I, 0.8460, 1.77, 0.234, 204, 201, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1024, 4ya3W, 0.8460, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1025, 4y8iW, 0.8460, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1026, 4y8iI, 0.8460, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1027, 4x6zJ, 0.8460, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1028, 4qxjW, 0.8460, 1.70, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1029, 4qxjI, 0.8460, 1.72, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1030, 4qvvW, 0.8460, 1.70, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1031, 4qvvI, 0.8460, 1.70, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1032, 4qbyW, 0.8460, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1033, 4qbyI, 0.8460, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1034, 4q1sI, 0.8460, 1.73, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1035, 3shjW, 0.8460, 1.73, 0.229, 204, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1036, 3shjI, 0.8460, 1.72, 0.229, 204, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1037, 3sdkW, 0.8460, 1.72, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1038, 1z7qJ, 0.8460, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1039, 4zzgJ, 0.8459, 1.73, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1040, 4ya3I, 0.8459, 1.77, 0.234, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1041, 4y8oW, 0.8459, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1042, 4y8oI, 0.8459, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1043, 4y78W, 0.8459, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1044, 4y78I, 0.8459, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1045, 5nifJ, 0.8458, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1046, 4qwjW, 0.8458, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1047, 4qlvW, 0.8458, 1.74, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1048, 4qlvI, 0.8458, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1049, 3wxrX, 0.8458, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1050, 3jcpSA, 0.8458, 1.71, 0.229, 204, 201, 
1051, 3jcpE, 0.8458, 1.75, 0.229, 204, 201, 
1052, 4qwjI, 0.8457, 1.73, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1053, 5nifX, 0.8455, 1.73, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1054, 4ya0W, 0.8454, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1055, 4ya0I, 0.8454, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1056, 3wxrJ, 0.8454, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1057, 4zzgX, 0.8453, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1058, 4x6zX, 0.8453, 1.76, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1059, 6avoU, 0.8452, 1.74, 0.229, 204, 201, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1060, 5mp9j, 0.8451, 1.76, 0.229, 204, 201, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1061, 4r67z, 0.8450, 1.87, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1062, 6avoY, 0.8449, 1.74, 0.229, 204, 201, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1063, 4r67X, 0.8449, 1.89, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1064, 4r67l, 0.8449, 1.88, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1065, 4r67J, 0.8449, 1.89, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1066, 5lf7W, 0.8448, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1067, 3unbI, 0.8448, 1.89, 0.223, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1068, 4v7oJ, 0.8447, 1.90, 0.223, 204, 202, 
1069, 5lf6I, 0.8446, 1.91, 0.218, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1070, 5lezI, 0.8446, 1.92, 0.233, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1071, 5le5W, 0.8446, 1.89, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1072, 4v7oX, 0.8446, 1.89, 0.223, 204, 202, 
1073, 3unbk, 0.8446, 1.90, 0.223, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1074, 5lf6W, 0.8445, 1.76, 0.229, 204, 201, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1075, 4v7oFB, 0.8445, 1.91, 0.218, 204, 202, 
1076, 5lf7I, 0.8444, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1077, 5lezW, 0.8444, 1.78, 0.229, 204, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1078, 5leyI, 0.8444, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1079, 4v7oRA, 0.8444, 1.90, 0.223, 204, 202, 
1080, 4g4sJ, 0.8444, 1.90, 0.223, 204, 202, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1081, 5lf1W, 0.8443, 1.78, 0.229, 204, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1082, 5lf1I, 0.8443, 1.77, 0.234, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1083, 5leyW, 0.8443, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1084, 5le5I, 0.8443, 1.89, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1085, 5lf3W, 0.8442, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1086, 5lexW, 0.8442, 1.90, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1087, 5lf3I, 0.8441, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1088, 5lf0W, 0.8441, 1.91, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1089, 5lf0I, 0.8440, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1090, 5lf4I, 0.8439, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1091, 5lexI, 0.8439, 1.90, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1092, 1iruX, 0.8439, 1.90, 0.223, 204, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1093, 1iruJ, 0.8439, 1.91, 0.223, 204, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1094, 5mp93, 0.8438, 1.90, 0.223, 204, 202, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1095, 4r3oX, 0.8438, 1.90, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME
1096, 4r3oJ, 0.8438, 1.81, 0.229, 204, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
1097, 5lf4W, 0.8437, 1.91, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1098, 3uneW, 0.8436, 1.91, 0.223, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
1099, 5t0gP, 0.8435, 1.90, 0.223, 204, 202, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1100, 3uneI, 0.8435, 1.93, 0.218, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
1101, 1fntJ, 0.8435, 1.77, 0.224, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1102, 1fntX, 0.8434, 1.92, 0.218, 204, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1103, 5gjqc, 0.8430, 1.79, 0.229, 204, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1104, 5vfoP, 0.8429, 1.79, 0.229, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1105, 3uney, 0.8429, 1.93, 0.223, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
1106, 5vfsIA, 0.8427, 1.77, 0.224, 204, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1107, 5gjrPA, 0.8427, 1.93, 0.218, 204, 202, 
1108, 5gjrBA, 0.8427, 1.92, 0.223, 204, 202, 
1109, 3unek, 0.8427, 1.77, 0.224, 204, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
1110, 5vfpJ, 0.8423, 1.77, 0.224, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1111, 5vfqJ, 0.8422, 1.78, 0.219, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1112, 5t0cHB, 0.8422, 1.78, 0.224, 204, 201, 
1113, 5t0cBA, 0.8422, 1.78, 0.207, 201, 193, 
1114, 3unfI, 0.8421, 1.78, 0.224, 204, 201, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1115, 5vfqIA, 0.8420, 1.99, 0.230, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1116, 3unhW, 0.8420, 1.77, 0.224, 204, 201, MOUSE 20S IMMUNOPROTEASOME
1117, 3unhI, 0.8420, 1.77, 0.224, 204, 201, MOUSE 20S IMMUNOPROTEASOME
1118, 3unfW, 0.8420, 1.94, 0.218, 204, 202, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1119, 3unbW, 0.8420, 1.80, 0.224, 204, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1120, 5vfuOA, 0.8419, 1.94, 0.218, 204, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1121, 5vftp, 0.8419, 1.94, 0.218, 204, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1122, 3jcoSA, 0.8418, 1.94, 0.218, 204, 202, 
1123, 3jcoE, 0.8418, 1.80, 0.219, 204, 201, 
1124, 5vfop, 0.8417, 1.93, 0.223, 204, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1125, 5vfsJ, 0.8416, 1.93, 0.223, 204, 202, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1126, 5vfpHA, 0.8415, 1.76, 0.229, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1127, 5vfrP, 0.8414, 1.76, 0.229, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1128, 3unby, 0.8411, 1.80, 0.224, 204, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1129, 5mpcX, 0.8410, 1.78, 0.224, 204, 201, 
1130, 5l4gJ, 0.8409, 1.99, 0.230, 199, 196, 
1131, 5mpaj, 0.8408, 1.79, 0.224, 204, 201, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1132, 5l4gX, 0.8408, 1.79, 0.224, 204, 201, 
1133, 5mpa3, 0.8407, 1.79, 0.219, 204, 201, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1134, 5vfrp, 0.8405, 1.77, 0.229, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1135, 5gjqq, 0.8404, 1.92, 0.223, 204, 202, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1136, 5vfuAA, 0.8394, 1.80, 0.234, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1137, 5vftP, 0.8394, 1.78, 0.224, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1138, 5m32W, 0.8392, 1.83, 0.229, 204, 201, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1139, 5m32I, 0.8392, 1.82, 0.224, 204, 201, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1140, 5mpcJ, 0.8386, 1.81, 0.224, 204, 201, 
1141, 5vfsMA, 0.8363, 1.84, 0.224, 204, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1142, 5vfuEA, 0.8362, 1.84, 0.224, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1143, 5vftT, 0.8362, 1.95, 0.223, 204, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1144, 5vfsN, 0.8361, 1.95, 0.223, 204, 202, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1145, 5t0iP, 0.8361, 1.85, 0.229, 204, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1146, 5vfoT, 0.8360, 2.13, 0.201, 215, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1147, 5l4gK, 0.8358, 2.12, 0.206, 215, 204, 
1148, 5vfot, 0.8356, 2.12, 0.206, 215, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1149, 6epd6, 0.8355, 2.13, 0.201, 215, 204, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
1150, 5l4gY, 0.8354, 1.87, 0.224, 204, 201, 
1151, 4cr23, 0.8351, 2.12, 0.201, 215, 204, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1152, 6avoW, 0.8348, 2.11, 0.201, 217, 204, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1153, 6avoa, 0.8348, 2.13, 0.201, 215, 204, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1154, 5vfpLA, 0.8345, 2.34, 0.038, 213, 210, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1155, 5gjqu, 0.8345, 2.14, 0.201, 217, 204, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1156, 5wvkC, 0.8344, 1.85, 0.229, 204, 201, 
1157, 5vfuSA, 0.8343, 2.14, 0.201, 216, 204, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1158, 5vftt, 0.8343, 2.14, 0.201, 216, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1159, 5gjqg, 0.8341, 2.14, 0.201, 215, 204, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1160, 5m32M, 0.8340, 2.16, 0.201, 217, 204, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1161, 5vfpN, 0.8339, 1.82, 0.229, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1162, 5vfrT, 0.8337, 2.15, 0.206, 215, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1163, 5m32a, 0.8337, 2.15, 0.206, 215, 204, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1164, 5vfqN, 0.8336, 2.16, 0.206, 216, 204, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1165, 5vfqMA, 0.8336, 2.12, 0.196, 216, 204, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1166, 5gjrTA, 0.8335, 2.15, 0.201, 215, 204, 
1167, 4r67p, 0.8335, 2.15, 0.201, 215, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1168, 4r67N, 0.8335, 2.12, 0.196, 216, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1169, 4r67b, 0.8335, 2.16, 0.201, 215, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1170, 4r672, 0.8335, 2.15, 0.201, 215, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1171, 5t0hP, 0.8334, 2.17, 0.201, 217, 204, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1172, 5gjrFA, 0.8334, 2.15, 0.201, 217, 204, 
1173, 5mpbJ, 0.8333, 2.15, 0.201, 217, 204, 
1174, 5vfrt, 0.8331, 2.15, 0.201, 217, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1175, 4r3oN, 0.8331, 2.15, 0.201, 217, 204, HUMAN CONSTITUTIVE 20S PROTEASOME
1176, 4r3o2, 0.8331, 2.00, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME
1177, 5wvkJ, 0.8329, 2.17, 0.201, 216, 204, 
1178, 5lf3a, 0.8328, 1.89, 0.229, 204, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1179, 5lf1a, 0.8328, 2.16, 0.201, 215, 204, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1180, 5lf4a, 0.8327, 2.16, 0.206, 217, 204, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1181, 5lf0a, 0.8327, 2.16, 0.206, 217, 204, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1182, 5le5a, 0.8327, 1.84, 0.229, 204, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1183, 4cr43, 0.8327, 2.18, 0.206, 216, 204, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1184, 6epe6, 0.8324, 2.17, 0.206, 216, 204, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
1185, 5lf0M, 0.8324, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1186, 5leya, 0.8324, 2.17, 0.201, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1187, 5lf1M, 0.8323, 2.17, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1188, 5lexa, 0.8323, 1.85, 0.224, 204, 201, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1189, 3unea, 0.8323, 2.44, 0.048, 213, 210, MOUSE CONSTITUTIVE 20S PROTEASOME
1190, 5lf7a, 0.8322, 2.18, 0.201, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1191, 5lf6a, 0.8322, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1192, 5lf6M, 0.8321, 2.18, 0.201, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1193, 5lf4M, 0.8321, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1194, 5lf3M, 0.8321, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1195, 5leza, 0.8320, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1196, 5leyM, 0.8320, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1197, 5lf7M, 0.8319, 2.18, 0.201, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1198, 5le5M, 0.8318, 2.18, 0.206, 216, 204, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1199, 5lexM, 0.8317, 2.18, 0.206, 216, 204, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1200, 5lezM, 0.8315, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1201, 3une3, 0.8315, 2.18, 0.201, 216, 204, MOUSE CONSTITUTIVE 20S PROTEASOME
1202, 5mpbX, 0.8312, 2.18, 0.201, 216, 204, 
1203, 1iruN, 0.8312, 2.18, 0.206, 216, 204, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1204, 1iru2, 0.8312, 2.18, 0.206, 216, 204, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1205, 3uneo, 0.8311, 2.18, 0.206, 216, 204, MOUSE CONSTITUTIVE 20S PROTEASOME
1206, 3uneM, 0.8311, 2.19, 0.206, 216, 204, MOUSE CONSTITUTIVE 20S PROTEASOME
1207, 3unb3, 0.8310, 1.93, 0.229, 204, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1208, 3unbM, 0.8307, 2.20, 0.201, 217, 204, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1209, 3unbo, 0.8306, 2.20, 0.201, 217, 204, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1210, 3unba, 0.8305, 2.19, 0.206, 216, 204, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1211, 3unhM, 0.8304, 2.19, 0.206, 216, 204, MOUSE 20S IMMUNOPROTEASOME
1212, 3unha, 0.8303, 2.19, 0.206, 216, 204, MOUSE 20S IMMUNOPROTEASOME
1213, 4g4sN, 0.8302, 2.20, 0.206, 216, 204, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1214, 3unfM, 0.8301, 2.20, 0.206, 216, 204, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1215, 3unfa, 0.8301, 2.20, 0.211, 216, 204, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1216, 5mpa7, 0.8300, 2.19, 0.206, 216, 204, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1217, 5mp9n, 0.8297, 2.19, 0.206, 216, 204, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1218, 5fgiH, 0.8296, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1219, 5cz5b, 0.8295, 2.19, 0.206, 216, 204, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1220, 5fgiV, 0.8294, 2.19, 0.206, 216, 204, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1221, 3gpj1, 0.8294, 2.17, 0.161, 229, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1222, 4q1sM, 0.8293, 2.19, 0.161, 232, 205, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1223, 3mg71, 0.8293, 2.07, 0.188, 234, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1224, 5l5rM, 0.8292, 2.04, 0.225, 206, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1225, 5l5ra, 0.8292, 2.07, 0.188, 234, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1226, 4intM, 0.8292, 2.45, 0.155, 233, 207, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1227, 3mg41, 0.8292, 2.44, 0.155, 233, 207, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1228, 3gpjM, 0.8292, 2.32, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1229, 5t0cLB, 0.8291, 2.32, 0.155, 233, 206, 
1230, 5t0cFA, 0.8291, 2.32, 0.155, 233, 206, 
1231, 5l6aM, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1232, 5l6aa, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1233, 5l5uM, 0.8291, 2.45, 0.150, 233, 207, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1234, 5l5ua, 0.8291, 2.20, 0.201, 215, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1235, 5l5qM, 0.8291, 2.20, 0.201, 215, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1236, 5l5qa, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1237, 5l5bM, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1238, 5l5ba, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1239, 5bxna, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1240, 4qvnM, 0.8291, 2.44, 0.155, 233, 207, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1241, 4q1sa, 0.8290, 2.44, 0.155, 233, 207, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1242, 4lqiM, 0.8290, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1243, 4lqia, 0.8290, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1244, 5laiM, 0.8289, 2.32, 0.155, 233, 206, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1245, 5laia, 0.8289, 2.32, 0.155, 233, 206, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1246, 5l5pa, 0.8289, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1247, 5fg7M, 0.8289, 2.45, 0.155, 233, 207, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1248, 4inta, 0.8289, 2.45, 0.155, 233, 207, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1249, 3sdkM, 0.8289, 2.44, 0.155, 233, 207, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1250, 3nzwM, 0.8289, 2.44, 0.155, 233, 207, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1251, 3nzw1, 0.8289, 2.32, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1252, 3d29M, 0.8289, 2.16, 0.156, 233, 205, PROTEASOME INHIBITION BY FELLUTAMIDE B
1253, 3d291, 0.8289, 2.32, 0.155, 233, 206, PROTEASOME INHIBITION BY FELLUTAMIDE B
1254, 5l61M, 0.8288, 2.17, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1255, 5l61a, 0.8288, 2.46, 0.155, 233, 207, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1256, 5fg7a, 0.8288, 2.46, 0.155, 233, 207, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1257, 4r17M, 0.8288, 2.32, 0.155, 233, 206, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1258, 4r17a, 0.8288, 2.32, 0.155, 233, 206, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1259, 5lajM, 0.8287, 2.32, 0.155, 233, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1260, 5laja, 0.8287, 2.32, 0.155, 233, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1261, 5l5ja, 0.8287, 2.17, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1262, 3oevM, 0.8287, 2.32, 0.155, 233, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1263, 3mg7M, 0.8287, 2.32, 0.155, 233, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1264, 2zcy0, 0.8287, 2.32, 0.155, 228, 206, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1265, 5m2bM, 0.8286, 2.32, 0.155, 231, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1266, 5m2ba, 0.8286, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1267, 5cz5N, 0.8286, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1268, 4qv5a, 0.8286, 2.32, 0.155, 233, 206, YCP BETA5-M45I MUTANT
1269, 4inua, 0.8286, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1270, 2zcyM, 0.8286, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1271, 5l67a, 0.8285, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1272, 5l5hM, 0.8285, 2.05, 0.225, 206, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1273, 5l5ha, 0.8285, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1274, 5fgib, 0.8285, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1275, 4qv5M, 0.8285, 2.33, 0.155, 233, 206, YCP BETA5-M45I MUTANT
1276, 4qv4a, 0.8285, 2.32, 0.155, 233, 206, YCP BETA5-M45T MUTANT
1277, 3bdmM, 0.8285, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1278, 3bdm0, 0.8285, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1279, 5mpan, 0.8284, 1.90, 0.226, 213, 199, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1280, 5l66M, 0.8284, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1281, 5l66a, 0.8284, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1282, 5fgiN, 0.8284, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1283, 4qwuM, 0.8284, 2.32, 0.155, 233, 206, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1284, 4qwua, 0.8284, 2.18, 0.161, 232, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1285, 4qltM, 0.8284, 2.32, 0.155, 233, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1286, 4qlta, 0.8284, 2.32, 0.155, 233, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1287, 3oev1, 0.8284, 1.90, 0.226, 213, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1288, 5l5vM, 0.8283, 2.33, 0.155, 233, 206,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1289, 5l5va, 0.8283, 2.33, 0.155, 233, 206,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1290, 5l54a, 0.8283, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1291, 5bxnM, 0.8283, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1292, 4ya4a, 0.8283, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1293, 4r18M, 0.8283, 2.32, 0.155, 233, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1294, 4r18a, 0.8283, 2.32, 0.155, 233, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1295, 4qvna, 0.8283, 2.33, 0.155, 233, 206, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1296, 4inuM, 0.8283, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1297, 5l5dM, 0.8282, 2.19, 0.156, 232, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1298, 5l5da, 0.8282, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1299, 5l54M, 0.8282, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1300, 5d0wM, 0.8282, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1301, 5d0wa, 0.8282, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1302, 4ya4M, 0.8282, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1303, 4qv9M, 0.8282, 2.20, 0.156, 233, 205, YCP BETA5-C63F MUTANT
1304, 4qv9a, 0.8282, 2.33, 0.155, 233, 206, YCP BETA5-C63F MUTANT
1305, 3oeuM, 0.8282, 2.19, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1306, 3nzjM, 0.8282, 2.19, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1307, 3nzj1, 0.8282, 2.19, 0.156, 229, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1308, 3dy31, 0.8282, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1309, 5l5pM, 0.8281, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1310, 5ahjM, 0.8281, 2.18, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1311, 5ahja, 0.8281, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1312, 4qlvM, 0.8281, 2.33, 0.155, 233, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1313, 4qlva, 0.8281, 2.33, 0.155, 233, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1314, 4qlsM, 0.8281, 2.19, 0.156, 233, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1315, 3sdk1, 0.8281, 2.19, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1316, 3sdi1, 0.8281, 2.19, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1317, 3mg4M, 0.8281, 2.33, 0.155, 233, 206, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1318, 3dy3M, 0.8281, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1319, 5l5tM, 0.8280, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1320, 5l5ta, 0.8280, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1321, 5l5oM, 0.8280, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1322, 5l5oa, 0.8280, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1323, 5bxlM, 0.8280, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1324, 5bxla, 0.8280, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1325, 4qv6M, 0.8280, 2.19, 0.156, 233, 205, YCP BETA5-A49V MUTANT
1326, 4qv6a, 0.8280, 2.19, 0.156, 233, 205, YCP BETA5-A49V MUTANT
1327, 4qluM, 0.8280, 2.19, 0.156, 233, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1328, 4qlua, 0.8280, 2.19, 0.156, 229, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1329, 4qlsa, 0.8280, 2.19, 0.156, 232, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1330, 3un8a, 0.8280, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1331, 2fakM, 0.8280, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1332, 2fak1, 0.8280, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1333, 5nif2, 0.8279, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1334, 5l69M, 0.8279, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1335, 5l69a, 0.8279, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1336, 5l63M, 0.8279, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1337, 5l63a, 0.8279, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1338, 4r02M, 0.8279, 2.46, 0.155, 233, 207, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1339, 4qv0M, 0.8279, 2.20, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1340, 4qv0a, 0.8279, 2.20, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1341, 4qbya, 0.8279, 2.19, 0.156, 233, 205, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1342, 4jsuM, 0.8279, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1343, 4jsua, 0.8279, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1344, 4inra, 0.8279, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1345, 4hnpM, 0.8279, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1346, 3mg8M, 0.8279, 2.33, 0.155, 233, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1347, 3e47M, 0.8279, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1348, 3e471, 0.8279, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1349, 1rypN, 0.8279, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1350, 5l6cM, 0.8278, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1351, 5l6ca, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1352, 5l6ba, 0.8278, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1353, 5l62M, 0.8278, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1354, 5l62a, 0.8278, 2.32, 0.150, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1355, 5l5yM, 0.8278, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1356, 5l5ya, 0.8278, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1357, 5l5sM, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1358, 5l5sa, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1359, 5l5jM, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1360, 5czaM, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1361, 5czaa, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1362, 4ya1M, 0.8278, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1363, 4ya1a, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1364, 4r02a, 0.8278, 2.19, 0.156, 233, 205, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1365, 4qvla, 0.8278, 2.20, 0.156, 229, 205, YCP IN COMPLEX WITH BORTEZOMIB
1366, 4quyM, 0.8278, 2.20, 0.156, 232, 205, YCP BETA5-A49S-MUTANT
1367, 4quya, 0.8278, 2.19, 0.156, 233, 205, YCP BETA5-A49S-MUTANT
1368, 4qbyM, 0.8278, 2.19, 0.156, 233, 205, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1369, 4fzgM, 0.8278, 2.19, 0.156, 233, 205, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1370, 4fzga, 0.8278, 2.20, 0.156, 233, 205, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1371, 3un4a, 0.8278, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1372, 3hyeM, 0.8278, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1373, 3hye1, 0.8278, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1374, 3gpwM, 0.8278, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1375, 3gpw1, 0.8278, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1376, 5l6bM, 0.8277, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1377, 5l67M, 0.8277, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1378, 5l64M, 0.8277, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1379, 5l64a, 0.8277, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1380, 5fggM, 0.8277, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1381, 5fgga, 0.8277, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1382, 4y8rM, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1383, 4y8ra, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1384, 4y8gM, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1385, 4y8ga, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1386, 4qvlM, 0.8277, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH BORTEZOMIB
1387, 4qv1M, 0.8277, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT
1388, 4qv1a, 0.8277, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT
1389, 3un4M, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1390, 3mg61, 0.8277, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1391, 5l68M, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1392, 5l60M, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1393, 5l60a, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1394, 5l5ia, 0.8276, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1395, 5fg9M, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1396, 5fg9a, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1397, 5cggM, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1398, 5cgga, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1399, 5bouM, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1400, 5boua, 0.8276, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1401, 4y9yM, 0.8276, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1402, 4y9ya, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1403, 4y8ma, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1404, 4qzzM, 0.8276, 2.20, 0.156, 229, 205, YCP IN COMPLEX WITH OMURALIDE
1405, 4qzza, 0.8276, 2.20, 0.156, 232, 205, YCP IN COMPLEX WITH OMURALIDE
1406, 4qv7M, 0.8276, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT
1407, 4qv7a, 0.8276, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT
1408, 4qv4M, 0.8276, 2.20, 0.156, 222, 205, YCP BETA5-M45T MUTANT
1409, 4quxM, 0.8276, 2.20, 0.156, 233, 205, YCP BETA5-A49T-MUTANT
1410, 4quxa, 0.8276, 2.20, 0.156, 233, 205, YCP BETA5-A49T-MUTANT
1411, 4inrM, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1412, 4eu22, 0.8276, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1413, 3mg6M, 0.8276, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1414, 3dy41, 0.8276, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1415, 1ryp2, 0.8276, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1416, 1jd2T, 0.8276, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1417, 1g0uM, 0.8276, 2.20, 0.156, 233, 205, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1418, 1g0u1, 0.8276, 2.18, 0.156, 233, 205, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1419, 5l68a, 0.8275, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1420, 5l5iM, 0.8275, 2.44, 0.150, 233, 207, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1421, 5fgaM, 0.8275, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1422, 5fgaa, 0.8275, 2.33, 0.150, 233, 206, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1423, 5cz6M, 0.8275, 2.33, 0.150, 233, 206, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1424, 5cz6a, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1425, 4y8tM, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1426, 4y8ta, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1427, 4y8mM, 0.8275, 2.20, 0.156, 232, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1428, 4y8hM, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1429, 4y8ha, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1430, 4qz7M, 0.8275, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1431, 4qv3M, 0.8275, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT
1432, 4qv3a, 0.8275, 2.20, 0.156, 222, 205, YCP BETA5-M45V MUTANT
1433, 4jsqM, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1434, 3sdiM, 0.8275, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1435, 2gpl1, 0.8275, 2.20, 0.156, 232, 205, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1436, 6gopa, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1437, 5l65M, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1438, 5l65a, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1439, 5l5wM, 0.8274, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1440, 5l5wa, 0.8274, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1441, 5l5aa, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1442, 5dkjM, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1443, 5dkja, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1444, 5dkiM, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1445, 5dkia, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1446, 5cgfM, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1447, 5cgfa, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1448, 4qz7a, 0.8274, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1449, 4qw1a, 0.8274, 2.33, 0.155, 233, 206, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1450, 4qv8M, 0.8274, 2.33, 0.155, 233, 206, YCP BETA5-C52F MUTANT
1451, 4qv8a, 0.8274, 2.20, 0.156, 233, 205, YCP BETA5-C52F MUTANT
1452, 4jt0M, 0.8274, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1453, 4jt0a, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1454, 4jsqa, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1455, 3dy4M, 0.8274, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1456, 2gplM, 0.8274, 2.20, 0.156, 233, 205, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1457, 2f161, 0.8274, 2.34, 0.150, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1458, 6gopM, 0.8273, 2.34, 0.150, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1459, 5l5zM, 0.8273, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1460, 5l5za, 0.8273, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1461, 5l5fa, 0.8273, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1462, 5l5aM, 0.8273, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1463, 4y6va, 0.8273, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1464, 4qwfM, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1465, 4qwfa, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1466, 4qw6M, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1467, 4qw6a, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1468, 4qw1M, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1469, 4qvyM, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1470, 4qvya, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1471, 4qvqM, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1472, 4qvqa, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1473, 4j70a, 0.8273, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1474, 4hrca, 0.8273, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1475, 3wxrN, 0.8273, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1476, 3shjM, 0.8273, 2.20, 0.156, 233, 205, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1477, 3shj1, 0.8273, 2.20, 0.156, 233, 205, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1478, 3nzxM, 0.8273, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1479, 3nzx1, 0.8273, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1480, 3gpt1, 0.8273, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1481, 2f16M, 0.8273, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1482, 5lttM, 0.8272, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1483, 5ltta, 0.8272, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1484, 5l5fM, 0.8272, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1485, 5l55M, 0.8272, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1486, 5l55a, 0.8272, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1487, 5jhsa, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1488, 5d0sM, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1489, 5d0sa, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1490, 5cghM, 0.8272, 2.20, 0.156, 228, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1491, 5cgha, 0.8272, 2.20, 0.156, 229, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1492, 4y84M, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1493, 4y84a, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1494, 4y6vM, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1495, 4y6aM, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1496, 4y6aa, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1497, 4qvwM, 0.8272, 2.20, 0.156, 233, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1498, 4qvwa, 0.8272, 2.20, 0.156, 233, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1499, 4qvpM, 0.8272, 2.20, 0.156, 233, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1500, 4qvpa, 0.8272, 2.20, 0.156, 233, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1501, 4qlqM, 0.8272, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1502, 4qlqa, 0.8272, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1503, 4j70M, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1504, 4fzcM, 0.8272, 2.20, 0.156, 233, 205, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1505, 4fzca, 0.8272, 2.20, 0.156, 233, 205, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1506, 4eu2N, 0.8272, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1507, 3tdd1, 0.8272, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1508, 3okjM, 0.8272, 2.20, 0.156, 233, 205, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1509, 3gptM, 0.8272, 2.35, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1510, 1rypH, 0.8272, 2.35, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1511, 5l5xM, 0.8271, 2.35, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1512, 5l5xa, 0.8271, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1513, 5jhsM, 0.8271, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1514, 5cz9M, 0.8271, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1515, 5cz9a, 0.8271, 2.02, 0.225, 205, 200, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1516, 5cz7M, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1517, 5cz7a, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1518, 4z1la, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1519, 4rurM, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1520, 4rura, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1521, 4qz0M, 0.8271, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1522, 4qz0a, 0.8271, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1523, 4qwlM, 0.8271, 2.20, 0.156, 232, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1524, 4qwla, 0.8271, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1525, 4ltca, 0.8271, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1526, 4hrda, 0.8271, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1527, 3tddM, 0.8271, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1528, 3mg81, 0.8271, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1529, 1jd2M, 0.8271, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1530, 5jhrM, 0.8270, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1531, 5jhra, 0.8270, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1532, 5fghM, 0.8270, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1533, 5fgha, 0.8270, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1534, 5d0tM, 0.8270, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1535, 5d0ta, 0.8270, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1536, 5a5b3, 0.8270, 2.21, 0.156, 233, 205, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
1537, 4zzg2, 0.8270, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1538, 4z1lM, 0.8270, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1539, 4y8pM, 0.8270, 2.20, 0.156, 231, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1540, 4y8pa, 0.8270, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1541, 4y8nM, 0.8270, 1.95, 0.224, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1542, 4y8na, 0.8270, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1543, 4y75M, 0.8270, 2.20, 0.156, 229, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1544, 4y75a, 0.8270, 2.20, 0.156, 224, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1545, 4y69M, 0.8270, 2.20, 0.156, 224, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1546, 4y69a, 0.8270, 2.20, 0.156, 224, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1547, 4x6z2, 0.8270, 2.20, 0.156, 223, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1548, 4qw7a, 0.8270, 2.21, 0.156, 224, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1549, 4cr33, 0.8270, 2.21, 0.156, 224, 205, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1550, 3un8M, 0.8270, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1551, 3oeu1, 0.8270, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1552, 5mp97, 0.8269, 2.35, 0.155, 233, 206, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1553, 5l5ea, 0.8269, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1554, 5fgiM, 0.8269, 1.95, 0.224, 204, 201, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1555, 5d0zM, 0.8269, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1556, 5d0za, 0.8269, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1557, 4y8uM, 0.8269, 2.21, 0.151, 229, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1558, 4y8ua, 0.8269, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1559, 4r00M, 0.8269, 2.08, 0.157, 232, 204, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1560, 4r00a, 0.8269, 2.20, 0.156, 233, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1561, 4qw7M, 0.8269, 2.20, 0.156, 233, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1562, 4qvmM, 0.8269, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1563, 4qvma, 0.8269, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1564, 4no6M, 0.8269, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1565, 4no6a, 0.8269, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1566, 4hnpa, 0.8269, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1567, 4gk7M, 0.8269, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1568, 4gk7a, 0.8269, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1569, 1g651, 0.8269, 2.21, 0.156, 233, 205, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1570, 5l5eM, 0.8268, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1571, 5l52M, 0.8268, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1572, 5l52a, 0.8268, 2.35, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1573, 5fgia, 0.8268, 2.35, 0.155, 233, 206, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1574, 4ya9M, 0.8268, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1575, 4ya9a, 0.8268, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1576, 4ya2M, 0.8268, 2.20, 0.156, 225, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1577, 4ya2a, 0.8268, 2.21, 0.156, 225, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1578, 4no8M, 0.8268, 2.08, 0.157, 232, 204, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1579, 4no8a, 0.8268, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1580, 5fhsM, 0.8267, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1581, 5fhsa, 0.8267, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1582, 5fgeM, 0.8267, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1583, 5fgea, 0.8267, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1584, 4y8kM, 0.8267, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1585, 4y8ka, 0.8267, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1586, 4qw5M, 0.8267, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1587, 4qw5a, 0.8267, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1588, 4qw4M, 0.8267, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH CARFILZOMIB
1589, 4qw4a, 0.8267, 2.20, 0.156, 230, 205, YCP IN COMPLEX WITH CARFILZOMIB
1590, 1z7qN, 0.8267, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1591, 1rypV, 0.8267, 2.21, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1592, 4ya5M, 0.8266, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1593, 4ya5a, 0.8266, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1594, 4y77M, 0.8266, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1595, 4y77a, 0.8266, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1596, 1z7qb, 0.8266, 2.02, 0.225, 205, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1597, 5fgfM, 0.8265, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1598, 5fgfa, 0.8265, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1599, 5d0vM, 0.8265, 2.21, 0.156, 224, 205, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1600, 5d0va, 0.8265, 2.21, 0.156, 223, 205, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1601, 4qz6M, 0.8265, 2.32, 0.155, 233, 206, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1602, 4qz6a, 0.8265, 2.21, 0.156, 233, 205, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1603, 4qz4M, 0.8265, 2.21, 0.156, 233, 205, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1604, 4qz4a, 0.8265, 2.21, 0.156, 233, 205, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1605, 4qz1M, 0.8265, 2.21, 0.156, 233, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1606, 4qz1a, 0.8265, 2.21, 0.156, 233, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1607, 5fgdM, 0.8264, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1608, 5fgda, 0.8264, 2.21, 0.156, 225, 205, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1609, 4ya7M, 0.8264, 2.21, 0.156, 225, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1610, 4ya7a, 0.8264, 2.21, 0.156, 231, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1611, 4y81a, 0.8264, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1612, 4qwxM, 0.8264, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1613, 4qwxa, 0.8264, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1614, 4qw0M, 0.8264, 2.21, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1615, 4qw0a, 0.8264, 2.21, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1616, 4ltcM, 0.8264, 2.21, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1617, 3mg01, 0.8264, 2.21, 0.156, 233, 205, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1618, 1g65M, 0.8264, 2.21, 0.156, 233, 205, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1619, 1fntb, 0.8264, 2.21, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1620, 5d0xM, 0.8263, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1621, 5d0xa, 0.8263, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1622, 5cgiM, 0.8263, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1623, 5cgia, 0.8263, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1624, 4y8qM, 0.8263, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1625, 4y8qa, 0.8263, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1626, 4y82M, 0.8263, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1627, 4y82a, 0.8263, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1628, 4y81M, 0.8263, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1629, 4x6zN, 0.8263, 2.21, 0.156, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1630, 4qz2M, 0.8263, 2.21, 0.156, 222, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1631, 4qz2a, 0.8263, 2.21, 0.156, 230, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1632, 4qw3M, 0.8263, 2.21, 0.156, 232, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1633, 4qw3a, 0.8263, 2.21, 0.156, 233, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1634, 5cz4M, 0.8262, 2.36, 0.155, 233, 206, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1635, 5cz4a, 0.8262, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1636, 4y8lM, 0.8262, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1637, 4y8la, 0.8262, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1638, 4y74M, 0.8262, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1639, 4y74a, 0.8262, 2.21, 0.156, 229, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1640, 4qz3M, 0.8262, 2.20, 0.156, 232, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1641, 4qz3a, 0.8262, 2.21, 0.156, 230, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1642, 4qwrM, 0.8262, 2.21, 0.156, 233, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1643, 4qwra, 0.8262, 2.22, 0.156, 233, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1644, 4qwkM, 0.8262, 2.22, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1645, 4qwka, 0.8262, 2.21, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1646, 4no1M, 0.8262, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1647, 4no1a, 0.8262, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1648, 4nnnM, 0.8262, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH MG132
1649, 4nnna, 0.8262, 2.21, 0.156, 230, 205, YCP IN COMPLEX WITH MG132
1650, 3mg0M, 0.8262, 2.21, 0.156, 230, 205, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1651, 1fntN, 0.8262, 2.22, 0.156, 233, 205, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1652, 5cz5M, 0.8261, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1653, 5cz5a, 0.8261, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1654, 4zzgN, 0.8261, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1655, 4y9zM, 0.8261, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1656, 4y9za, 0.8261, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1657, 4y6zM, 0.8261, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1658, 4y6za, 0.8261, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1659, 4no9M, 0.8261, 2.23, 0.156, 232, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1660, 4no9a, 0.8261, 2.22, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1661, 5nifN, 0.8260, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1662, 4y7xM, 0.8260, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1663, 4y7xa, 0.8260, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1664, 4qz5M, 0.8260, 2.21, 0.156, 233, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1665, 4qz5a, 0.8260, 2.21, 0.156, 233, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1666, 4hrdM, 0.8260, 2.23, 0.156, 232, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1667, 5cz8M, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1668, 5cz8a, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1669, 4ya3a, 0.8259, 2.21, 0.156, 225, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1670, 4y8sM, 0.8259, 2.21, 0.156, 225, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1671, 4y8sa, 0.8259, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1672, 4y8oM, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1673, 4y8oa, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1674, 4y8iM, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1675, 4y8ia, 0.8259, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1676, 4qzwM, 0.8259, 2.22, 0.156, 233, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1677, 4qzwa, 0.8259, 2.21, 0.156, 222, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1678, 4qwiM, 0.8259, 2.21, 0.156, 222, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1679, 4qwia, 0.8259, 2.21, 0.156, 233, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1680, 4nnwM, 0.8259, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1681, 4nnwa, 0.8259, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1682, 3wxr2, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1683, 4ya3M, 0.8258, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1684, 4y80M, 0.8258, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1685, 4y80a, 0.8258, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1686, 4y8jM, 0.8257, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1687, 4y8ja, 0.8257, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1688, 4qwgM, 0.8257, 2.21, 0.156, 233, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1689, 4ya0a, 0.8256, 2.21, 0.156, 232, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1690, 4y70M, 0.8256, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1691, 4y70a, 0.8256, 2.22, 0.156, 230, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1692, 4qwsM, 0.8256, 2.22, 0.156, 233, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1693, 4qwsa, 0.8256, 2.21, 0.156, 233, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1694, 4qwga, 0.8256, 2.21, 0.156, 233, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1695, 4ya0M, 0.8255, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1696, 4y7wM, 0.8255, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1697, 4y7wa, 0.8255, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1698, 4qzxM, 0.8255, 2.21, 0.156, 233, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1699, 4qzxa, 0.8255, 2.21, 0.156, 233, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1700, 4qvvM, 0.8255, 2.21, 0.156, 233, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1701, 4qvva, 0.8255, 2.22, 0.156, 233, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1702, 4y7yM, 0.8254, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1703, 4y7ya, 0.8254, 2.21, 0.156, 231, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1704, 4qxjM, 0.8254, 2.21, 0.156, 232, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1705, 4qxja, 0.8254, 2.21, 0.156, 233, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1706, 4qwjM, 0.8254, 2.21, 0.156, 233, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1707, 4qwja, 0.8253, 2.22, 0.156, 233, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1708, 4y78M, 0.8251, 2.22, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1709, 4y78a, 0.8250, 2.22, 0.156, 228, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1710, 4hrcM, 0.8248, 2.22, 0.156, 226, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1711, 5t0iT, 0.8243, 2.21, 0.156, 230, 205, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1712, 5t0gT, 0.8240, 2.21, 0.156, 228, 205, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1713, 3jcpC, 0.8233, 2.22, 0.156, 233, 205, 
1714, 3jcpQA, 0.8228, 2.22, 0.156, 233, 205, 
1715, 5cz8K, 0.8221, 2.24, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1716, 5cz8Y, 0.8220, 2.22, 0.201, 215, 204, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1717, 5a0qM, 0.8219, 2.24, 0.201, 215, 204, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1718, 5a0qa, 0.8219, 2.09, 0.225, 205, 200, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1719, 5fg7V, 0.8217, 2.10, 0.225, 205, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1720, 5fg7H, 0.8215, 2.21, 0.187, 220, 203, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1721, 5fgeK, 0.8209, 2.35, 0.186, 221, 204, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1722, 5fgeY, 0.8206, 1.17, 0.495, 190, 190, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1723, 5t0jT, 0.8205, 1.17, 0.495, 190, 190, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1724, 5wviE, 0.8204, 1.88, 0.191, 228, 199, 
1725, 5wviGA, 0.8201, 1.89, 0.191, 228, 199, 
1726, 3jcoC, 0.8197, 2.12, 0.194, 218, 201, 
1727, 3jcoQA, 0.8196, 2.11, 0.194, 218, 201, 
1728, 4r3oY, 0.8194, 2.41, 0.205, 215, 205, HUMAN CONSTITUTIVE 20S PROTEASOME
1729, 4r3oK, 0.8194, 2.08, 0.224, 204, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
1730, 5gjrQA, 0.8190, 2.15, 0.222, 205, 198, 
1731, 5gjrCA, 0.8190, 2.02, 0.229, 204, 201, 
1732, 4r67Y, 0.8189, 2.06, 0.226, 205, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1733, 4r67m, 0.8189, 2.07, 0.226, 205, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1734, 4r67K, 0.8189, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1735, 4r670, 0.8189, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1736, 5gjqr, 0.8184, 1.74, 0.230, 199, 196, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1737, 1iruY, 0.8180, 1.74, 0.230, 199, 196, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1738, 1iruK, 0.8180, 1.74, 0.230, 199, 196, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1739, 5gjqd, 0.8178, 1.74, 0.230, 199, 196, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1740, 6epc6, 0.8166, 1.74, 0.230, 199, 196, GROUND STATE 26S PROTEASOME (GS2)
1741, 5fgdY, 0.8165, 1.74, 0.230, 199, 196, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1742, 3wxrV, 0.8165, 1.79, 0.230, 199, 196, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1743, 5ln33, 0.8160, 1.76, 0.230, 199, 196, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
1744, 5d0vK, 0.8160, 1.76, 0.230, 199, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1745, 5cz7Y, 0.8153, 1.76, 0.230, 199, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1746, 5l4gW, 0.8151, 2.57, 0.048, 213, 209, 
1747, 5l4gI, 0.8148, 2.05, 0.196, 216, 199, 
1748, 5cz7K, 0.8148, 1.63, 0.232, 199, 194, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1749, 5fg9H, 0.8144, 2.19, 0.223, 205, 202, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1750, 5fg9V, 0.8143, 2.23, 0.194, 218, 201, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1751, 3unbl, 0.8138, 2.14, 0.200, 217, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1752, 5t0hT, 0.8135, 1.83, 0.230, 199, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1753, 6avoV, 0.8132, 1.83, 0.230, 199, 196, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1754, 6avoT, 0.8132, 2.15, 0.200, 217, 200, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1755, 3unbJ, 0.8131, 1.86, 0.193, 230, 197, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1756, 5fgdK, 0.8128, 1.86, 0.193, 230, 197, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1757, 3unbX, 0.8127, 1.63, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1758, 3unbz, 0.8126, 2.24, 0.207, 215, 203, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1759, 5vy4Z, 0.8125, 1.65, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1760, 5vy4X, 0.8125, 1.65, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1761, 5vy4V, 0.8125, 1.64, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1762, 5vy4T, 0.8125, 2.04, 0.197, 215, 198, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1763, 5vy4R, 0.8125, 1.65, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1764, 5vy4P, 0.8125, 1.65, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1765, 5vy4N, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1766, 5vy4L, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1767, 5vy4J, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1768, 5vy4H, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1769, 5vy4F, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1770, 5vy4D, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1771, 5vy4BA, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1772, 5vy4B, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1773, 5vy41, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1774, 3unhX, 0.8124, 1.63, 0.219, 203, 192, MOUSE 20S IMMUNOPROTEASOME
1775, 3unhJ, 0.8124, 1.63, 0.219, 203, 192, MOUSE 20S IMMUNOPROTEASOME
1776, 3okj1, 0.8124, 1.63, 0.219, 203, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1777, 3uneJ, 0.8123, 1.63, 0.219, 203, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
1778, 3unfX, 0.8121, 1.63, 0.219, 203, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1779, 3unfJ, 0.8121, 1.63, 0.219, 203, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1780, 5t0jP, 0.8120, 1.63, 0.219, 203, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1781, 3unez, 0.8120, 1.66, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
1782, 3uneX, 0.8117, 1.66, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
1783, 3unel, 0.8117, 2.42, 0.147, 228, 204, MOUSE CONSTITUTIVE 20S PROTEASOME
1784, 1pmaY, 0.8112, 1.66, 0.232, 196, 194, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1785, 1pmaX, 0.8112, 1.66, 0.232, 196, 194, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1786, 3c92X, 0.8111, 1.66, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1787, 3c92J, 0.8111, 2.26, 0.214, 204, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1788, 3c91X, 0.8111, 1.66, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1789, 3c91J, 0.8111, 1.66, 0.232, 196, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1790, 1pmaQ, 0.8111, 1.66, 0.232, 196, 194, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1791, 5vy3Z, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1792, 5vy3X, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1793, 5vy3V, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1794, 5vy3T, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1795, 5vy3R, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1796, 5vy3P, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1797, 5vy3N, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1798, 5vy3L, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1799, 5vy3J, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1800, 5vy3H, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1801, 5vy3F, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1802, 5vy3D, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1803, 5vy3B, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1804, 5vy31, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1805, 3c92W, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1806, 3c92N, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1807, 3c92I, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1808, 3c922, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1809, 3c91W, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1810, 3c91N, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1811, 3c91I, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1812, 3c912, 0.8110, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1813, 1pmaV, 0.8110, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1814, 1pmaU, 0.8110, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1815, 1pmaP, 0.8110, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1816, 1pma1, 0.8110, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1817, 3c92M, 0.8108, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1818, 3c921, 0.8108, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1819, 3c91M, 0.8108, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1820, 3c911, 0.8108, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1821, 1pmaT, 0.8108, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1822, 4cr21, 0.8107, 1.65, 0.219, 203, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1823, 3c92Z, 0.8107, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1824, 3c92L, 0.8107, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1825, 3c91Z, 0.8107, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1826, 3c91L, 0.8107, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1827, 1pmaS, 0.8107, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1828, 1pma2, 0.8107, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1829, 1pmaW, 0.8106, 2.34, 0.224, 205, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1830, 3c92V, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1831, 3c92H, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1832, 3c91V, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1833, 3c91H, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1834, 1pmaB, 0.8104, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1835, 3c92Y, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1836, 3c92K, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1837, 3c91Y, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1838, 3c91K, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1839, 1pmaR, 0.8103, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1840, 1yauJ, 0.8102, 1.65, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1841, 1yauI, 0.8101, 1.65, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1842, 1pmaZ, 0.8101, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1843, 1yauK, 0.8100, 1.65, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1844, 1yauH, 0.8100, 1.65, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1845, 5lexX, 0.8099, 1.65, 0.219, 203, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1846, 5le5J, 0.8099, 1.65, 0.219, 203, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1847, 4cr47, 0.8099, 1.65, 0.224, 203, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1848, 5lf7J, 0.8098, 1.65, 0.224, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1849, 5lexJ, 0.8098, 1.66, 0.219, 203, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1850, 5le5X, 0.8098, 1.64, 0.224, 203, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1851, 1yarK, 0.8098, 1.65, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1852, 1g0uN, 0.8098, 1.71, 0.237, 195, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1853, 3jseH, 0.8097, 1.71, 0.237, 195, 194, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1854, 1ya7K, 0.8097, 2.74, 0.154, 233, 208, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1855, 1ya7I, 0.8097, 1.71, 0.237, 195, 194, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1856, 1ya7H, 0.8097, 1.71, 0.237, 195, 194, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1857, 5vfon, 0.8096, 1.71, 0.237, 195, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1858, 1yarI, 0.8096, 1.67, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1859, 5lf7X, 0.8095, 1.90, 0.228, 196, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1860, 5lf4J, 0.8095, 1.66, 0.219, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1861, 5leyJ, 0.8095, 1.65, 0.224, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1862, 3jseL, 0.8095, 1.67, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1863, 3jseK, 0.8095, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1864, 3jseJ, 0.8095, 1.51, 0.236, 191, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1865, 3jseI, 0.8095, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1866, 3jrmJ, 0.8095, 1.71, 0.237, 195, 194, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1867, 1yarJ, 0.8095, 1.72, 0.237, 195, 194, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1868, 1g0u2, 0.8095, 1.72, 0.237, 195, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1869, 5lf3J, 0.8094, 1.67, 0.224, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1870, 5lezJ, 0.8094, 1.66, 0.219, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1871, 5leyX, 0.8094, 1.67, 0.219, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1872, 3jseM, 0.8094, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1873, 3jrmK, 0.8094, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1874, 3jrmI, 0.8094, 1.68, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1875, 3jrmH, 0.8094, 1.91, 0.228, 196, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1876, 1yarL, 0.8094, 1.72, 0.237, 195, 194, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1877, 1ya7J, 0.8094, 1.72, 0.237, 195, 194, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1878, 5lf0J, 0.8093, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1879, 5lezX, 0.8093, 1.67, 0.224, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1880, 4cr27, 0.8093, 1.67, 0.224, 203, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1881, 3jtlN, 0.8093, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1882, 3jtlH, 0.8093, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1883, 3jseN, 0.8093, 1.54, 0.220, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1884, 3jrmM, 0.8093, 1.67, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1885, 3jrmL, 0.8093, 1.72, 0.237, 195, 194, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1886, 1yarH, 0.8093, 1.72, 0.237, 195, 194, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1887, 5vfuNA, 0.8092, 2.58, 0.155, 233, 207, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1888, 5vfto, 0.8092, 1.66, 0.219, 203, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1889, 5lf4X, 0.8092, 1.66, 0.219, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1890, 5l4gM, 0.8092, 1.67, 0.219, 203, 192, 
1891, 5l4gAA, 0.8092, 1.67, 0.224, 203, 192, 
1892, 3jtlM, 0.8092, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1893, 3jtlL, 0.8092, 1.68, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1894, 3jtlK, 0.8092, 1.73, 0.187, 220, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1895, 3jtlJ, 0.8092, 1.73, 0.187, 220, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1896, 3jtlI, 0.8092, 1.72, 0.237, 195, 194, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1897, 1yauN, 0.8092, 1.64, 0.234, 200, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1898, 5lf6J, 0.8091, 1.65, 0.234, 199, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1899, 5lf3X, 0.8091, 1.66, 0.219, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1900, 4qwjN, 0.8091, 1.66, 0.219, 203, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1901, 4qwjb, 0.8091, 1.66, 0.219, 203, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1902, 4eu2H, 0.8091, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1903, 3jrmN, 0.8091, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1904, 5lf1J, 0.8090, 1.65, 0.224, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1905, 5lf0X, 0.8090, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1906, 5lajN, 0.8090, 1.72, 0.237, 195, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1907, 5lajb, 0.8090, 1.73, 0.229, 196, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1908, 4r18N, 0.8090, 1.73, 0.229, 196, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1909, 6avoE, 0.8089, 1.74, 0.229, 196, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1910, 6avoB, 0.8089, 1.67, 0.224, 203, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1911, 5lf1X, 0.8089, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1912, 4r18b, 0.8089, 1.73, 0.237, 195, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1913, 1yauL, 0.8089, 1.72, 0.229, 196, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1914, 5l55N, 0.8088, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1915, 5l55b, 0.8088, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1916, 5jhsN, 0.8088, 1.70, 0.187, 219, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1917, 5jhsb, 0.8088, 1.70, 0.187, 219, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1918, 4y8mb, 0.8088, 1.72, 0.237, 195, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1919, 4x6zV, 0.8088, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1920, 4qzxN, 0.8088, 1.67, 0.224, 203, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1921, 4eu2V, 0.8088, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1922, 6avoD, 0.8087, 1.74, 0.229, 196, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1923, 6avoC, 0.8087, 1.74, 0.229, 196, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1924, 5lf6X, 0.8087, 1.74, 0.229, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1925, 5cz9N, 0.8087, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1926, 5cz9b, 0.8087, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1927, 4y8mN, 0.8087, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1928, 4y7xN, 0.8087, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1929, 4y7xb, 0.8087, 1.70, 0.202, 201, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1930, 4x6zH, 0.8087, 1.70, 0.202, 201, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1931, 4qzxb, 0.8087, 1.73, 0.237, 195, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1932, 5l52N, 0.8086, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1933, 5l52b, 0.8086, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1934, 5fhsN, 0.8086, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1935, 5fhsb, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1936, 5cgiN, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1937, 5cghN, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1938, 5cggN, 0.8086, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1939, 5cggb, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1940, 4ya1b, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1941, 4y80N, 0.8086, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1942, 4y80b, 0.8086, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1943, 4qxjN, 0.8086, 1.75, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1944, 4qxjb, 0.8086, 1.75, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1945, 4no8N, 0.8086, 1.72, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1946, 4no8b, 0.8086, 1.72, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1947, 4inub, 0.8086, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1948, 3mkaP, 0.8086, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1949, 1ya7N, 0.8086, 1.75, 0.229, 196, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1950, 5nifH, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1951, 5lttY, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1952, 5lttK, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1953, 5jhrN, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1954, 5jhrb, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1955, 5d0zN, 0.8085, 2.32, 0.180, 250, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1956, 5cgib, 0.8085, 1.68, 0.219, 203, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1957, 5cghb, 0.8085, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1958, 4ya5N, 0.8085, 1.87, 0.206, 211, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1959, 4ya5b, 0.8085, 1.87, 0.206, 211, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1960, 4ya3b, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1961, 4y7yN, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1962, 4y7yb, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1963, 4y6vN, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1964, 4qwsN, 0.8085, 1.75, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1965, 4qwsb, 0.8085, 1.76, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1966, 4qwkN, 0.8085, 1.76, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1967, 4qwkb, 0.8085, 1.76, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1968, 4qwiN, 0.8085, 1.75, 0.229, 196, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1969, 4qwib, 0.8085, 1.75, 0.229, 196, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1970, 4ltcN, 0.8085, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1971, 4intN, 0.8085, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1972, 1ya7L, 0.8085, 1.74, 0.229, 196, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1973, 5l54N, 0.8084, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1974, 5l54b, 0.8084, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1975, 5fg7N, 0.8084, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1976, 5d0zb, 0.8084, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1977, 5d0sN, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1978, 5d0sb, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1979, 5cgfN, 0.8084, 1.69, 0.224, 203, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1980, 5cgfb, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1981, 4zzgH, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1982, 4ya3N, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1983, 4ya1N, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1984, 4y9yN, 0.8084, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1985, 4y8qN, 0.8084, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1986, 4y82N, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1987, 4qv3N, 0.8084, 1.76, 0.229, 196, 192, YCP BETA5-M45V MUTANT
1988, 4qv3b, 0.8084, 1.56, 0.230, 196, 191, YCP BETA5-M45V MUTANT
1989, 4no9N, 0.8084, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1990, 4no9b, 0.8084, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1991, 4ltcb, 0.8084, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1992, 4jt0N, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1993, 4jt0b, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1994, 4jsqN, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1995, 4jsqb, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1996, 4intb, 0.8084, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1997, 4hnpN, 0.8084, 1.72, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1998, 3tddN, 0.8084, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1999, 3tdd2, 0.8084, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2000, 2gplN, 0.8084, 1.75, 0.229, 196, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2001, 2gpl2, 0.8084, 1.75, 0.229, 196, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2002, 1g65N, 0.8084, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2003, 5fgeN, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2004, 5fgdN, 0.8083, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2005, 5fgdb, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2006, 5fg7b, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2007, 4y8qb, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2008, 4y82b, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2009, 4y6vb, 0.8083, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2010, 4y6aN, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2011, 4y6ab, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2012, 4y69b, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2013, 4qlvN, 0.8083, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2014, 4qlvb, 0.8083, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2015, 4qlsN, 0.8083, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2016, 4qlsb, 0.8083, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2017, 4inuN, 0.8083, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2018, 4hrdN, 0.8083, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2019, 4hrcN, 0.8083, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2020, 4hnpb, 0.8083, 1.73, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2021, 3sdi2, 0.8083, 1.73, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2022, 3nzjN, 0.8083, 1.72, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2023, 3nzj2, 0.8083, 1.72, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2024, 5m32X, 0.8082, 1.75, 0.229, 196, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2025, 5l5vY, 0.8082, 1.73, 0.229, 196, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2026, 5l5qY, 0.8082, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2027, 5l5qK, 0.8082, 1.55, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2028, 5l5pY, 0.8082, 1.55, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2029, 5l5pK, 0.8082, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2030, 5l5hY, 0.8082, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2031, 5l5hK, 0.8082, 1.72, 0.232, 196, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2032, 5fgeb, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2033, 4zzgV, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2034, 4y8uN, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2035, 4y78b, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2036, 4y69N, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2037, 4qz3N, 0.8082, 1.88, 0.206, 211, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2038, 4qwgN, 0.8082, 1.88, 0.206, 211, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2039, 4qwgb, 0.8082, 1.75, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2040, 4qlqN, 0.8082, 1.56, 0.230, 196, 191, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2041, 4qlqb, 0.8082, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2042, 4inrb, 0.8082, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2043, 4g4sH, 0.8082, 1.76, 0.229, 196, 192, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2044, 5ln37, 0.8081, 1.75, 0.229, 196, 192, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2045, 5l5vK, 0.8081, 1.75, 0.229, 196, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2046, 5l5oY, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2047, 5l5oK, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2048, 4y8ub, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2049, 4y78N, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2050, 4y77N, 0.8081, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2051, 4y70N, 0.8081, 2.49, 0.191, 218, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2052, 4y70b, 0.8081, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2053, 4r00N, 0.8081, 1.88, 0.206, 211, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2054, 4r00b, 0.8081, 1.88, 0.206, 211, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2055, 4qzwN, 0.8081, 1.76, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2056, 4qzwb, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2057, 4qz7N, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2058, 4qz7b, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2059, 4qz3b, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2060, 4qz2N, 0.8081, 1.74, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2061, 4qz2b, 0.8081, 1.74, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2062, 4qz0N, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2063, 4qz0b, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2064, 4qwxN, 0.8081, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2065, 4qwxb, 0.8081, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2066, 4qwrN, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2067, 4qwrb, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2068, 4qwlN, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2069, 4qwlb, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2070, 4no1N, 0.8081, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2071, 4no1b, 0.8081, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2072, 4j70N, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2073, 4j70b, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2074, 4inrN, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2075, 4hrcb, 0.8081, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2076, 3shj2, 0.8081, 1.75, 0.229, 196, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2077, 3okjN, 0.8081, 1.75, 0.229, 196, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2078, 3mg4N, 0.8081, 1.75, 0.229, 196, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2079, 3e47N, 0.8081, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2080, 1g652, 0.8081, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2081, 5vfpFA, 0.8080, 1.75, 0.229, 196, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2082, 5vfoN, 0.8080, 1.76, 0.229, 196, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2083, 5t0cGB, 0.8080, 1.76, 0.229, 196, 192, 
2084, 5t0cAA, 0.8080, 1.75, 0.229, 196, 192, 
2085, 5nifV, 0.8080, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2086, 5mp91, 0.8080, 1.76, 0.229, 196, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2087, 5fggN, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2088, 5fggb, 0.8080, 1.54, 0.236, 191, 191, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2089, 5cz8N, 0.8080, 1.54, 0.236, 191, 191, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2090, 5cz8b, 0.8080, 1.68, 0.187, 220, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2091, 4y81N, 0.8080, 1.68, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2092, 4y81b, 0.8080, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2093, 4y77b, 0.8080, 1.55, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2094, 4y6zb, 0.8080, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2095, 4qz6N, 0.8080, 1.73, 0.229, 196, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2096, 4qz6b, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2097, 4qw7N, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2098, 4qw7b, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2099, 4qw4N, 0.8080, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH CARFILZOMIB
2100, 4qw4b, 0.8080, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH CARFILZOMIB
2101, 4qv7N, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT
2102, 4qv7b, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT
2103, 4qltN, 0.8080, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2104, 4qltb, 0.8080, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2105, 3un4N, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2106, 3un4b, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2107, 3shjN, 0.8080, 1.75, 0.229, 196, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2108, 3e472, 0.8080, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2109, 1yarN, 0.8080, 1.74, 0.229, 196, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
2110, 5mp9h, 0.8079, 1.73, 0.229, 196, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2111, 5m32J, 0.8079, 1.73, 0.229, 196, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2112, 5l5sY, 0.8079, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2113, 5l5sK, 0.8079, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2114, 5l5jY, 0.8079, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2115, 4z1lN, 0.8079, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2116, 4z1lb, 0.8079, 1.71, 0.219, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2117, 4y8rN, 0.8079, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2118, 4y8kN, 0.8079, 1.72, 0.232, 196, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2119, 4y8kb, 0.8079, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2120, 4y8jN, 0.8079, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2121, 4y84N, 0.8079, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2122, 4y84b, 0.8079, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2123, 4y7wN, 0.8079, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2124, 4y7wb, 0.8079, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2125, 4y6zN, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2126, 4v7oV, 0.8079, 1.75, 0.229, 196, 192, 
2127, 4v7oPA, 0.8079, 1.75, 0.229, 196, 192, 
2128, 4qz5N, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2129, 4qz5b, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2130, 4qw6N, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2131, 4qw6b, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2132, 4quyN, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-A49S-MUTANT
2133, 4quyb, 0.8079, 1.56, 0.230, 196, 191, YCP BETA5-A49S-MUTANT
2134, 3wxrH, 0.8079, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2135, 3mg42, 0.8079, 1.75, 0.229, 196, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2136, 3gpjN, 0.8079, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2137, 3gpj2, 0.8079, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2138, 2fakN, 0.8079, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2139, 2fak2, 0.8079, 1.77, 0.229, 196, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2140, 1yauM, 0.8079, 1.77, 0.229, 196, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
2141, 5lttN, 0.8078, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2142, 5lttb, 0.8078, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2143, 5l5uY, 0.8078, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2144, 5l5uK, 0.8078, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2145, 5l5tN, 0.8078, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2146, 5l5jK, 0.8078, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2147, 5l5eN, 0.8078, 1.69, 0.224, 203, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2148, 5fgfN, 0.8078, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2149, 5fgfb, 0.8078, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2150, 5cz4N, 0.8078, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2151, 5cz4b, 0.8078, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2152, 4y8oN, 0.8078, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2153, 4y8ob, 0.8078, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2154, 4y8lb, 0.8078, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2155, 4y8jb, 0.8078, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2156, 4y8hN, 0.8078, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2157, 4y75b, 0.8078, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2158, 4r67Z, 0.8078, 1.58, 0.230, 196, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2159, 4r67L, 0.8078, 1.76, 0.229, 196, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2160, 4qw5N, 0.8078, 1.76, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2161, 4qw5b, 0.8078, 1.75, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2162, 4qv5N, 0.8078, 1.76, 0.229, 196, 192, YCP BETA5-M45I MUTANT
2163, 4qv5b, 0.8078, 1.72, 0.229, 196, 192, YCP BETA5-M45I MUTANT
2164, 4no6N, 0.8078, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2165, 4no6b, 0.8078, 1.90, 0.201, 201, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2166, 3nzwN, 0.8078, 1.90, 0.201, 201, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2167, 3nzw2, 0.8078, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2168, 3mg62, 0.8078, 1.76, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2169, 3gptN, 0.8078, 1.77, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2170, 3gpt2, 0.8078, 1.77, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2171, 4y8lN, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2172, 4y8hb, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2173, 4y74b, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2174, 4v7oH, 0.8077, 1.76, 0.229, 196, 192, 
2175, 4v7oDB, 0.8077, 1.56, 0.230, 196, 191, 
2176, 4r67n, 0.8077, 1.76, 0.229, 196, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2177, 4qz4N, 0.8077, 1.76, 0.229, 196, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2178, 4qz4b, 0.8077, 1.76, 0.229, 196, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2179, 4qwfN, 0.8077, 1.73, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2180, 4qwfb, 0.8077, 1.76, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2181, 4qv8N, 0.8077, 1.56, 0.230, 196, 191, YCP BETA5-C52F MUTANT
2182, 4qv8b, 0.8077, 1.56, 0.230, 196, 191, YCP BETA5-C52F MUTANT
2183, 3un8N, 0.8077, 1.90, 0.201, 201, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2184, 3un8b, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2185, 3nzx2, 0.8077, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2186, 3mg72, 0.8077, 1.75, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2187, 3j9iZ, 0.8077, 1.76, 0.229, 196, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2188, 3j9iY, 0.8077, 1.74, 0.229, 196, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2189, 3j9iX, 0.8077, 1.75, 0.229, 196, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2190, 3j9iW, 0.8077, 1.76, 0.229, 196, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2191, 3j9iV, 0.8077, 1.76, 0.229, 196, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2192, 3j9iN, 0.8077, 1.76, 0.229, 196, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2193, 3j9iM, 0.8077, 1.56, 0.230, 196, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2194, 3j9iL, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2195, 3j9iK, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2196, 3j9iJ, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2197, 3j9iI, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2198, 3j9iH, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2199, 3j9i2, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2200, 3j9i1, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2201, 3dy4N, 0.8077, 1.87, 0.214, 203, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2202, 3dy42, 0.8077, 1.87, 0.214, 203, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2203, 5fgfY, 0.8076, 1.87, 0.214, 203, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2204, 5ahjN, 0.8076, 1.87, 0.214, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2205, 5ahjb, 0.8076, 1.87, 0.214, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2206, 4y8ib, 0.8076, 1.87, 0.214, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2207, 4y75N, 0.8076, 1.87, 0.214, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2208, 4qvvN, 0.8076, 1.56, 0.230, 196, 191, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2209, 4qvvb, 0.8076, 1.56, 0.230, 196, 191, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2210, 3sdiN, 0.8076, 2.05, 0.203, 214, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2211, 3nzxN, 0.8076, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2212, 3mkaG, 0.8076, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2213, 3gpwN, 0.8076, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2214, 4y9yb, 0.8075, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2215, 4y8iN, 0.8075, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2216, 4y74N, 0.8075, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2217, 4r02N, 0.8075, 1.58, 0.230, 196, 191, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2218, 4qz1N, 0.8075, 1.76, 0.229, 196, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2219, 4qz1b, 0.8075, 2.20, 0.181, 251, 199, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2220, 4qvyN, 0.8075, 1.76, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2221, 4qvyb, 0.8075, 1.58, 0.230, 196, 191, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2222, 4qv9N, 0.8075, 1.76, 0.229, 196, 192, YCP BETA5-C63F MUTANT
2223, 4qv0N, 0.8075, 1.76, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2224, 4qv0b, 0.8075, 1.74, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2225, 4qluN, 0.8075, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2226, 4qlub, 0.8075, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2227, 4jsuN, 0.8075, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2228, 4jsub, 0.8075, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2229, 3mkaT, 0.8075, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2230, 3gpw2, 0.8075, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2231, 5vfqGA, 0.8074, 1.75, 0.229, 196, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2232, 5lezK, 0.8074, 1.74, 0.229, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2233, 5laiN, 0.8074, 1.74, 0.229, 196, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2234, 5laib, 0.8074, 1.76, 0.229, 196, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2235, 5l65N, 0.8074, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2236, 5l65b, 0.8074, 2.34, 0.180, 250, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2237, 5l5vN, 0.8074, 1.76, 0.229, 196, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2238, 5l5vb, 0.8074, 1.54, 0.236, 191, 191,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2239, 5fgfK, 0.8074, 1.91, 0.201, 200, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2240, 5fg9N, 0.8074, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2241, 5fg9b, 0.8074, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2242, 5d0xN, 0.8074, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2243, 5d0xb, 0.8074, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2244, 4ya2N, 0.8074, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2245, 4ya0N, 0.8074, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2246, 4ya0b, 0.8074, 2.06, 0.203, 214, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2247, 4y9zb, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2248, 4y8gN, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2249, 4y8gb, 0.8074, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2250, 4rurN, 0.8074, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2251, 4qv9b, 0.8074, 1.73, 0.229, 196, 192, YCP BETA5-C63F MUTANT
2252, 4q1sb, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2253, 4fzcb, 0.8074, 1.58, 0.230, 196, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2254, 3hyeN, 0.8074, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2255, 3hye2, 0.8074, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2256, 3dy3N, 0.8074, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2257, 3dy32, 0.8074, 1.58, 0.230, 196, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2258, 3bdm1, 0.8074, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2259, 1yarM, 0.8074, 1.57, 0.230, 196, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
2260, 1jd2N, 0.8074, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2261, 5vfsI, 0.8073, 1.77, 0.229, 196, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2262, 5vfsHA, 0.8073, 1.77, 0.229, 196, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2263, 5vfrn, 0.8073, 1.57, 0.230, 196, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2264, 5l5sN, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2265, 5l5sb, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2266, 5l5pb, 0.8073, 1.71, 0.219, 203, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2267, 5d0wN, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2268, 5d0wb, 0.8073, 1.92, 0.223, 204, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2269, 5d0vN, 0.8073, 1.76, 0.192, 220, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2270, 5d0vb, 0.8073, 1.75, 0.192, 220, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2271, 5d0tN, 0.8073, 1.54, 0.236, 191, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2272, 5d0tb, 0.8073, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2273, 5bxlN, 0.8073, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2274, 5bxlb, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2275, 5bouN, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2276, 5boub, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2277, 4ya7N, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2278, 4ya7b, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2279, 4ya2b, 0.8073, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2280, 4y9zN, 0.8073, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2281, 4y8sN, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2282, 4y8sb, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2283, 4y8nN, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2284, 4y8nb, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2285, 4rurb, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2286, 4r673, 0.8073, 1.76, 0.229, 196, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2287, 4r17N, 0.8073, 1.73, 0.229, 196, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2288, 4r17b, 0.8073, 1.76, 0.229, 196, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2289, 4qw0N, 0.8073, 1.73, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2290, 4qw0b, 0.8073, 1.73, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2291, 4quxN, 0.8073, 1.58, 0.230, 196, 191, YCP BETA5-A49T-MUTANT
2292, 4quxb, 0.8073, 1.58, 0.230, 196, 191, YCP BETA5-A49T-MUTANT
2293, 4fzcN, 0.8073, 1.58, 0.230, 196, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2294, 3mg82, 0.8073, 1.91, 0.201, 201, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2295, 3bdmN, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2296, 5m32N, 0.8072, 1.58, 0.230, 196, 191, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2297, 5m32b, 0.8072, 1.77, 0.229, 196, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2298, 5l64N, 0.8072, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2299, 5l64b, 0.8072, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2300, 5l5qN, 0.8072, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2301, 5l5qb, 0.8072, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2302, 5l5pN, 0.8072, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2303, 5l5hN, 0.8072, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2304, 5czaN, 0.8072, 1.84, 0.233, 202, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2305, 5czab, 0.8072, 1.84, 0.233, 203, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2306, 4y8pN, 0.8072, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2307, 4y8pb, 0.8072, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2308, 4r02b, 0.8072, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2309, 4qzzN, 0.8072, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH OMURALIDE
2310, 4qzzb, 0.8072, 1.57, 0.230, 196, 191, YCP IN COMPLEX WITH OMURALIDE
2311, 4qvwb, 0.8072, 1.75, 0.229, 196, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2312, 4nnnN, 0.8072, 1.58, 0.230, 196, 191, YCP IN COMPLEX WITH MG132
2313, 4nnnb, 0.8072, 1.58, 0.230, 196, 191, YCP IN COMPLEX WITH MG132
2314, 4fzgN, 0.8072, 1.77, 0.229, 196, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2315, 3oeuN, 0.8072, 1.77, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2316, 3mkaJ, 0.8072, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2317, 1ya7M, 0.8072, 1.59, 0.230, 196, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
2318, 5vfpH, 0.8071, 1.59, 0.230, 196, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2319, 5lf1Y, 0.8071, 1.78, 0.229, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2320, 5l5oN, 0.8071, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2321, 5l5ob, 0.8071, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2322, 5l5iY, 0.8071, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2323, 5l5hb, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2324, 5l5fY, 0.8071, 2.34, 0.180, 252, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2325, 5l5bN, 0.8071, 1.71, 0.219, 203, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2326, 5l5bb, 0.8071, 1.79, 0.224, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2327, 5fmgY, 0.8071, 1.55, 0.236, 191, 191, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2328, 5fmgK, 0.8071, 1.92, 0.201, 201, 194, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2329, 5fgaN, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2330, 5fgab, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2331, 4ya9N, 0.8071, 1.71, 0.207, 211, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2332, 4ya9b, 0.8071, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2333, 4qvwN, 0.8071, 1.89, 0.206, 211, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2334, 4qv4N, 0.8071, 1.59, 0.230, 196, 191, YCP BETA5-M45T MUTANT
2335, 4qv4b, 0.8071, 1.59, 0.230, 196, 191, YCP BETA5-M45T MUTANT
2336, 4q1sN, 0.8071, 1.63, 0.224, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2337, 4lqiN, 0.8071, 1.63, 0.224, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2338, 4lqib, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2339, 4fzgb, 0.8071, 1.59, 0.230, 196, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2340, 3sdk2, 0.8071, 1.76, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2341, 3oeu2, 0.8071, 1.77, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2342, 3mkaN, 0.8071, 1.78, 0.229, 196, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2343, 5vfoq, 0.8070, 1.59, 0.230, 196, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2344, 5l5tb, 0.8070, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2345, 5l5iK, 0.8070, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2346, 5l5fK, 0.8070, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2347, 5l5eb, 0.8070, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2348, 5l5aN, 0.8070, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2349, 5l5ab, 0.8070, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2350, 5l4gN, 0.8070, 1.57, 0.230, 196, 191, 
2351, 5l4gBA, 0.8070, 2.35, 0.180, 252, 200, 
2352, 4ya4N, 0.8070, 1.97, 0.230, 199, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2353, 4ya4b, 0.8070, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2354, 4y8rb, 0.8070, 1.71, 0.207, 211, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2355, 4qw3N, 0.8070, 1.89, 0.206, 211, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2356, 4qw3b, 0.8070, 1.57, 0.230, 196, 191, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2357, 3d29N, 0.8070, 1.59, 0.230, 196, 191, PROTEASOME INHIBITION BY FELLUTAMIDE B
2358, 3d292, 0.8070, 1.59, 0.230, 196, 191, PROTEASOME INHIBITION BY FELLUTAMIDE B
2359, 5vfqH, 0.8069, 1.71, 0.181, 220, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2360, 5lezY, 0.8069, 1.69, 0.181, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2361, 5l6cN, 0.8069, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2362, 5l6cb, 0.8069, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2363, 5l6bN, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2364, 5l6bb, 0.8069, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2365, 5l67N, 0.8069, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2366, 5l67b, 0.8069, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2367, 5l63N, 0.8069, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2368, 5l63b, 0.8069, 1.56, 0.236, 191, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2369, 5l5uN, 0.8069, 1.84, 0.192, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2370, 5l5tY, 0.8069, 1.74, 0.202, 199, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2371, 5l5jN, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2372, 5cz6N, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2373, 5cz6b, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2374, 4qvmN, 0.8069, 1.59, 0.230, 196, 191, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2375, 4qvmb, 0.8069, 1.59, 0.230, 196, 191, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2376, 4qv1N, 0.8069, 1.59, 0.230, 196, 191, YCP BETA5-M45A MUTANT
2377, 4qv1b, 0.8069, 1.76, 0.229, 196, 192, YCP BETA5-M45A MUTANT
2378, 4qbyN, 0.8069, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2379, 4qbyb, 0.8069, 1.59, 0.230, 196, 191, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2380, 4hrdb, 0.8069, 1.72, 0.207, 211, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2381, 3sdkN, 0.8069, 1.59, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2382, 3oev2, 0.8069, 1.59, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2383, 5mpa1, 0.8068, 1.59, 0.230, 196, 191, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2384, 5lf7Y, 0.8068, 1.78, 0.229, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2385, 5lf1K, 0.8068, 1.78, 0.229, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2386, 5l6bY, 0.8068, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2387, 5l6bK, 0.8068, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2388, 5l5ub, 0.8068, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2389, 5l5tK, 0.8068, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2390, 5l5jb, 0.8068, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2391, 5l5fN, 0.8068, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2392, 5dkjN, 0.8068, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2393, 5dkjb, 0.8068, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2394, 4y8tN, 0.8068, 1.92, 0.201, 201, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2395, 4y8tb, 0.8068, 1.92, 0.201, 200, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2396, 4qw1N, 0.8068, 1.90, 0.216, 211, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2397, 4qw1b, 0.8068, 1.90, 0.216, 211, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2398, 4qvlN, 0.8068, 1.59, 0.230, 196, 191, YCP IN COMPLEX WITH BORTEZOMIB
2399, 4qvlb, 0.8068, 1.72, 0.207, 211, 193, YCP IN COMPLEX WITH BORTEZOMIB
2400, 2f16N, 0.8068, 1.59, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2401, 2f162, 0.8068, 1.78, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2402, 5leyK, 0.8067, 1.78, 0.229, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2403, 5l6aY, 0.8067, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2404, 5l6aK, 0.8067, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2405, 5l62N, 0.8067, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2406, 5l61N, 0.8067, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2407, 5l61b, 0.8067, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2408, 5l5rN, 0.8067, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2409, 5l5rb, 0.8067, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2410, 5l5fb, 0.8067, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2411, 5l5dN, 0.8067, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2412, 5l5db, 0.8067, 1.92, 0.201, 200, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2413, 3oevN, 0.8067, 1.90, 0.216, 211, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2414, 3mg6N, 0.8067, 1.90, 0.216, 211, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2415, 6gopN, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2416, 5l68Y, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2417, 5l68K, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2418, 5l67K, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2419, 5l62b, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2420, 5l5iN, 0.8066, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2421, 5l5ib, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2422, 5bxnb, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2423, 3mkaL, 0.8066, 1.60, 0.230, 196, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2424, 3mkaH, 0.8066, 1.60, 0.230, 196, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2425, 3mg8N, 0.8066, 1.79, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2426, 6gopb, 0.8065, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2427, 5l6aN, 0.8065, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2428, 5l6ab, 0.8065, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2429, 5l68N, 0.8065, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2430, 5l68b, 0.8065, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2431, 5l60N, 0.8065, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2432, 5l60b, 0.8065, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2433, 5l5dY, 0.8065, 2.35, 0.180, 251, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2434, 5l5dK, 0.8065, 2.18, 0.181, 249, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2435, 5fghN, 0.8065, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2436, 5fghb, 0.8065, 1.79, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2437, 5dkiN, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2438, 5dkib, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2439, 4nnwN, 0.8065, 1.60, 0.230, 196, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2440, 4nnwb, 0.8065, 1.60, 0.230, 196, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2441, 4gk7N, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2442, 4gk7b, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2443, 2zcyN, 0.8065, 1.72, 0.207, 211, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2444, 2zcy1, 0.8065, 1.72, 0.207, 211, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2445, 1z7qV, 0.8065, 1.59, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2446, 5l66Y, 0.8064, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2447, 5l66N, 0.8064, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2448, 5l66K, 0.8064, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2449, 5l66b, 0.8064, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2450, 4qvqN, 0.8064, 1.77, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2451, 4qvqb, 0.8064, 1.77, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2452, 3sdkJ, 0.8064, 1.77, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2453, 3mg7N, 0.8064, 1.58, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2454, 3h4pi, 0.8064, 1.58, 0.230, 196, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2455, 1z7qH, 0.8064, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2456, 5leyY, 0.8063, 1.90, 0.216, 211, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2457, 5l5xN, 0.8063, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2458, 5gjqo, 0.8063, 1.90, 0.216, 211, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2459, 4ltcJ, 0.8063, 1.78, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2460, 3mkaV, 0.8063, 1.78, 0.229, 196, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2461, 3mg02, 0.8063, 1.78, 0.229, 196, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2462, 5mpah, 0.8062, 1.70, 0.228, 198, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2463, 5m2bN, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2464, 5m2bb, 0.8062, 1.74, 0.281, 202, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2465, 5lf4Y, 0.8062, 1.77, 0.229, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2466, 5lf0Y, 0.8062, 1.75, 0.202, 199, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2467, 5le5b, 0.8062, 1.59, 0.230, 196, 191, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2468, 5l69N, 0.8062, 1.67, 0.234, 202, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2469, 5l69b, 0.8062, 1.72, 0.228, 198, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2470, 5l5yN, 0.8062, 2.25, 0.181, 249, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2471, 5l5yb, 0.8062, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2472, 5l5xb, 0.8062, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2473, 5l5wN, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2474, 5l5wb, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2475, 5cz7N, 0.8062, 1.93, 0.201, 201, 194, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2476, 5cz7b, 0.8062, 1.92, 0.201, 201, 194, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2477, 4hrcX, 0.8062, 1.68, 0.234, 203, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2478, 2h6jN, 0.8062, 1.60, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2479, 2h6jM, 0.8062, 1.60, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2480, 5vfrN, 0.8061, 1.60, 0.230, 196, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2481, 5vfoQ, 0.8061, 1.60, 0.230, 196, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2482, 5mpai, 0.8061, 1.60, 0.230, 196, 191, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2483, 5lf7K, 0.8061, 1.60, 0.230, 196, 191, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2484, 5lf0K, 0.8061, 1.60, 0.230, 196, 191, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2485, 5lf0b, 0.8061, 1.58, 0.230, 196, 191, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2486, 5l69Y, 0.8061, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2487, 5l69K, 0.8061, 1.71, 0.228, 198, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2488, 5gjrZ, 0.8061, 2.21, 0.201, 242, 199, 
2489, 5gjrNA, 0.8061, 2.21, 0.201, 242, 199, 
2490, 3mg0N, 0.8061, 1.58, 0.236, 191, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2491, 5vfsGA, 0.8060, 1.98, 0.230, 199, 196, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2492, 5le5N, 0.8060, 1.74, 0.192, 226, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2493, 4qv6N, 0.8060, 1.93, 0.201, 200, 194, YCP BETA5-A49V MUTANT
2494, 4qv6b, 0.8060, 1.92, 0.201, 200, 194, YCP BETA5-A49V MUTANT
2495, 3mg8J, 0.8060, 1.86, 0.233, 203, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2496, 2h6jK, 0.8060, 1.90, 0.216, 211, 194, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2497, 5vfuPA, 0.8059, 1.90, 0.216, 211, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2498, 5vftq, 0.8059, 1.68, 0.234, 202, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2499, 5lf1b, 0.8059, 1.68, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2500, 5l62Y, 0.8059, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2501, 5l62K, 0.8059, 1.58, 0.236, 191, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2502, 5l61Y, 0.8059, 1.68, 0.234, 202, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2503, 5l5yK, 0.8059, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2504, 5l4gZ, 0.8059, 1.60, 0.230, 196, 191, 
2505, 5gjqa, 0.8059, 1.71, 0.228, 198, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2506, 4qvpN, 0.8059, 2.21, 0.201, 242, 199, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2507, 4qvpb, 0.8059, 1.96, 0.230, 199, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2508, 3unhY, 0.8059, 1.96, 0.230, 199, 196, MOUSE 20S IMMUNOPROTEASOME
2509, 3unhK, 0.8059, 1.68, 0.234, 203, 192, MOUSE 20S IMMUNOPROTEASOME
2510, 3h4pe, 0.8059, 1.91, 0.216, 211, 194, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2511, 2h6jL, 0.8059, 1.91, 0.216, 211, 194, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2512, 2h6jJ, 0.8059, 1.91, 0.216, 211, 194, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2513, 2h6jI, 0.8059, 1.91, 0.216, 211, 194, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2514, 1jd2U, 0.8059, 1.77, 0.207, 201, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2515, 5lf4K, 0.8058, 1.68, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2516, 5lf1N, 0.8058, 1.59, 0.230, 196, 191, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2517, 5l65Y, 0.8058, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2518, 5l65K, 0.8058, 1.74, 0.212, 201, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2519, 5l61K, 0.8058, 1.74, 0.212, 201, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2520, 5l5yY, 0.8058, 1.75, 0.281, 202, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2521, 5l4gL, 0.8058, 2.21, 0.201, 242, 199, 
2522, 4qwuN, 0.8058, 2.22, 0.201, 242, 199, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2523, 4qwub, 0.8058, 2.21, 0.201, 242, 199, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2524, 3sdkX, 0.8058, 1.58, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2525, 3h4pn, 0.8058, 1.93, 0.201, 200, 194, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2526, 5vfuMA, 0.8057, 1.69, 0.234, 202, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2527, 5vftn, 0.8057, 1.73, 0.218, 211, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2528, 5l67Y, 0.8057, 1.73, 0.218, 211, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2529, 5gjrRA, 0.8057, 1.91, 0.216, 211, 194, 
2530, 5gjqb, 0.8057, 1.91, 0.216, 211, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2531, 5bxnN, 0.8057, 1.76, 0.197, 201, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2532, 4ltcX, 0.8057, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2533, 3mkaC, 0.8057, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2534, 3h4pc, 0.8057, 1.71, 0.228, 198, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2535, 3h4pa, 0.8057, 1.74, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2536, 5vfuY, 0.8056, 1.58, 0.236, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2537, 5vftN, 0.8056, 1.58, 0.236, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2538, 5vfsH, 0.8056, 1.73, 0.218, 211, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2539, 5vfpIA, 0.8056, 1.77, 0.197, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2540, 5mpcV, 0.8056, 1.73, 0.187, 220, 193, 
2541, 5lf3Y, 0.8056, 1.60, 0.230, 196, 191, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2542, 5l6cK, 0.8056, 1.73, 0.228, 198, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2543, 5l60Y, 0.8056, 2.22, 0.181, 250, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2544, 5l60K, 0.8056, 1.75, 0.281, 202, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2545, 5l5zN, 0.8056, 1.75, 0.281, 202, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2546, 5l5zb, 0.8056, 1.57, 0.236, 191, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2547, 5gjrDA, 0.8056, 1.57, 0.236, 191, 191, 
2548, 4hnpJ, 0.8056, 1.75, 0.192, 220, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2549, 3h4pk, 0.8056, 1.58, 0.236, 191, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2550, 5lf6K, 0.8055, 1.98, 0.224, 199, 196, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2551, 5l6cY, 0.8055, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2552, 5l5eK, 0.8055, 1.93, 0.201, 201, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2553, 5gjqp, 0.8055, 1.73, 0.218, 211, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2554, 2h6jH, 0.8055, 1.91, 0.216, 211, 194, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2555, 5l63Y, 0.8054, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2556, 5l63K, 0.8054, 1.61, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2557, 5l5eY, 0.8054, 1.61, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2558, 5gjrOA, 0.8054, 1.77, 0.197, 201, 193, 
2559, 4cr41, 0.8054, 1.72, 0.228, 198, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2560, 3mg6J, 0.8054, 1.75, 0.281, 202, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2561, 3h4pl, 0.8054, 1.94, 0.201, 200, 194, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2562, 5m32Y, 0.8053, 1.73, 0.218, 211, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2563, 5lf7b, 0.8053, 1.74, 0.202, 211, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2564, 5lf3K, 0.8053, 1.75, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2565, 5lf0N, 0.8053, 2.22, 0.201, 242, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2566, 5l5xY, 0.8053, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2567, 5l5xK, 0.8053, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2568, 4qvnN, 0.8053, 1.74, 0.202, 211, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2569, 4qvnb, 0.8053, 1.73, 0.187, 220, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2570, 3oeuX, 0.8053, 2.33, 0.224, 205, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2571, 3oeuJ, 0.8053, 1.72, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2572, 3h4pg, 0.8053, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2573, 5vfuCA, 0.8052, 1.78, 0.197, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2574, 5vftR, 0.8052, 1.87, 0.233, 203, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2575, 5m32K, 0.8052, 1.94, 0.201, 200, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2576, 5lf7N, 0.8052, 1.69, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2577, 5leyb, 0.8052, 1.91, 0.216, 211, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2578, 5gjrAA, 0.8052, 1.91, 0.216, 211, 194, 
2579, 4intJ, 0.8052, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2580, 3unfV, 0.8052, 1.60, 0.230, 196, 191, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2581, 3unfH, 0.8052, 1.71, 0.228, 198, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2582, 3mg8X, 0.8052, 1.72, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2583, 3mg7J, 0.8052, 1.76, 0.281, 202, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2584, 3mg6X, 0.8052, 1.75, 0.207, 201, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2585, 3h4pd, 0.8052, 1.75, 0.207, 201, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2586, 5vfqJA, 0.8051, 1.78, 0.197, 200, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2587, 5t0gO, 0.8051, 1.87, 0.233, 202, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2588, 5leyN, 0.8051, 1.69, 0.234, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2589, 5le5H, 0.8051, 1.73, 0.187, 220, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2590, 4r3oH, 0.8051, 1.73, 0.228, 198, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2591, 4hrdX, 0.8051, 1.75, 0.181, 219, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2592, 3unfY, 0.8051, 1.75, 0.181, 219, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2593, 5vfuZ, 0.8050, 1.71, 0.228, 198, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2594, 5vftO, 0.8050, 1.71, 0.228, 198, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2595, 4r3oV, 0.8050, 1.71, 0.228, 198, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2596, 3unhV, 0.8050, 1.76, 0.281, 202, 192, MOUSE 20S IMMUNOPROTEASOME
2597, 3unhH, 0.8050, 1.99, 0.230, 199, 196, MOUSE 20S IMMUNOPROTEASOME
2598, 3unfK, 0.8050, 1.72, 0.187, 220, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2599, 3h4pb, 0.8050, 1.69, 0.234, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2600, 5lf3N, 0.8049, 1.72, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2601, 5lf1H, 0.8049, 1.69, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2602, 5l64Y, 0.8049, 1.73, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2603, 5l64K, 0.8049, 1.74, 0.212, 201, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2604, 4jsqX, 0.8049, 1.78, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2605, 4jsqJ, 0.8049, 1.78, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2606, 4intX, 0.8049, 1.69, 0.234, 202, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2607, 3unep, 0.8049, 1.77, 0.181, 219, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2608, 3h4pm, 0.8049, 1.77, 0.181, 219, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2609, 1jd2Q, 0.8049, 1.74, 0.212, 201, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2610, 5lf6Y, 0.8048, 1.75, 0.281, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2611, 5lf6N, 0.8048, 1.87, 0.233, 202, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2612, 5lf1V, 0.8048, 1.73, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2613, 4hrcJ, 0.8048, 1.92, 0.211, 211, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2614, 3nzwX, 0.8048, 1.92, 0.216, 211, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2615, 3nzwJ, 0.8048, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2616, 3mg7X, 0.8048, 1.74, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2617, 5lf6b, 0.8047, 1.74, 0.228, 198, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2618, 4hnpX, 0.8047, 1.70, 0.229, 202, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2619, 3oevJ, 0.8047, 1.75, 0.281, 202, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2620, 1jd2J, 0.8047, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2621, 1fntV, 0.8047, 1.77, 0.202, 201, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2622, 4hrdJ, 0.8046, 1.70, 0.234, 202, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2623, 3uneN, 0.8046, 1.73, 0.187, 220, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2624, 3uneH, 0.8046, 1.74, 0.228, 198, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2625, 3uneb, 0.8046, 1.74, 0.228, 198, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2626, 3h4ph, 0.8046, 1.74, 0.228, 198, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2627, 3h4pf, 0.8046, 1.72, 0.228, 198, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2628, 1q5rN, 0.8046, 1.70, 0.234, 203, 192, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2629, 1q5rM, 0.8046, 1.73, 0.228, 198, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2630, 1q5rL, 0.8046, 1.72, 0.228, 198, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2631, 1q5rI, 0.8046, 1.74, 0.228, 198, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2632, 1fntH, 0.8046, 1.61, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2633, 6bdfZ, 0.8045, 1.74, 0.228, 198, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2634, 6bdfX, 0.8045, 1.88, 0.228, 202, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2635, 6bdfV, 0.8045, 1.74, 0.192, 220, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2636, 6bdfT, 0.8045, 1.88, 0.228, 202, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2637, 6bdfR, 0.8045, 1.76, 0.281, 202, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2638, 6bdfP, 0.8045, 1.76, 0.281, 202, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2639, 6bdfN, 0.8045, 2.24, 0.196, 251, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2640, 6bdfL, 0.8045, 2.23, 0.196, 251, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2641, 6bdfJ, 0.8045, 2.24, 0.196, 251, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2642, 6bdfH, 0.8045, 2.24, 0.196, 251, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2643, 6bdfF, 0.8045, 1.62, 0.230, 196, 191, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2644, 6bdfD, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2645, 6bdfB, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2646, 6bdf1, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2647, 5vfor, 0.8045, 1.62, 0.221, 201, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2648, 5t0gR, 0.8045, 1.62, 0.221, 201, 190, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2649, 5le5V, 0.8045, 1.62, 0.221, 201, 190, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2650, 5gjqs, 0.8045, 1.62, 0.221, 201, 190, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2651, 3unex, 0.8045, 1.62, 0.221, 201, 190, MOUSE CONSTITUTIVE 20S PROTEASOME
2652, 3nzjX, 0.8045, 1.62, 0.221, 201, 190, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2653, 3nzjJ, 0.8045, 1.62, 0.221, 201, 190, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2654, 3mg4J, 0.8045, 1.62, 0.221, 201, 190, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2655, 1q5rK, 0.8045, 1.62, 0.221, 201, 190, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2656, 1q5rJ, 0.8045, 1.62, 0.221, 201, 190, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2657, 1q5rH, 0.8045, 1.62, 0.221, 201, 190, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2658, 5lexb, 0.8044, 1.78, 0.207, 201, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2659, 5gjqe, 0.8044, 1.75, 0.207, 201, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2660, 3sdiX, 0.8044, 1.73, 0.187, 220, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2661, 3sdiJ, 0.8044, 1.78, 0.207, 201, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2662, 3nzxX, 0.8044, 1.74, 0.192, 220, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2663, 3nzxJ, 0.8044, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2664, 3ipmM, 0.8044, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2665, 3ipmK, 0.8044, 1.76, 0.228, 198, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2666, 3ipmH, 0.8044, 2.24, 0.196, 251, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2667, 1iruH, 0.8044, 2.24, 0.196, 251, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2668, 5lf4b, 0.8043, 2.24, 0.196, 251, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2669, 5lf3b, 0.8043, 1.71, 0.234, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2670, 5lexN, 0.8043, 1.78, 0.202, 201, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2671, 5l5zK, 0.8043, 1.76, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2672, 4inrJ, 0.8043, 1.76, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2673, 3okjJ, 0.8043, 1.74, 0.228, 198, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2674, 3ipmN, 0.8043, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2675, 3ipmL, 0.8043, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2676, 3ipmJ, 0.8043, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2677, 3ipmI, 0.8043, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2678, 1j2qI, 0.8043, 1.70, 0.234, 202, 192, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2679, 1j2qH, 0.8043, 1.88, 0.233, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2680, 1iruV, 0.8043, 1.70, 0.234, 203, 192, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2681, 5vfuBA, 0.8042, 1.71, 0.234, 202, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2682, 5vftQ, 0.8042, 1.93, 0.216, 211, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2683, 5l5zY, 0.8042, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2684, 4jsuX, 0.8042, 1.74, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2685, 4jsuJ, 0.8042, 1.73, 0.224, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2686, 4inrX, 0.8042, 1.73, 0.224, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2687, 3une4, 0.8042, 1.73, 0.224, 203, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
2688, 3okjX, 0.8042, 1.73, 0.224, 203, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2689, 1j2qL, 0.8042, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2690, 1j2qJ, 0.8042, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2691, 6avoF, 0.8041, 1.70, 0.234, 202, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2692, 6avoA, 0.8041, 1.99, 0.230, 199, 196, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2693, 5vfqK, 0.8041, 1.99, 0.230, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2694, 5vfpK, 0.8041, 1.93, 0.216, 211, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2695, 5mp9i, 0.8041, 1.75, 0.228, 198, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2696, 5mp92, 0.8041, 1.75, 0.228, 198, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2697, 5lf4N, 0.8041, 1.75, 0.228, 198, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2698, 5a5b1, 0.8041, 1.73, 0.229, 202, 192, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2699, 4gk7X, 0.8041, 1.74, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2700, 4gk7J, 0.8041, 1.64, 0.262, 202, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2701, 4cr31, 0.8041, 1.64, 0.262, 202, 191, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2702, 1j2qN, 0.8041, 1.81, 0.208, 199, 192, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2703, 1j2qM, 0.8041, 1.81, 0.208, 199, 192, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2704, 5m32V, 0.8040, 2.01, 0.230, 199, 196, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2705, 5lexY, 0.8040, 1.80, 0.207, 201, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2706, 3un4J, 0.8040, 0.86, 0.484, 213, 213, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2707, 1j2qK, 0.8040, 2.00, 0.230, 199, 196, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2708, 5vfqL, 0.8039, 1.77, 0.192, 226, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2709, 3un4X, 0.8039, 1.76, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2710, 1g65X, 0.8039, 1.88, 0.233, 202, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2711, 5vfsKA, 0.8038, 2.40, 0.224, 205, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2712, 5m2bY, 0.8038, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2713, 5m2bK, 0.8038, 1.74, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2714, 5leyV, 0.8038, 2.40, 0.224, 205, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2715, 4r67V, 0.8038, 1.64, 0.262, 202, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2716, 4r67H, 0.8038, 1.64, 0.262, 202, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2717, 4cr22, 0.8038, 1.77, 0.181, 220, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2718, 3unej, 0.8038, 1.79, 0.197, 199, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2719, 3unbx, 0.8038, 1.75, 0.228, 198, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2720, 3unbb, 0.8038, 1.64, 0.262, 202, 191, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2721, 3okj2, 0.8038, 0.86, 0.484, 213, 213, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2722, 3mg0X, 0.8038, 1.78, 0.207, 201, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2723, 3mg0J, 0.8038, 1.75, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2724, 3h4pj, 0.8038, 1.76, 0.228, 198, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2725, 5vfpJA, 0.8037, 1.79, 0.207, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2726, 5m32H, 0.8037, 1.76, 0.202, 211, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2727, 4r67x, 0.8037, 1.76, 0.202, 211, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2728, 4r3oW, 0.8037, 1.74, 0.187, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2729, 4r3oI, 0.8037, 1.72, 0.234, 202, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
2730, 4inuJ, 0.8037, 1.72, 0.234, 202, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2731, 4inrK, 0.8037, 1.70, 0.192, 223, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2732, 3mg4K, 0.8037, 1.75, 0.192, 220, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2733, 2f16X, 0.8037, 1.74, 0.192, 220, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2734, 5vfsL, 0.8036, 1.89, 0.228, 202, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2735, 5vfoR, 0.8036, 1.75, 0.230, 195, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2736, 5lf6H, 0.8036, 1.77, 0.228, 198, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2737, 5lezN, 0.8036, 1.76, 0.228, 198, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2738, 5lezb, 0.8036, 1.77, 0.281, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2739, 5leyH, 0.8036, 1.78, 0.207, 201, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2740, 4r67j, 0.8036, 1.78, 0.181, 221, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2741, 2f16J, 0.8036, 1.72, 0.234, 202, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2742, 5lf7H, 0.8035, 1.74, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2743, 4jt0Y, 0.8035, 1.74, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2744, 4jt0K, 0.8035, 1.76, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2745, 4inuX, 0.8035, 1.99, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2746, 3unb4, 0.8035, 2.00, 0.195, 212, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2747, 3sdkV, 0.8035, 1.76, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2748, 5vfpL, 0.8034, 0.88, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2749, 5lf7V, 0.8034, 1.79, 0.207, 201, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2750, 5lf6V, 0.8034, 1.78, 0.207, 201, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2751, 5lf0H, 0.8034, 1.74, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2752, 4inrY, 0.8034, 1.72, 0.234, 202, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2753, 3uneV, 0.8034, 1.72, 0.234, 203, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
2754, 5vfrq, 0.8033, 1.74, 0.187, 220, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2755, 5vfqKA, 0.8033, 1.72, 0.234, 202, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2756, 5mpa2, 0.8033, 1.76, 0.228, 198, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2757, 4jt0X, 0.8033, 1.74, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2758, 4jt0J, 0.8033, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2759, 1g65J, 0.8033, 2.00, 0.195, 212, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2760, 1g0uH, 0.8033, 1.76, 0.228, 198, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2761, 5lexK, 0.8032, 1.90, 0.228, 202, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2762, 5le5Y, 0.8032, 1.77, 0.192, 222, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2763, 5vfuQA, 0.8031, 2.14, 0.201, 215, 204, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2764, 5vftr, 0.8031, 1.79, 0.207, 201, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2765, 5lf4H, 0.8031, 1.75, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2766, 4r3oZ, 0.8031, 1.75, 0.187, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2767, 3un8J, 0.8031, 1.74, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2768, 3mg4X, 0.8031, 1.99, 0.195, 212, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2769, 5vfsK, 0.8030, 1.75, 0.192, 220, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2770, 5lf4V, 0.8030, 2.00, 0.230, 199, 196, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2771, 5lf0V, 0.8030, 1.80, 0.207, 201, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2772, 5lexH, 0.8030, 1.79, 0.192, 226, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2773, 4r3oL, 0.8030, 1.76, 0.228, 198, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2774, 4fzgX, 0.8030, 1.76, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2775, 4fzgJ, 0.8030, 1.76, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2776, 3un8X, 0.8030, 1.75, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2777, 3mg4Y, 0.8030, 1.79, 0.202, 200, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2778, 3d29J, 0.8030, 1.79, 0.197, 199, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
2779, 5vfsJA, 0.8029, 1.79, 0.202, 201, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2780, 5lezH, 0.8029, 1.79, 0.202, 201, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2781, 5lexV, 0.8029, 1.75, 0.187, 220, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2782, 5le5K, 0.8029, 1.80, 0.197, 201, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2783, 4inuY, 0.8029, 1.77, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2784, 4inuK, 0.8029, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2785, 4fzcJ, 0.8029, 1.79, 0.207, 201, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2786, 3d29X, 0.8029, 1.99, 0.230, 199, 196, PROTEASOME INHIBITION BY FELLUTAMIDE B
2787, 5vfrQ, 0.8028, 1.75, 0.187, 220, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2788, 5lf3H, 0.8028, 1.75, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2789, 4jsuK, 0.8028, 1.75, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2790, 4jsqY, 0.8028, 1.80, 0.197, 201, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2791, 4jsqK, 0.8028, 1.77, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2792, 4fzcX, 0.8028, 1.77, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2793, 3un4Y, 0.8028, 1.77, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2794, 3un4K, 0.8028, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2795, 3mg6V, 0.8028, 1.76, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2796, 5lezV, 0.8027, 1.99, 0.230, 199, 196, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2797, 5a0qZ, 0.8027, 1.75, 0.187, 220, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2798, 5a0qL, 0.8027, 1.75, 0.187, 220, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2799, 4jsuY, 0.8027, 1.80, 0.197, 201, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2800, 5lf3V, 0.8026, 2.00, 0.195, 212, 195, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2801, 5l5rK, 0.8026, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2802, 4intY, 0.8026, 1.77, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2803, 3sdiV, 0.8026, 1.76, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2804, 3oevY, 0.8026, 2.04, 0.230, 199, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2805, 3mg7H, 0.8026, 1.75, 0.187, 220, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2806, 1rypY, 0.8026, 2.00, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2807, 1g0uV, 0.8026, 2.00, 0.195, 212, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2808, 5vfrR, 0.8025, 2.01, 0.195, 212, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2809, 5t0jO, 0.8025, 1.77, 0.228, 198, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2810, 5t0cJB, 0.8025, 2.01, 0.195, 212, 195, 
2811, 5t0cDA, 0.8025, 2.01, 0.195, 212, 195, 
2812, 5l5rY, 0.8025, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2813, 4r02Y, 0.8025, 1.76, 0.187, 220, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2814, 5cghV, 0.8024, 1.69, 0.199, 192, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2815, 5a5b7, 0.8024, 1.69, 0.199, 192, 191, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2816, 4r67I, 0.8024, 2.00, 0.195, 212, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2817, 4inrH, 0.8024, 1.76, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2818, 4hnpV, 0.8024, 1.77, 0.202, 211, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2819, 4cr37, 0.8024, 2.01, 0.195, 212, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2820, 3unbp, 0.8024, 1.77, 0.192, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2821, 3oevK, 0.8024, 2.01, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2822, 3mg8V, 0.8024, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2823, 3mg7V, 0.8024, 1.78, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2824, 5l5vV, 0.8023, 1.77, 0.192, 222, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2825, 5l5vH, 0.8023, 1.80, 0.207, 201, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2826, 5l5bK, 0.8023, 1.72, 0.187, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2827, 5cghH, 0.8023, 1.80, 0.207, 201, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2828, 4r67y, 0.8023, 1.80, 0.207, 201, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2829, 4r02V, 0.8023, 1.78, 0.202, 211, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2830, 4intK, 0.8023, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2831, 4eu2I, 0.8023, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2832, 3unbY, 0.8023, 2.72, 0.155, 233, 207, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2833, 5l60V, 0.8022, 1.75, 0.187, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2834, 5l60H, 0.8022, 1.77, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2835, 5l5bY, 0.8022, 1.77, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2836, 4x6zW, 0.8022, 2.72, 0.155, 233, 207, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2837, 4qwjY, 0.8022, 1.72, 0.229, 202, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2838, 4qwjK, 0.8022, 2.02, 0.195, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2839, 3unbN, 0.8022, 1.78, 0.192, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2840, 3un8K, 0.8022, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2841, 3shjK, 0.8022, 1.78, 0.192, 226, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2842, 3sdiH, 0.8022, 1.78, 0.192, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2843, 3oevV, 0.8022, 1.78, 0.202, 211, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2844, 3mkaE, 0.8022, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2845, 3gpwX, 0.8022, 1.75, 0.187, 220, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2846, 3gpwJ, 0.8022, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2847, 3gptY, 0.8022, 2.01, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2848, 3gptK, 0.8022, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2849, 5l6cV, 0.8021, 1.96, 0.206, 201, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2850, 5l6cH, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2851, 5l5tV, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2852, 5l5tH, 0.8021, 1.78, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2853, 5l5qV, 0.8021, 1.79, 0.192, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2854, 5l5qH, 0.8021, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2855, 5fghY, 0.8021, 2.01, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2856, 5fghK, 0.8021, 1.73, 0.229, 202, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2857, 4r67k, 0.8021, 2.02, 0.195, 212, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2858, 4r02K, 0.8021, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2859, 3unbV, 0.8021, 1.78, 0.192, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2860, 3shjY, 0.8021, 1.78, 0.192, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2861, 3oeuV, 0.8021, 2.23, 0.182, 248, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2862, 3mka2, 0.8021, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2863, 3hyeY, 0.8021, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2864, 3gpwY, 0.8021, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2865, 3gpwK, 0.8021, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2866, 3gptJ, 0.8021, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2867, 1fntW, 0.8021, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2868, 5l64V, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2869, 5l64H, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2870, 5l61V, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2871, 5l61H, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2872, 5l5sV, 0.8020, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2873, 5l5sH, 0.8020, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2874, 5l55V, 0.8020, 1.76, 0.187, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2875, 5l55H, 0.8020, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2876, 5jhrY, 0.8020, 1.76, 0.192, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2877, 5jhrK, 0.8020, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2878, 5fhsY, 0.8020, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2879, 4y8kY, 0.8020, 2.20, 0.182, 246, 198, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2880, 4r67W, 0.8020, 2.02, 0.195, 212, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2881, 4q1sJ, 0.8020, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2882, 3mg8H, 0.8020, 2.02, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2883, 3hyeK, 0.8020, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2884, 3gptX, 0.8020, 1.77, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2885, 1rypK, 0.8020, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2886, 1iruZ, 0.8020, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2887, 1iruL, 0.8020, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2888, 1fntI, 0.8020, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2889, 6gopK, 0.8019, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2890, 5vfrr, 0.8019, 1.78, 0.192, 226, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2891, 5l5hV, 0.8019, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2892, 5l5hH, 0.8019, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2893, 5fhsK, 0.8019, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2894, 4y8kK, 0.8019, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2895, 4y7xY, 0.8019, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2896, 4y7xK, 0.8019, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2897, 4r02H, 0.8019, 1.76, 0.187, 220, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2898, 4qluV, 0.8019, 1.80, 0.228, 198, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2899, 4qluH, 0.8019, 1.78, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2900, 4lqiJ, 0.8019, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2901, 4hnpH, 0.8019, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2902, 4cr42, 0.8019, 1.79, 0.228, 198, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2903, 3un8Y, 0.8019, 1.81, 0.202, 201, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2904, 3nzjY, 0.8019, 1.81, 0.202, 201, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2905, 3nzjV, 0.8019, 1.77, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2906, 3nzjK, 0.8019, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2907, 3mg6H, 0.8019, 1.81, 0.207, 201, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2908, 3gpjY, 0.8019, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2909, 3gpjX, 0.8019, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2910, 2zcyX, 0.8019, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2911, 2zcyJ, 0.8019, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2912, 2gplX, 0.8019, 2.02, 0.195, 212, 195, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2913, 2gplJ, 0.8019, 2.02, 0.195, 212, 195, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2914, 2fakY, 0.8019, 1.78, 0.192, 226, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2915, 6gopY, 0.8018, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2916, 5wvkA, 0.8018, 1.79, 0.192, 222, 193, 
2917, 5mpcH, 0.8018, 1.78, 0.228, 198, 193, 
2918, 5l67V, 0.8018, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2919, 5l67H, 0.8018, 1.76, 0.192, 223, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2920, 5fggY, 0.8018, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2921, 5fggK, 0.8018, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2922, 5d0tV, 0.8018, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2923, 5d0tH, 0.8018, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2924, 4y8kV, 0.8018, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2925, 4y8kH, 0.8018, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2926, 4y7yY, 0.8018, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2927, 4y7yK, 0.8018, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2928, 4x6zI, 0.8018, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2929, 4qvwY, 0.8018, 1.78, 0.228, 198, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2930, 4qvwK, 0.8018, 1.78, 0.228, 198, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2931, 4q1sH, 0.8018, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2932, 4ltcV, 0.8018, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2933, 4lqiX, 0.8018, 1.82, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2934, 4j70J, 0.8018, 1.83, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2935, 4intV, 0.8018, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2936, 4intH, 0.8018, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2937, 3unhN, 0.8018, 2.01, 0.190, 212, 195, MOUSE 20S IMMUNOPROTEASOME
2938, 3unhb, 0.8018, 2.01, 0.190, 212, 195, MOUSE 20S IMMUNOPROTEASOME
2939, 3sdkH, 0.8018, 1.79, 0.192, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2940, 3oeuY, 0.8018, 1.79, 0.192, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2941, 3oeuH, 0.8018, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2942, 3nzjH, 0.8018, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2943, 3gpjK, 0.8018, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2944, 3gpjJ, 0.8018, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2945, 2fakK, 0.8018, 1.79, 0.192, 221, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2946, 1g65Y, 0.8018, 2.02, 0.190, 212, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2947, 5lttV, 0.8017, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2948, 5lttH, 0.8017, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2949, 5l5iV, 0.8017, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2950, 5l5iH, 0.8017, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2951, 5fggX, 0.8017, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2952, 5fggJ, 0.8017, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2953, 5d0xY, 0.8017, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2954, 5cz9Y, 0.8017, 1.67, 0.215, 199, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2955, 5cz9K, 0.8017, 1.67, 0.215, 199, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2956, 4qlsV, 0.8017, 1.78, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2957, 4qlsH, 0.8017, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2958, 4inrV, 0.8017, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2959, 3unb1, 0.8017, 1.78, 0.192, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2960, 3mg4V, 0.8017, 2.01, 0.195, 212, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2961, 5laiV, 0.8016, 1.78, 0.228, 198, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2962, 5laiH, 0.8016, 2.02, 0.195, 212, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2963, 5l5uV, 0.8016, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2964, 5l5uH, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2965, 5l5rH, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2966, 5l5pV, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2967, 5fgiJ, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2968, 5d0xK, 0.8016, 1.69, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2969, 4y81V, 0.8016, 1.69, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2970, 4qwkY, 0.8016, 2.02, 0.195, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2971, 4qwkK, 0.8016, 2.02, 0.190, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2972, 4qw3Y, 0.8016, 2.02, 0.190, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2973, 4qw3K, 0.8016, 1.79, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2974, 4ltcK, 0.8016, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2975, 4lqiV, 0.8016, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2976, 4lqiH, 0.8016, 1.80, 0.207, 201, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2977, 4j70X, 0.8016, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2978, 3uneK, 0.8016, 1.79, 0.192, 226, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2979, 3unbH, 0.8016, 1.79, 0.192, 226, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2980, 3oevH, 0.8016, 1.79, 0.192, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2981, 3mg4H, 0.8016, 1.79, 0.192, 226, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2982, 2fakJ, 0.8016, 1.79, 0.192, 226, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2983, 1g65K, 0.8016, 1.79, 0.192, 226, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2984, 5l69V, 0.8015, 1.69, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2985, 5l69H, 0.8015, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2986, 5l5rV, 0.8015, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2987, 5l5pH, 0.8015, 2.02, 0.185, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2988, 5jhsV, 0.8015, 2.02, 0.185, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2989, 5jhsH, 0.8015, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2990, 5cggV, 0.8015, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2991, 5cggH, 0.8015, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2992, 4y81H, 0.8015, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2993, 4qwsY, 0.8015, 1.78, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2994, 4qwsK, 0.8015, 1.79, 0.228, 198, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2995, 4qwiY, 0.8015, 1.80, 0.207, 201, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2996, 4qwiK, 0.8015, 1.77, 0.192, 220, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2997, 4q1sX, 0.8015, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2998, 4inuH, 0.8015, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2999, 3tddX, 0.8015, 1.79, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3000, 3tddJ, 0.8015, 2.01, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3001, 3okjH, 0.8015, 1.79, 0.192, 226, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3002, 3hyeX, 0.8015, 1.79, 0.192, 226, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3003, 3hyeJ, 0.8015, 1.79, 0.192, 226, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3004, 2fakX, 0.8015, 1.79, 0.192, 226, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3005, 5m2bV, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3006, 5m2bH, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3007, 5l62V, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3008, 5l62H, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3009, 5l5oV, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3010, 5l5oH, 0.8014, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3011, 5l5jV, 0.8014, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3012, 5l5jH, 0.8014, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3013, 5l5aY, 0.8014, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3014, 5l5aK, 0.8014, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3015, 5dkiY, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3016, 5dkiK, 0.8014, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3017, 4y8qY, 0.8014, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3018, 4y8qV, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3019, 4y8qH, 0.8014, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3020, 4y7xV, 0.8014, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3021, 4y7xH, 0.8014, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3022, 4qz7V, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3023, 4qz7H, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3024, 4qwrY, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3025, 4qwrK, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3026, 4qwlX, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3027, 4qwlJ, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3028, 4qwkV, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3029, 4qw6J, 0.8014, 1.79, 0.192, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3030, 4qw1Y, 0.8014, 1.79, 0.202, 211, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3031, 4qw1K, 0.8014, 1.79, 0.202, 211, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3032, 4qvlY, 0.8014, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH BORTEZOMIB
3033, 4ltcY, 0.8014, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3034, 4ltcH, 0.8014, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3035, 3okjV, 0.8014, 1.80, 0.192, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3036, 3nzwV, 0.8014, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3037, 3nzwH, 0.8014, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3038, 3mg8Y, 0.8014, 1.80, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3039, 3mg0K, 0.8014, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3040, 3bdmX, 0.8014, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3041, 3bdmJ, 0.8014, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3042, 5jhrX, 0.8013, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3043, 5jhrJ, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3044, 5dkjY, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3045, 5dkjK, 0.8013, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3046, 5d0sX, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3047, 5d0sJ, 0.8013, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3048, 5bxnY, 0.8013, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3049, 4y8qK, 0.8013, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3050, 4y75H, 0.8013, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3051, 4qwkH, 0.8013, 1.79, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3052, 4qw6X, 0.8013, 1.79, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3053, 4qw5X, 0.8013, 1.79, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3054, 4q1sV, 0.8013, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3055, 4no1Y, 0.8013, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3056, 4no1K, 0.8013, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3057, 4hrcK, 0.8013, 1.79, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3058, 3unfN, 0.8013, 1.79, 0.228, 198, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3059, 3unfb, 0.8013, 1.70, 0.229, 195, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3060, 3unbK, 0.8013, 1.70, 0.229, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3061, 3shjX, 0.8013, 2.02, 0.195, 212, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3062, 3okjY, 0.8013, 2.02, 0.195, 212, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3063, 3okjK, 0.8013, 1.70, 0.229, 195, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3064, 3bdmY, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3065, 2f16K, 0.8013, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3066, 1jd2H, 0.8013, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3067, 1g0uX, 0.8013, 1.79, 0.192, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3068, 5lajV, 0.8012, 1.80, 0.192, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3069, 5l65V, 0.8012, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3070, 5l65H, 0.8012, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3071, 5l54V, 0.8012, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3072, 5l54H, 0.8012, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3073, 5l52V, 0.8012, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3074, 5l52H, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3075, 5d0vY, 0.8012, 1.69, 0.215, 199, 191, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3076, 5d0tY, 0.8012, 1.69, 0.215, 199, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3077, 5d0tK, 0.8012, 1.81, 0.207, 201, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3078, 5cgfH, 0.8012, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3079, 5bxnK, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3080, 4y75V, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3081, 4v7oW, 0.8012, 2.02, 0.195, 212, 195, 
3082, 4rurH, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3083, 4r18V, 0.8012, 1.79, 0.192, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3084, 4r18H, 0.8012, 1.81, 0.228, 198, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3085, 4r17H, 0.8012, 1.80, 0.192, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3086, 4qzwY, 0.8012, 1.79, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3087, 4qw7Y, 0.8012, 1.79, 0.192, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3088, 4qw7X, 0.8012, 1.80, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3089, 4qw7K, 0.8012, 1.80, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3090, 4qw7J, 0.8012, 1.80, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3091, 4qw5J, 0.8012, 1.80, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3092, 4qvpY, 0.8012, 2.04, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3093, 4qvpK, 0.8012, 2.02, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3094, 4qvlK, 0.8012, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH BORTEZOMIB
3095, 4no8V, 0.8012, 1.80, 0.192, 226, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3096, 4no8H, 0.8012, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3097, 4hrcH, 0.8012, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3098, 4gk7Y, 0.8012, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3099, 4gk7K, 0.8012, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3100, 3shjJ, 0.8012, 1.80, 0.192, 226, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3101, 3mg7K, 0.8012, 1.80, 0.192, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3102, 3bdmK, 0.8012, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3103, 2gplK, 0.8012, 2.03, 0.195, 212, 195, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3104, 1z7qW, 0.8012, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3105, 1z7qI, 0.8012, 1.70, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3106, 5lajH, 0.8011, 2.02, 0.195, 212, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3107, 5l6aV, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3108, 5l6aH, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3109, 5l5yV, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3110, 5l5yH, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3111, 5l5eV, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3112, 5l5eH, 0.8011, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3113, 5fhsV, 0.8011, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3114, 5fhsH, 0.8011, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3115, 5fgiX, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3116, 5fgeX, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3117, 5fgaH, 0.8011, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3118, 5d0vJ, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3119, 5d0sY, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3120, 5d0sK, 0.8011, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3121, 5cz9H, 0.8011, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3122, 5cz5Y, 0.8011, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3123, 5cz5K, 0.8011, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3124, 5cggX, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3125, 5cggJ, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3126, 5cgfV, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3127, 4ya9X, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3128, 4ya9J, 0.8011, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3129, 4y8oV, 0.8011, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3130, 4y8lH, 0.8011, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3131, 4y82V, 0.8011, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3132, 4y82H, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3133, 4v7oQA, 0.8011, 1.70, 0.229, 195, 192, 
3134, 4v7oI, 0.8011, 1.80, 0.192, 226, 193, 
3135, 4v7oEB, 0.8011, 1.70, 0.229, 195, 192, 
3136, 4r17V, 0.8011, 2.02, 0.195, 212, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3137, 4qzwK, 0.8011, 2.02, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3138, 4qz6X, 0.8011, 1.80, 0.192, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3139, 4qz6J, 0.8011, 2.03, 0.195, 212, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3140, 4qz0X, 0.8011, 2.03, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3141, 4qz0J, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3142, 4qwgV, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3143, 4qwgH, 0.8011, 1.80, 0.192, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3144, 4qw6Y, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3145, 4qvnK, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3146, 4qvnJ, 0.8011, 1.80, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3147, 4qvmY, 0.8011, 1.80, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3148, 4qvmK, 0.8011, 1.80, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3149, 4hrdV, 0.8011, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3150, 3mg7Y, 0.8011, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3151, 3mg6Y, 0.8011, 0.43, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3152, 2f16Y, 0.8011, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3153, 1rypL, 0.8011, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3154, 5l63H, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3155, 5l5wH, 0.8010, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3156, 5jhsX, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3157, 5jhsJ, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3158, 5fghV, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3159, 5fghH, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3160, 5fgeJ, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3161, 5fgeH, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3162, 5fgdV, 0.8010, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3163, 5fgdH, 0.8010, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3164, 5fgaV, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3165, 5d0zJ, 0.8010, 2.03, 0.200, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3166, 5d0wV, 0.8010, 2.03, 0.200, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3167, 5d0wH, 0.8010, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3168, 5d0vX, 0.8010, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3169, 5czaH, 0.8010, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3170, 5cz9X, 0.8010, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3171, 5cz9V, 0.8010, 2.03, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3172, 5cz9J, 0.8010, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3173, 5cz8X, 0.8010, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3174, 5cz8J, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3175, 5ahjX, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3176, 5ahjJ, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3177, 4y8oH, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3178, 4y8mV, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3179, 4y8mH, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3180, 4y82Y, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3181, 4y82K, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3182, 4y80K, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3183, 4y78K, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3184, 4y6vV, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3185, 4x6zY, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3186, 4rurV, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3187, 4qwrJ, 0.8010, 1.80, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3188, 4qwjV, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3189, 4qwjH, 0.8010, 1.80, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3190, 4qwgY, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3191, 4qwfX, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3192, 4qwfJ, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3193, 4qw6K, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3194, 4qvyY, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3195, 4qvyK, 0.8010, 1.80, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3196, 4qvvY, 0.8010, 1.80, 0.192, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3197, 4qvvK, 0.8010, 1.80, 0.192, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3198, 4qvqY, 0.8010, 2.03, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3199, 4qvqK, 0.8010, 2.03, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3200, 4qvnY, 0.8010, 2.03, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3201, 4qv7H, 0.8010, 2.03, 0.195, 212, 195, YCP BETA5-A50V MUTANT
3202, 4qv6Y, 0.8010, 1.80, 0.192, 226, 193, YCP BETA5-A49V MUTANT
3203, 4qv6K, 0.8010, 1.76, 0.228, 196, 193, YCP BETA5-A49V MUTANT
3204, 3wxrY, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3205, 3un8H, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3206, 3shjV, 0.8010, 1.81, 0.192, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3207, 3nzxV, 0.8010, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3208, 3nzxH, 0.8010, 2.03, 0.190, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3209, 1jd2O, 0.8010, 1.70, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3210, 1g0uK, 0.8010, 1.70, 0.229, 195, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3211, 1g0uJ, 0.8010, 2.02, 0.195, 212, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3212, 5mpbW, 0.8009, 2.03, 0.190, 212, 195, 
3213, 5l68V, 0.8009, 2.03, 0.190, 212, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3214, 5l68H, 0.8009, 2.03, 0.190, 212, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3215, 5l63V, 0.8009, 2.03, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3216, 5l5wV, 0.8009, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3217, 5l5bH, 0.8009, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3218, 5l55X, 0.8009, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3219, 5l55J, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3220, 5fgiY, 0.8009, 2.03, 0.190, 212, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3221, 5fgiK, 0.8009, 2.03, 0.190, 212, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3222, 5fgeV, 0.8009, 1.81, 0.228, 198, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3223, 5d0zY, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3224, 5d0zX, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3225, 5d0zK, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3226, 5d0tX, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3227, 5d0tJ, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3228, 5czaV, 0.8009, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3229, 5cz4H, 0.8009, 1.81, 0.228, 198, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3230, 5bouV, 0.8009, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3231, 5bouH, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3232, 4y8sY, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3233, 4y8sK, 0.8009, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3234, 4y8pX, 0.8009, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3235, 4y8pJ, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3236, 4y8lV, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3237, 4y80Y, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3238, 4y78Y, 0.8009, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3239, 4y77H, 0.8009, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3240, 4y6vH, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3241, 4qz6Y, 0.8009, 2.03, 0.195, 212, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3242, 4qz6K, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3243, 4qwrX, 0.8009, 2.03, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3244, 4qwlY, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3245, 4qwgK, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3246, 4qw5Y, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3247, 4qw5K, 0.8009, 1.81, 0.192, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3248, 4qvqX, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3249, 4qvnX, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3250, 4qv7V, 0.8009, 2.03, 0.195, 212, 195, YCP BETA5-A50V MUTANT
3251, 4qv5V, 0.8009, 2.03, 0.195, 212, 195, YCP BETA5-M45I MUTANT
3252, 4qv5H, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT
3253, 4qv3V, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT
3254, 4qv3H, 0.8009, 1.80, 0.192, 222, 193, YCP BETA5-M45V MUTANT
3255, 4qltV, 0.8009, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3256, 4qltH, 0.8009, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3257, 4j70K, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3258, 4eu2W, 0.8009, 1.80, 0.192, 226, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3259, 3un8V, 0.8009, 2.03, 0.185, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3260, 3shjH, 0.8009, 2.03, 0.185, 212, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3261, 3mg6K, 0.8009, 1.70, 0.229, 195, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3262, 5l5bV, 0.8008, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3263, 5l5aV, 0.8008, 2.03, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3264, 5jhsY, 0.8008, 2.03, 0.200, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3265, 5jhsK, 0.8008, 2.03, 0.200, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3266, 5fggV, 0.8008, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3267, 5d0sV, 0.8008, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3268, 5cggY, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3269, 4zzgW, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3270, 4ya7J, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3271, 4y9yH, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3272, 4y8iV, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3273, 4y8gX, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3274, 4y8gJ, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3275, 4y7wY, 0.8008, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3276, 4y77V, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3277, 4y6aV, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3278, 4y6aH, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3279, 4r00Y, 0.8008, 2.03, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3280, 4r00K, 0.8008, 1.80, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3281, 4qz5Y, 0.8008, 1.80, 0.192, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3282, 4qz5K, 0.8008, 2.03, 0.195, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3283, 4qz2X, 0.8008, 2.03, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3284, 4qz2J, 0.8008, 1.80, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3285, 4qwlK, 0.8008, 1.80, 0.192, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3286, 4qwlH, 0.8008, 2.03, 0.195, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3287, 4qwiV, 0.8008, 1.80, 0.192, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3288, 4qwiH, 0.8008, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3289, 4qwfK, 0.8008, 1.80, 0.192, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3290, 4qvqJ, 0.8008, 1.81, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3291, 4quxV, 0.8008, 1.70, 0.229, 195, 192, YCP BETA5-A49T-MUTANT
3292, 4quxH, 0.8008, 1.70, 0.229, 195, 192, YCP BETA5-A49T-MUTANT
3293, 4inuV, 0.8008, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3294, 4hrdK, 0.8008, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3295, 4hrdH, 0.8008, 1.80, 0.197, 226, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3296, 3uneY, 0.8008, 1.80, 0.197, 226, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3297, 3e47Y, 0.8008, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3298, 3e47K, 0.8008, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3299, 1jd2K, 0.8008, 2.03, 0.190, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3300, 1g65H, 0.8008, 2.03, 0.190, 212, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3301, 5nifW, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3302, 5mpcI, 0.8007, 1.70, 0.229, 195, 192, 
3303, 5mpbV, 0.8007, 2.03, 0.190, 212, 195, 
3304, 5l5wY, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3305, 5l5wK, 0.8007, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3306, 5l5aH, 0.8007, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3307, 5l52X, 0.8007, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3308, 5l52J, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3309, 5fhsX, 0.8007, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3310, 5fhsJ, 0.8007, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3311, 5fggH, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3312, 5d0sH, 0.8007, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3313, 5cz5X, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3314, 5cz5J, 0.8007, 1.81, 0.207, 201, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3315, 5cz4V, 0.8007, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3316, 5cghY, 0.8007, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3317, 5cghK, 0.8007, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3318, 5cggK, 0.8007, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3319, 4ya7X, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3320, 4ya5V, 0.8007, 1.86, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3321, 4ya5H, 0.8007, 1.66, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3322, 4y9yV, 0.8007, 1.80, 0.212, 211, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3323, 4y8nV, 0.8007, 1.80, 0.212, 211, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3324, 4y8nH, 0.8007, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3325, 4y8lY, 0.8007, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3326, 4y8lK, 0.8007, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3327, 4y8iH, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3328, 4y8hX, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3329, 4y8hJ, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3330, 4y81Y, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3331, 4y81K, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3332, 4y7wK, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3333, 4y77Y, 0.8007, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3334, 4y70Y, 0.8007, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3335, 4y70K, 0.8007, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3336, 4qz4X, 0.8007, 2.03, 0.195, 212, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3337, 4qz4J, 0.8007, 1.71, 0.229, 195, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3338, 4qwsV, 0.8007, 1.80, 0.197, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3339, 4qwsH, 0.8007, 1.80, 0.197, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3340, 4qwlV, 0.8007, 1.80, 0.192, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3341, 4qwfY, 0.8007, 1.80, 0.192, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3342, 4qw4X, 0.8007, 1.80, 0.192, 226, 193, YCP IN COMPLEX WITH CARFILZOMIB
3343, 4qw4J, 0.8007, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH CARFILZOMIB
3344, 4qw1X, 0.8007, 2.03, 0.195, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3345, 4qvpX, 0.8007, 1.81, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3346, 4qvpJ, 0.8007, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3347, 4qv4V, 0.8007, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT
3348, 4qv4H, 0.8007, 2.03, 0.195, 212, 195, YCP BETA5-M45T MUTANT
3349, 4qv1V, 0.8007, 2.03, 0.195, 212, 195, YCP BETA5-M45A MUTANT
3350, 4qv1H, 0.8007, 2.03, 0.195, 212, 195, YCP BETA5-M45A MUTANT
3351, 4qv0K, 0.8007, 2.03, 0.195, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3352, 4qlvH, 0.8007, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3353, 4qlqX, 0.8007, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3354, 4qlqJ, 0.8007, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3355, 4no8Y, 0.8007, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3356, 3oeuK, 0.8007, 1.81, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3357, 3nzxY, 0.8007, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3358, 3nzxK, 0.8007, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3359, 2fakH, 0.8007, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3360, 1rypZ, 0.8007, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3361, 5l5dV, 0.8006, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3362, 5l5dH, 0.8006, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3363, 5jhrV, 0.8006, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3364, 5jhrH, 0.8006, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3365, 5cz6V, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3366, 5cz6H, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3367, 5cz5V, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3368, 5cz5H, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3369, 5cghX, 0.8006, 2.04, 0.185, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3370, 5cghJ, 0.8006, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3371, 4z1lK, 0.8006, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3372, 4ya4V, 0.8006, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3373, 4ya4H, 0.8006, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3374, 4ya1H, 0.8006, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3375, 4y9zY, 0.8006, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3376, 4y9zJ, 0.8006, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3377, 4y8lJ, 0.8006, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3378, 4y77K, 0.8006, 2.04, 0.190, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3379, 4y69H, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3380, 4qzxY, 0.8006, 1.80, 0.192, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3381, 4qzxK, 0.8006, 1.80, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3382, 4qwxX, 0.8006, 1.80, 0.192, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3383, 4qwxJ, 0.8006, 1.80, 0.192, 226, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3384, 4qw7H, 0.8006, 1.80, 0.192, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3385, 4qw4V, 0.8006, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
3386, 4qw4H, 0.8006, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
3387, 4qw1J, 0.8006, 1.71, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3388, 4qw0Y, 0.8006, 1.71, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3389, 4qv9Y, 0.8006, 2.05, 0.195, 212, 195, YCP BETA5-C63F MUTANT
3390, 4qv9K, 0.8006, 1.80, 0.197, 226, 193, YCP BETA5-C63F MUTANT
3391, 4qv8V, 0.8006, 1.80, 0.197, 226, 193, YCP BETA5-C52F MUTANT
3392, 4qv8H, 0.8006, 1.80, 0.192, 226, 193, YCP BETA5-C52F MUTANT
3393, 4quyV, 0.8006, 2.03, 0.195, 212, 195, YCP BETA5-A49S-MUTANT
3394, 4quyH, 0.8006, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT
3395, 4qlvV, 0.8006, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3396, 4qlsY, 0.8006, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3397, 4qlsK, 0.8006, 1.80, 0.192, 226, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3398, 4no8K, 0.8006, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3399, 4nnnJ, 0.8006, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH MG132
3400, 4jt0V, 0.8006, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3401, 4jt0H, 0.8006, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3402, 4jsqV, 0.8006, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3403, 4jsqH, 0.8006, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3404, 4j70V, 0.8006, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3405, 3unbj, 0.8006, 1.70, 0.229, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3406, 3mg8K, 0.8006, 2.04, 0.185, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3407, 2fakV, 0.8006, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3408, 1g65V, 0.8006, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3409, 5nifI, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3410, 5l6bV, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3411, 5l6bH, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3412, 5l5xV, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3413, 5l5xH, 0.8005, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3414, 5fgfX, 0.8005, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3415, 5d0zV, 0.8005, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3416, 5d0zH, 0.8005, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3417, 5cgiX, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3418, 5cgiJ, 0.8005, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3419, 4zzgZ, 0.8005, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3420, 4z1lY, 0.8005, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3421, 4ya2X, 0.8005, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3422, 4ya2J, 0.8005, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3423, 4y9zX, 0.8005, 1.79, 0.197, 220, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3424, 4y9zK, 0.8005, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3425, 4y8uH, 0.8005, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3426, 4y8sX, 0.8005, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3427, 4y8sJ, 0.8005, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3428, 4y8lX, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3429, 4y84V, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3430, 4y84H, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3431, 4y6zV, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3432, 4y6zK, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3433, 4y6zH, 0.8005, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3434, 4qzzY, 0.8005, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH OMURALIDE
3435, 4qzzK, 0.8005, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH OMURALIDE
3436, 4qzwX, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3437, 4qz7X, 0.8005, 2.04, 0.195, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3438, 4qz7J, 0.8005, 2.05, 0.195, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3439, 4qz5V, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3440, 4qz5H, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3441, 4qz3Y, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3442, 4qz3X, 0.8005, 2.03, 0.195, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3443, 4qz3J, 0.8005, 1.81, 0.192, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3444, 4qz1X, 0.8005, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3445, 4qz1J, 0.8005, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3446, 4qwuJ, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3447, 4qw7V, 0.8005, 1.81, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3448, 4qw0K, 0.8005, 1.80, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3449, 4qv8Y, 0.8005, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT
3450, 4qv8K, 0.8005, 2.03, 0.195, 212, 195, YCP BETA5-C52F MUTANT
3451, 4qluX, 0.8005, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3452, 4qluJ, 0.8005, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3453, 4nnwX, 0.8005, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3454, 4nnwJ, 0.8005, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3455, 4nnnX, 0.8005, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH MG132
3456, 4hrdY, 0.8005, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3457, 4hnpY, 0.8005, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3458, 4hnpK, 0.8005, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3459, 4eu2K, 0.8005, 2.03, 0.190, 212, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3460, 3unem, 0.8005, 1.71, 0.229, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3461, 3sdiK, 0.8005, 1.71, 0.229, 195, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3462, 3dy3V, 0.8005, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3463, 3dy3H, 0.8005, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3464, 1jd2R, 0.8005, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3465, 1iruW, 0.8005, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3466, 5vfpGA, 0.8004, 2.04, 0.185, 212, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3467, 5l54Y, 0.8004, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3468, 5l54K, 0.8004, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3469, 5l52Y, 0.8004, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3470, 5l52K, 0.8004, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3471, 5fgfV, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3472, 5fgfH, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3473, 5fgdX, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3474, 5fgdJ, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3475, 5bxnJ, 0.8004, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3476, 4zzgI, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3477, 4z1lH, 0.8004, 1.78, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3478, 4ya7Y, 0.8004, 1.81, 0.207, 201, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3479, 4ya7K, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3480, 4ya2Y, 0.8004, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3481, 4ya2K, 0.8004, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3482, 4ya1V, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3483, 4y8uV, 0.8004, 1.79, 0.192, 220, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3484, 4y8pV, 0.8004, 1.84, 0.192, 220, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3485, 4y8pH, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3486, 4y8kX, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3487, 4y8kJ, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3488, 4y8jY, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3489, 4y8jK, 0.8004, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3490, 4y8iY, 0.8004, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3491, 4y8iK, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3492, 4y77X, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3493, 4y77J, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3494, 4y75Y, 0.8004, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3495, 4y75X, 0.8004, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3496, 4y75K, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3497, 4y75J, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3498, 4y6zY, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3499, 4y69V, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3500, 4r02X, 0.8004, 1.81, 0.192, 226, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3501, 4qzwJ, 0.8004, 1.81, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3502, 4qw6V, 0.8004, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3503, 4qw6H, 0.8004, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3504, 4qv0Y, 0.8004, 1.71, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3505, 4qlvY, 0.8004, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3506, 4qlvK, 0.8004, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3507, 4no8J, 0.8004, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3508, 3une1, 0.8004, 2.03, 0.195, 212, 195, MOUSE CONSTITUTIVE 20S PROTEASOME
3509, 3unbm, 0.8004, 2.03, 0.195, 212, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3510, 3un4V, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3511, 3un4H, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3512, 3oevX, 0.8004, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3513, 3nzwY, 0.8004, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3514, 3nzwK, 0.8004, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3515, 3e47X, 0.8004, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3516, 3e47J, 0.8004, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3517, 1iruI, 0.8004, 1.81, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3518, 5fgfJ, 0.8003, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3519, 5bxnX, 0.8003, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3520, 4z1lV, 0.8003, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3521, 4y8oK, 0.8003, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3522, 4y7yX, 0.8003, 2.04, 0.185, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3523, 4y74Y, 0.8003, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3524, 4qzxX, 0.8003, 2.03, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3525, 4qzxJ, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3526, 4qz5X, 0.8003, 1.82, 0.207, 201, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3527, 4qz5J, 0.8003, 1.82, 0.207, 201, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3528, 4qz3K, 0.8003, 1.81, 0.192, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3529, 4qxjX, 0.8003, 1.81, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3530, 4qxjJ, 0.8003, 1.72, 0.229, 197, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3531, 4qwsX, 0.8003, 2.03, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3532, 4qwsJ, 0.8003, 2.03, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3533, 4qwrV, 0.8003, 1.82, 0.228, 198, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3534, 4qwrH, 0.8003, 1.82, 0.228, 198, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3535, 4qwkX, 0.8003, 1.79, 0.192, 220, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3536, 4qwkJ, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3537, 4qwiX, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3538, 4qwiJ, 0.8003, 1.81, 0.192, 226, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3539, 4qw4Y, 0.8003, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH CARFILZOMIB
3540, 4qw4K, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH CARFILZOMIB
3541, 4qvyV, 0.8003, 2.03, 0.195, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3542, 4qvyH, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3543, 4qvlJ, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH BORTEZOMIB
3544, 4qv0H, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3545, 4qlqV, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3546, 4qlqH, 0.8003, 2.03, 0.190, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3547, 4no9X, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3548, 4no9J, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3549, 4no9H, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3550, 4no8X, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3551, 4no1X, 0.8003, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3552, 4no1J, 0.8003, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3553, 4nnnK, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH MG132
3554, 4j70H, 0.8003, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3555, 3wxrW, 0.8003, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3556, 3wxrI, 0.8003, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3557, 3mg0Y, 0.8003, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3558, 2zcyY, 0.8003, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3559, 2zcyK, 0.8003, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3560, 2gplY, 0.8003, 1.81, 0.192, 226, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3561, 1g0uY, 0.8003, 1.70, 0.229, 195, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3562, 5t0cZ, 0.8002, 1.81, 0.192, 226, 193, 
3563, 5t0cFB, 0.8002, 1.81, 0.192, 222, 193, 
3564, 5l55Y, 0.8002, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3565, 5l55K, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3566, 5fgaY, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3567, 5fgaK, 0.8002, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3568, 5d0wY, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3569, 5d0wK, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3570, 5cgiY, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3571, 5cgiK, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3572, 5cgfY, 0.8002, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3573, 5a5b2, 0.8002, 1.81, 0.192, 222, 193, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3574, 4ya9Y, 0.8002, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3575, 4y8pY, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3576, 4y8oY, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3577, 4y8jX, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3578, 4y8jJ, 0.8002, 1.88, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3579, 4y8iX, 0.8002, 1.88, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3580, 4y8iJ, 0.8002, 1.65, 0.236, 191, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3581, 4y8hV, 0.8002, 1.65, 0.236, 191, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3582, 4y8gV, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3583, 4y8gH, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3584, 4y84X, 0.8002, 2.05, 0.190, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3585, 4y84J, 0.8002, 2.05, 0.190, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3586, 4y7yJ, 0.8002, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3587, 4y74K, 0.8002, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3588, 4y74J, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3589, 4qz3V, 0.8002, 2.03, 0.195, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3590, 4qz3H, 0.8002, 2.05, 0.195, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3591, 4qw5V, 0.8002, 1.76, 0.192, 223, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3592, 4qw5H, 0.8002, 2.03, 0.195, 212, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3593, 4qv0V, 0.8002, 2.03, 0.195, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3594, 4qltX, 0.8002, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3595, 4qltJ, 0.8002, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3596, 4no9V, 0.8002, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3597, 4no1V, 0.8002, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3598, 4no1H, 0.8002, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3599, 4nnnY, 0.8002, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH MG132
3600, 4hrcV, 0.8002, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3601, 4cr32, 0.8002, 1.81, 0.192, 222, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3602, 3tddY, 0.8002, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3603, 3tddK, 0.8002, 1.71, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3604, 3sdiY, 0.8002, 1.71, 0.229, 195, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3605, 3jcpRA, 0.8002, 2.03, 0.195, 212, 195, 
3606, 3jcpD, 0.8002, 1.71, 0.229, 195, 192, 
3607, 3e47V, 0.8002, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3608, 3d29V, 0.8002, 1.81, 0.192, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3609, 3d29H, 0.8002, 1.81, 0.192, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3610, 1rypW, 0.8002, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3611, 1rypI, 0.8002, 1.81, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3612, 5nifZ, 0.8001, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3613, 5cgfK, 0.8001, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3614, 5ahjY, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3615, 5ahjK, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3616, 4ya9K, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3617, 4ya3V, 0.8001, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3618, 4ya3H, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3619, 4ya0V, 0.8001, 1.76, 0.192, 223, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3620, 4ya0H, 0.8001, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3621, 4y8pK, 0.8001, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3622, 4y8hH, 0.8001, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3623, 4y80V, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3624, 4y80H, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3625, 4y74X, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3626, 4qwfV, 0.8001, 1.81, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3627, 4qwfH, 0.8001, 1.81, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3628, 4qvmX, 0.8001, 1.81, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3629, 4qvmJ, 0.8001, 1.80, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3630, 4qv9V, 0.8001, 2.05, 0.195, 212, 195, YCP BETA5-C63F MUTANT
3631, 4qv9H, 0.8001, 2.05, 0.195, 212, 195, YCP BETA5-C63F MUTANT
3632, 4qluY, 0.8001, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3633, 4qluK, 0.8001, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3634, 4qltY, 0.8001, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3635, 4qltK, 0.8001, 1.81, 0.192, 226, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3636, 4qlsX, 0.8001, 1.81, 0.192, 226, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3637, 4qlsJ, 0.8001, 1.82, 0.192, 226, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3638, 4g4sK, 0.8001, 1.81, 0.192, 226, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3639, 4fzcV, 0.8001, 2.03, 0.195, 212, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3640, 4fzcH, 0.8001, 1.81, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3641, 3e47H, 0.8001, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3642, 3bdmV, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3643, 3bdmH, 0.8001, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3644, 5vfqHA, 0.8000, 1.81, 0.192, 222, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3645, 5ln32, 0.8000, 1.81, 0.192, 222, 193, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3646, 5l5fV, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3647, 5l5fH, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3648, 5dkjJ, 0.8000, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3649, 5cz8V, 0.8000, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3650, 5cz8H, 0.8000, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3651, 5a0qW, 0.8000, 2.04, 0.195, 212, 195, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3652, 5a0qI, 0.8000, 2.03, 0.195, 212, 195, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3653, 4y82X, 0.8000, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3654, 4y82J, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3655, 4y7wX, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3656, 4y7wJ, 0.8000, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3657, 4y70X, 0.8000, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3658, 4y70J, 0.8000, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3659, 4r00V, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3660, 4r00H, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3661, 4qzwV, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3662, 4qzwH, 0.8000, 1.84, 0.192, 220, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3663, 4qz4V, 0.8000, 1.74, 0.187, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3664, 4qz4H, 0.8000, 1.81, 0.192, 226, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3665, 4qz0Y, 0.8000, 1.81, 0.192, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3666, 4qz0V, 0.8000, 1.72, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3667, 4qz0K, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3668, 4qz0H, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3669, 4qxjY, 0.8000, 1.57, 0.189, 198, 190, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3670, 4qxjV, 0.8000, 1.57, 0.189, 198, 190, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3671, 4qxjK, 0.8000, 1.72, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3672, 4qxjH, 0.8000, 1.72, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3673, 4qvwJ, 0.8000, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3674, 4qvlX, 0.8000, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH BORTEZOMIB
3675, 4qv6V, 0.8000, 1.71, 0.229, 195, 192, YCP BETA5-A49V MUTANT
3676, 4qv6H, 0.8000, 1.71, 0.229, 195, 192, YCP BETA5-A49V MUTANT
3677, 4quyK, 0.8000, 1.81, 0.192, 226, 193, YCP BETA5-A49S-MUTANT
3678, 4qbyY, 0.8000, 1.81, 0.192, 226, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3679, 4qbyK, 0.8000, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3680, 4lqiY, 0.8000, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3681, 4eu2L, 0.8000, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3682, 3sdkY, 0.8000, 1.81, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3683, 3dy4V, 0.8000, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3684, 5l54J, 0.7999, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3685, 5fg7Y, 0.7999, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3686, 5fg7K, 0.7999, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3687, 5dkjX, 0.7999, 2.04, 0.200, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3688, 5dkjV, 0.7999, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3689, 5czaY, 0.7999, 2.04, 0.200, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3690, 5czaK, 0.7999, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3691, 5cgiV, 0.7999, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3692, 4y8qX, 0.7999, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3693, 4y8qJ, 0.7999, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3694, 4y80X, 0.7999, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3695, 4y80J, 0.7999, 2.05, 0.190, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3696, 4y6zX, 0.7999, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3697, 4y6zJ, 0.7999, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3698, 4qzxV, 0.7999, 1.88, 0.196, 212, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3699, 4qzxH, 0.7999, 2.04, 0.190, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3700, 4qwxV, 0.7999, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3701, 4qwxH, 0.7999, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3702, 4qwuX, 0.7999, 1.71, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3703, 4lqiK, 0.7999, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3704, 4eu2Y, 0.7999, 2.05, 0.195, 212, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3705, 3sdkK, 0.7999, 1.72, 0.229, 195, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3706, 3dy4H, 0.7999, 1.81, 0.192, 226, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3707, 5vfro, 0.7998, 2.05, 0.195, 212, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3708, 5mpa5, 0.7998, 2.05, 0.195, 212, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3709, 5l5zV, 0.7998, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3710, 5l54X, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3711, 5dkjH, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3712, 5d0vV, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3713, 5cgiH, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3714, 4ya4Y, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3715, 4ya4K, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3716, 4y8rV, 0.7998, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3717, 4y8rK, 0.7998, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3718, 4y8rH, 0.7998, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3719, 4y78X, 0.7998, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3720, 4y78J, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3721, 4y74V, 0.7998, 1.88, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3722, 4qzzV, 0.7998, 1.81, 0.228, 196, 193, YCP IN COMPLEX WITH OMURALIDE
3723, 4qzzH, 0.7998, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH OMURALIDE
3724, 4qz6V, 0.7998, 1.81, 0.192, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3725, 4qz6H, 0.7998, 1.85, 0.192, 220, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3726, 4qwgX, 0.7998, 1.89, 0.196, 212, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3727, 4qwgJ, 0.7998, 1.81, 0.192, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3728, 4qvwX, 0.7998, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3729, 4qv6J, 0.7998, 1.81, 0.192, 226, 193, YCP BETA5-A49V MUTANT
3730, 4qv4Y, 0.7998, 1.81, 0.192, 222, 193, YCP BETA5-M45T MUTANT
3731, 4qv4K, 0.7998, 1.82, 0.192, 222, 193, YCP BETA5-M45T MUTANT
3732, 4qv1Y, 0.7998, 2.05, 0.195, 212, 195, YCP BETA5-M45A MUTANT
3733, 4qv1K, 0.7998, 2.05, 0.195, 212, 195, YCP BETA5-M45A MUTANT
3734, 4quxK, 0.7998, 1.81, 0.192, 226, 193, YCP BETA5-A49T-MUTANT
3735, 4qbyJ, 0.7998, 2.05, 0.195, 212, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3736, 4no6X, 0.7998, 1.81, 0.192, 226, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3737, 4no6J, 0.7998, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3738, 4j70Y, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3739, 4g4sI, 0.7998, 1.81, 0.192, 222, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3740, 3tddH, 0.7998, 1.81, 0.192, 226, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3741, 3mkaR, 0.7998, 1.81, 0.192, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
3742, 3gpjV, 0.7998, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3743, 3gpjH, 0.7998, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3744, 3dy3X, 0.7998, 1.72, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3745, 3dy3J, 0.7998, 1.72, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3746, 5l5zH, 0.7997, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3747, 5dkiV, 0.7997, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3748, 5dkiH, 0.7997, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3749, 5d0vH, 0.7997, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3750, 5cz6Y, 0.7997, 1.89, 0.201, 212, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3751, 5cz6K, 0.7997, 1.89, 0.201, 212, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3752, 5ahjV, 0.7997, 1.89, 0.191, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3753, 5ahjH, 0.7997, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3754, 4y8hY, 0.7997, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3755, 4y74H, 0.7997, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3756, 4y70V, 0.7997, 1.88, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3757, 4r02J, 0.7997, 1.81, 0.192, 220, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3758, 4qz4Y, 0.7997, 1.81, 0.192, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3759, 4qz4K, 0.7997, 2.09, 0.184, 246, 196, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3760, 4qwjX, 0.7997, 1.81, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3761, 4qwjJ, 0.7997, 1.81, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3762, 4qv7Y, 0.7997, 1.82, 0.228, 198, 193, YCP BETA5-A50V MUTANT
3763, 4qv7K, 0.7997, 1.82, 0.228, 198, 193, YCP BETA5-A50V MUTANT
3764, 4qv5K, 0.7997, 1.81, 0.192, 226, 193, YCP BETA5-M45I MUTANT
3765, 4qv3Y, 0.7997, 1.81, 0.192, 226, 193, YCP BETA5-M45V MUTANT
3766, 4qv3K, 0.7997, 1.81, 0.192, 226, 193, YCP BETA5-M45V MUTANT
3767, 4quxY, 0.7997, 1.81, 0.192, 222, 193, YCP BETA5-A49T-MUTANT
3768, 4qbyX, 0.7997, 1.89, 0.196, 212, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3769, 4no9Y, 0.7997, 1.89, 0.196, 212, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3770, 4no9K, 0.7997, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3771, 4no6K, 0.7997, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3772, 4jsuV, 0.7997, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3773, 4jsuH, 0.7997, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3774, 4fzgV, 0.7997, 1.82, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3775, 3tddV, 0.7997, 1.72, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3776, 3dy4Y, 0.7997, 2.04, 0.190, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3777, 3dy4K, 0.7997, 2.04, 0.190, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3778, 2gplV, 0.7997, 1.72, 0.229, 195, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3779, 2gplH, 0.7997, 1.72, 0.229, 195, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3780, 5vfqI, 0.7996, 2.05, 0.190, 212, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3781, 5l66V, 0.7996, 2.05, 0.190, 212, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3782, 5l66H, 0.7996, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3783, 4ya0Y, 0.7996, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3784, 4ya0K, 0.7996, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3785, 4y8hK, 0.7996, 1.89, 0.191, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3786, 4y81J, 0.7996, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3787, 4y7wV, 0.7996, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3788, 4y70H, 0.7996, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3789, 4qz2V, 0.7996, 2.04, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3790, 4qz2H, 0.7996, 1.81, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3791, 4qwxK, 0.7996, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3792, 4qw0V, 0.7996, 1.81, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3793, 4qw0H, 0.7996, 1.81, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3794, 4qv6X, 0.7996, 2.05, 0.195, 212, 195, YCP BETA5-A49V MUTANT
3795, 4qv5Y, 0.7996, 2.05, 0.195, 212, 195, YCP BETA5-M45I MUTANT
3796, 4qbyV, 0.7996, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3797, 4qbyH, 0.7996, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3798, 4no6Y, 0.7996, 1.80, 0.224, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3799, 4fzgH, 0.7996, 1.85, 0.187, 220, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3800, 3mg0H, 0.7996, 1.81, 0.192, 226, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3801, 3gpwV, 0.7996, 1.81, 0.192, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3802, 3gpwH, 0.7996, 1.89, 0.196, 212, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3803, 2zcyV, 0.7996, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3804, 2zcyH, 0.7996, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3805, 6gopX, 0.7995, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3806, 6gopJ, 0.7995, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3807, 5d0xV, 0.7995, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3808, 5d0xH, 0.7995, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3809, 4y8oX, 0.7995, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3810, 4y8oJ, 0.7995, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3811, 4y81X, 0.7995, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3812, 4y7yV, 0.7995, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3813, 4y7yH, 0.7995, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3814, 4y7wH, 0.7995, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3815, 4qz1V, 0.7995, 1.81, 0.192, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3816, 4qz1H, 0.7995, 1.81, 0.192, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3817, 4qwxY, 0.7995, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3818, 4hrcY, 0.7995, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3819, 4gk7V, 0.7995, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3820, 4gk7H, 0.7995, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3821, 3wxrL, 0.7995, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3822, 3mg0V, 0.7995, 1.81, 0.192, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3823, 3dy3Y, 0.7995, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3824, 3dy3K, 0.7995, 1.72, 0.229, 195, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3825, 5lajY, 0.7994, 1.72, 0.229, 195, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3826, 5lajK, 0.7994, 1.82, 0.192, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3827, 5cz7V, 0.7994, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3828, 5cz7H, 0.7994, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3829, 4zzgL, 0.7994, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3830, 4ya5Y, 0.7994, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3831, 4ya5K, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3832, 4ya3Y, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3833, 4ya3K, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3834, 4ya2V, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3835, 4ya2H, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3836, 4y8tX, 0.7994, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3837, 4y8tJ, 0.7994, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3838, 4y8jV, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3839, 4y8jH, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3840, 4y8gK, 0.7994, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3841, 4y78V, 0.7994, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3842, 4y78H, 0.7994, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3843, 4y69K, 0.7994, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3844, 4qz7Y, 0.7994, 1.90, 0.196, 212, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3845, 4qz7K, 0.7994, 1.90, 0.196, 212, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3846, 4qz2Y, 0.7994, 1.82, 0.192, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3847, 4qz2K, 0.7994, 1.82, 0.192, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3848, 4qw3J, 0.7994, 1.88, 0.196, 212, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3849, 4qvwV, 0.7994, 1.89, 0.196, 212, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3850, 4qvwH, 0.7994, 1.89, 0.196, 212, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3851, 4qvvV, 0.7994, 1.89, 0.196, 212, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3852, 4qvvH, 0.7994, 1.89, 0.196, 212, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3853, 4qvlV, 0.7994, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH BORTEZOMIB
3854, 4qvlH, 0.7994, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH BORTEZOMIB
3855, 4qlqY, 0.7994, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3856, 4qlqK, 0.7994, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3857, 4fzcY, 0.7994, 1.82, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3858, 4fzcK, 0.7994, 1.82, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3859, 3d29Y, 0.7994, 2.04, 0.195, 212, 195, PROTEASOME INHIBITION BY FELLUTAMIDE B
3860, 3d29K, 0.7994, 1.82, 0.192, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3861, 5l63X, 0.7993, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3862, 5l63J, 0.7993, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3863, 5l61X, 0.7993, 2.04, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3864, 5l61J, 0.7993, 2.04, 0.190, 212, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3865, 4zzgY, 0.7993, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3866, 4y9zV, 0.7993, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3867, 4y8gY, 0.7993, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3868, 4y84Y, 0.7993, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3869, 4y84K, 0.7993, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3870, 4y6vY, 0.7993, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3871, 4y6vK, 0.7993, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3872, 4y69Y, 0.7993, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3873, 4x6zL, 0.7993, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3874, 4nnwV, 0.7993, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3875, 4nnwH, 0.7993, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3876, 3hyeH, 0.7993, 2.05, 0.195, 212, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3877, 5vfoO, 0.7992, 2.05, 0.195, 212, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3878, 5vfoo, 0.7992, 2.04, 0.195, 212, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3879, 5nifL, 0.7992, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3880, 5mpcW, 0.7992, 1.73, 0.229, 195, 192, 
3881, 5l5wX, 0.7992, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3882, 5l5wJ, 0.7992, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3883, 5cz4K, 0.7992, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3884, 4ya7V, 0.7992, 1.82, 0.228, 196, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3885, 4ya7H, 0.7992, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3886, 4y9zH, 0.7992, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3887, 4y9yY, 0.7992, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3888, 4y9yK, 0.7992, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3889, 4y8uK, 0.7992, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3890, 4y8nY, 0.7992, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3891, 4y8nK, 0.7992, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3892, 4y7xX, 0.7992, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3893, 4y7xJ, 0.7992, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3894, 4qw3X, 0.7992, 1.82, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3895, 4fzgK, 0.7992, 1.82, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3896, 3wxrZ, 0.7992, 1.86, 0.192, 220, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3897, 3hyeV, 0.7992, 1.86, 0.192, 220, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3898, 5mp95, 0.7991, 1.89, 0.196, 212, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3899, 5l64J, 0.7991, 1.85, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3900, 5l62X, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3901, 5l62J, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3902, 5l5zX, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3903, 5l5zJ, 0.7991, 1.82, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3904, 5l5xX, 0.7991, 1.82, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3905, 5l5xJ, 0.7991, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3906, 5fgaJ, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3907, 5cz4Y, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3908, 4y8uY, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3909, 4y8tV, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3910, 4y8tH, 0.7991, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3911, 4x6zZ, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3912, 4rurY, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3913, 4rurK, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3914, 4qz1Y, 0.7991, 2.05, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3915, 4qz1K, 0.7991, 1.89, 0.196, 212, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3916, 4qw1V, 0.7991, 1.82, 0.192, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3917, 4qw1H, 0.7991, 1.89, 0.196, 212, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3918, 4qv8X, 0.7991, 1.73, 0.229, 195, 192, YCP BETA5-C52F MUTANT
3919, 4qv8J, 0.7991, 1.73, 0.229, 195, 192, YCP BETA5-C52F MUTANT
3920, 4quyY, 0.7991, 1.73, 0.229, 195, 192, YCP BETA5-A49S-MUTANT
3921, 4qlvX, 0.7991, 1.73, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3922, 4qlvJ, 0.7991, 1.73, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3923, 4q1sK, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3924, 4nnnH, 0.7991, 1.73, 0.229, 195, 192, YCP IN COMPLEX WITH MG132
3925, 4fzgY, 0.7991, 1.73, 0.229, 195, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3926, 3dy4J, 0.7991, 1.90, 0.196, 212, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3927, 5nifY, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3928, 5l64X, 0.7990, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3929, 5bouY, 0.7990, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3930, 5bouK, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3931, 4ya9V, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3932, 4ya9H, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3933, 4ya1Y, 0.7990, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3934, 4ya1K, 0.7990, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3935, 4y6aY, 0.7990, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3936, 4y6aK, 0.7990, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3937, 4x6zK, 0.7990, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3938, 4r00X, 0.7990, 1.73, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3939, 4r00J, 0.7990, 1.90, 0.191, 212, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3940, 4qw3V, 0.7990, 1.72, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3941, 4qw3H, 0.7990, 1.72, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3942, 4qvmV, 0.7990, 1.90, 0.196, 212, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3943, 4qvmH, 0.7990, 1.82, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3944, 4no6V, 0.7990, 2.05, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3945, 4no6H, 0.7990, 1.83, 0.228, 198, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3946, 4nnnV, 0.7990, 1.83, 0.228, 196, 193, YCP IN COMPLEX WITH MG132
3947, 3gptV, 0.7990, 1.73, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3948, 3gptH, 0.7990, 1.90, 0.196, 212, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3949, 3dy4X, 0.7990, 1.90, 0.196, 212, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3950, 5wvkH, 0.7989, 1.82, 0.197, 222, 193, 
3951, 5t0cIB, 0.7989, 1.82, 0.197, 222, 193, 
3952, 5t0cCA, 0.7989, 1.90, 0.196, 212, 194, 
3953, 5fgaX, 0.7989, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3954, 5dkiJ, 0.7989, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3955, 5bxlY, 0.7989, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3956, 5bxlK, 0.7989, 1.84, 0.228, 196, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3957, 4y8rY, 0.7989, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3958, 4qzzJ, 0.7989, 1.73, 0.229, 195, 192, YCP IN COMPLEX WITH OMURALIDE
3959, 4qv5X, 0.7989, 1.82, 0.192, 226, 193, YCP BETA5-M45I MUTANT
3960, 4qv1X, 0.7989, 1.82, 0.192, 226, 193, YCP BETA5-M45A MUTANT
3961, 4qv1J, 0.7989, 1.82, 0.192, 226, 193, YCP BETA5-M45A MUTANT
3962, 4qv0X, 0.7989, 1.82, 0.192, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3963, 4qv0J, 0.7989, 1.82, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3964, 4eu2Z, 0.7989, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3965, 2f16H, 0.7989, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3966, 5l60X, 0.7988, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3967, 5l60J, 0.7988, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3968, 5l5yX, 0.7988, 1.83, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3969, 5l5yJ, 0.7988, 1.67, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3970, 5dkiX, 0.7988, 2.03, 0.224, 199, 196, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3971, 4y8mY, 0.7988, 2.03, 0.224, 199, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3972, 4y8mK, 0.7988, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3973, 4qzzX, 0.7988, 1.73, 0.229, 195, 192, YCP IN COMPLEX WITH OMURALIDE
3974, 4qvvX, 0.7988, 1.90, 0.196, 212, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3975, 4qv9X, 0.7988, 1.90, 0.196, 212, 194, YCP BETA5-C63F MUTANT
3976, 4qv9J, 0.7988, 1.90, 0.196, 212, 194, YCP BETA5-C63F MUTANT
3977, 4qv5J, 0.7988, 1.73, 0.229, 195, 192, YCP BETA5-M45I MUTANT
3978, 4qv4J, 0.7988, 1.74, 0.229, 195, 192, YCP BETA5-M45T MUTANT
3979, 4quyJ, 0.7988, 1.73, 0.229, 195, 192, YCP BETA5-A49S-MUTANT
3980, 2f16V, 0.7988, 1.73, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3981, 5fg9Y, 0.7987, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3982, 5fg9K, 0.7987, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3983, 5d0xX, 0.7987, 1.90, 0.191, 212, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3984, 5d0xJ, 0.7987, 1.82, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3985, 5cz7X, 0.7987, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3986, 5cz7J, 0.7987, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3987, 4y8sH, 0.7987, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3988, 4qvyX, 0.7987, 1.74, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3989, 4qvyJ, 0.7987, 1.73, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3990, 4quyX, 0.7987, 1.90, 0.196, 212, 194, YCP BETA5-A49S-MUTANT
3991, 4g4sL, 0.7987, 1.90, 0.196, 212, 194, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3992, 5fghX, 0.7986, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3993, 5fghJ, 0.7986, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3994, 5czaX, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3995, 5czaJ, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3996, 4zzgK, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3997, 4y8sV, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3998, 4qvqV, 0.7986, 1.74, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3999, 4qvqH, 0.7986, 1.82, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4000, 4qv3X, 0.7986, 1.90, 0.196, 212, 194, YCP BETA5-M45V MUTANT
4001, 4qv3J, 0.7986, 1.90, 0.196, 212, 194, YCP BETA5-M45V MUTANT
4002, 5vfpI, 0.7985, 1.74, 0.229, 195, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4003, 4ya4X, 0.7985, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4004, 4ya4J, 0.7985, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4005, 4qvpV, 0.7985, 1.74, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4006, 4qvpH, 0.7985, 1.83, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4007, 4qv4X, 0.7985, 1.73, 0.229, 195, 192, YCP BETA5-M45T MUTANT
4008, 1z7qY, 0.7985, 1.73, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4009, 1z7qK, 0.7985, 1.74, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4010, 5d0wX, 0.7984, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4011, 5d0wJ, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4012, 5cz6X, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4013, 5cz6J, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4014, 5bxlX, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4015, 5bxlJ, 0.7984, 1.84, 0.228, 196, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4016, 4y8tY, 0.7984, 1.83, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4017, 4y8tK, 0.7984, 1.83, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4018, 4y8rJ, 0.7984, 1.83, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4019, 4qw0J, 0.7984, 1.74, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4020, 4qvvJ, 0.7984, 1.74, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4021, 4qvnV, 0.7984, 1.98, 0.224, 199, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4022, 4qvnH, 0.7984, 1.86, 0.187, 220, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4023, 4nnwY, 0.7984, 1.74, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4024, 4nnwK, 0.7984, 1.74, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4025, 6gopV, 0.7983, 1.83, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4026, 6gopH, 0.7983, 1.83, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4027, 4y8rX, 0.7983, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4028, 4qw0X, 0.7983, 1.87, 0.228, 198, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4029, 5nifK, 0.7982, 1.87, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4030, 4y9yJ, 0.7982, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4031, 4qv7X, 0.7982, 1.74, 0.229, 195, 192, YCP BETA5-A50V MUTANT
4032, 5cgfX, 0.7981, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4033, 5cgfJ, 0.7981, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4034, 5bxnV, 0.7981, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4035, 4y9yX, 0.7981, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4036, 1fntY, 0.7981, 1.91, 0.196, 212, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4037, 1fntK, 0.7981, 1.91, 0.196, 212, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4038, 4ya1X, 0.7980, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4039, 4qwuV, 0.7980, 1.74, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4040, 4qwuH, 0.7980, 1.74, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4041, 4quxJ, 0.7980, 1.83, 0.192, 226, 193, YCP BETA5-A49T-MUTANT
4042, 5fg7X, 0.7979, 1.83, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4043, 5fg7J, 0.7979, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4044, 4ya1J, 0.7979, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4045, 4y8uX, 0.7979, 1.83, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4046, 4y8uJ, 0.7979, 1.83, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4047, 4quxX, 0.7979, 1.74, 0.229, 195, 192, YCP BETA5-A49T-MUTANT
4048, 5mp94, 0.7978, 1.74, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4049, 5bouX, 0.7978, 1.85, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4050, 5bouJ, 0.7978, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4051, 4z1lX, 0.7978, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4052, 4z1lJ, 0.7978, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4053, 4y8mX, 0.7978, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4054, 4y8mJ, 0.7978, 1.89, 0.187, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4055, 4r18X, 0.7978, 1.74, 0.229, 195, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4056, 4r18J, 0.7978, 1.88, 0.228, 198, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4057, 4r17X, 0.7978, 1.88, 0.228, 198, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4058, 4r17J, 0.7978, 1.75, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4059, 4qv7J, 0.7978, 1.83, 0.192, 226, 193, YCP BETA5-A50V MUTANT
4060, 5lajX, 0.7977, 1.83, 0.192, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4061, 5lajJ, 0.7977, 1.74, 0.229, 195, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4062, 5fg9X, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4063, 5fg9J, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4064, 4y6aX, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4065, 4y6aJ, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4066, 4y69X, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4067, 4y69J, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4068, 3wxrK, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4069, 5mp9l, 0.7975, 1.75, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4070, 4y8nJ, 0.7975, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4071, 5vfrO, 0.7974, 1.75, 0.229, 195, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4072, 4y6vX, 0.7974, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4073, 4y6vJ, 0.7974, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4074, 4y8nX, 0.7973, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4075, 4rurX, 0.7973, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4076, 4rurJ, 0.7973, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4077, 5mpbH, 0.7972, 1.74, 0.229, 195, 192, 
4078, 4ya5J, 0.7972, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4079, 1fntZ, 0.7972, 1.76, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4080, 1fntL, 0.7972, 1.74, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4081, 4ya5X, 0.7971, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4082, 1z7qL, 0.7971, 1.75, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4083, 6epf6, 0.7970, 1.75, 0.229, 195, 192, GROUND STATE 26S PROTEASOME (GS1)
4084, 1z7qZ, 0.7970, 1.75, 0.229, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4085, 5laiX, 0.7969, 1.75, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4086, 5laiJ, 0.7969, 1.75, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4087, 5bxlH, 0.7969, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4088, 5mpal, 0.7968, 1.82, 0.229, 197, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4089, 4ya3J, 0.7968, 1.91, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4090, 5bxnH, 0.7967, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4091, 4ya3X, 0.7967, 1.88, 0.192, 220, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4092, 5cz4X, 0.7966, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4093, 4ya0X, 0.7966, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4094, 4ya0J, 0.7966, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4095, 5cz4J, 0.7965, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4096, 5fmgX, 0.7964, 1.75, 0.229, 195, 192, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4097, 5fmgJ, 0.7964, 1.86, 0.229, 196, 192, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4098, 3mkaX, 0.7961, 1.76, 0.229, 195, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4099, 5l5dX, 0.7959, 1.92, 0.191, 212, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4100, 5l5dJ, 0.7959, 1.92, 0.191, 212, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4101, 5bxlV, 0.7959, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4102, 5l6bJ, 0.7956, 1.92, 0.191, 212, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4103, 5l5jX, 0.7956, 2.66, 0.053, 213, 208, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4104, 5l5jJ, 0.7956, 1.92, 0.191, 212, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4105, 5mp9k, 0.7955, 1.76, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4106, 5l6bX, 0.7955, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4107, 5l5oJ, 0.7955, 2.02, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4108, 5t0gN, 0.7954, 1.93, 0.196, 212, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4109, 5l5uX, 0.7954, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4110, 5l5uJ, 0.7954, 2.02, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4111, 5l5tX, 0.7954, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4112, 5l5tJ, 0.7954, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4113, 5l5oX, 0.7954, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4114, 5l5iX, 0.7954, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4115, 5l5iJ, 0.7954, 1.77, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4116, 4r18Y, 0.7954, 1.49, 0.207, 191, 188, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4117, 4r18K, 0.7954, 1.49, 0.207, 191, 188, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4118, 5l5hX, 0.7953, 2.46, 0.180, 249, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4119, 5l5hJ, 0.7953, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4120, 5l6aX, 0.7952, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4121, 5l6aJ, 0.7952, 1.89, 0.193, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4122, 5l68X, 0.7952, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4123, 5l68J, 0.7952, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4124, 6epe3, 0.7951, 1.79, 0.229, 195, 192, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4125, 5l65X, 0.7951, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4126, 5l65J, 0.7951, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4127, 5l5sX, 0.7951, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4128, 5l5sJ, 0.7951, 1.70, 0.236, 191, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4129, 5t0hO, 0.7950, 1.80, 0.229, 195, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4130, 5l66X, 0.7950, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4131, 5l66J, 0.7950, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4132, 5lttJ, 0.7949, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4133, 5l5qX, 0.7949, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4134, 5l5qJ, 0.7949, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4135, 5l5fX, 0.7949, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4136, 5l5fJ, 0.7949, 1.89, 0.197, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4137, 5m2bJ, 0.7948, 1.89, 0.197, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4138, 5lttX, 0.7948, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4139, 5l5vX, 0.7948, 1.80, 0.229, 195, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4140, 5l5vJ, 0.7948, 1.80, 0.229, 195, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4141, 5l5rX, 0.7948, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4142, 5l5rJ, 0.7948, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4143, 5l5pX, 0.7948, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4144, 5l5pJ, 0.7948, 2.23, 0.050, 205, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4145, 5l5bJ, 0.7948, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4146, 4r17Y, 0.7948, 1.80, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4147, 4r17K, 0.7948, 1.81, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4148, 5m2bX, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4149, 5l6cX, 0.7947, 1.82, 0.192, 220, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4150, 5l6cJ, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4151, 5l67X, 0.7947, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4152, 5l67J, 0.7947, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4153, 5l5bX, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4154, 5mpak, 0.7946, 1.81, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4155, 5l69X, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4156, 5l69J, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4157, 5l5eX, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4158, 5l5eJ, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4159, 3jcoRA, 0.7946, 1.81, 0.229, 195, 192, 
4160, 3jcoD, 0.7946, 1.81, 0.229, 195, 192, 
4161, 5laiY, 0.7944, 1.81, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4162, 5laiK, 0.7944, 1.81, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4163, 5l5aJ, 0.7943, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4164, 5wviEA, 0.7942, 1.81, 0.229, 195, 192, 
4165, 5l5aX, 0.7942, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4166, 4q1sY, 0.7939, 1.90, 0.197, 211, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4167, 5ts0W, 0.7937, 1.90, 0.197, 211, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4168, 5ln31, 0.7936, 1.81, 0.229, 195, 192, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4169, 4qwuY, 0.7936, 1.81, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4170, 4qwuK, 0.7936, 1.81, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4171, 5wvkI, 0.7935, 1.81, 0.229, 195, 192, 
4172, 5mpa4, 0.7929, 1.81, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4173, 5trrW, 0.7926, 1.81, 0.229, 195, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4174, 5lzpI, 0.7926, 1.78, 0.229, 195, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4175, 5lzpC, 0.7925, 1.81, 0.229, 195, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4176, 5ts0I, 0.7924, 1.81, 0.229, 195, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4177, 5t0iN, 0.7924, 1.81, 0.229, 195, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4178, 5trsW, 0.7923, 1.81, 0.229, 195, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4179, 5trrI, 0.7923, 1.86, 0.192, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4180, 5tryW, 0.7922, 1.86, 0.192, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4181, 5tryI, 0.7919, 1.91, 0.197, 211, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4182, 5lzpK, 0.7919, 1.91, 0.197, 211, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4183, 5trgI, 0.7918, 1.82, 0.229, 195, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4184, 5lzpE, 0.7918, 2.15, 0.222, 205, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4185, 5wviQA, 0.7917, 1.82, 0.229, 195, 192, 
4186, 5trsI, 0.7916, 1.91, 0.197, 211, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4187, 5trgY, 0.7916, 2.02, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4188, 5lzpR, 0.7915, 2.32, 0.226, 214, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4189, 3mi0E, 0.7915, 2.13, 0.195, 212, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4190, 5thoW, 0.7914, 2.12, 0.195, 212, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4191, 5thoI, 0.7914, 1.90, 0.192, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4192, 5lzpU, 0.7914, 1.81, 0.229, 195, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4193, 5lzpT, 0.7913, 2.04, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4194, 3mi0L, 0.7913, 2.04, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4195, 5ts0b, 0.7912, 2.04, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4196, 5trrY, 0.7912, 2.04, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4197, 5mpbI, 0.7912, 1.74, 0.236, 191, 191, 
4198, 5lzpO, 0.7912, 2.04, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4199, 5lzpG, 0.7912, 2.04, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4200, 5ts0a, 0.7911, 2.03, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4201, 5trgK, 0.7911, 2.05, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4202, 5lzpN, 0.7911, 2.05, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4203, 5wvkB, 0.7910, 2.04, 0.181, 222, 193, 
4204, 5trsY, 0.7910, 2.05, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4205, 6bgoZ, 0.7909, 2.18, 0.222, 205, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4206, 6bgoY, 0.7909, 2.06, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4207, 6bgoX, 0.7909, 2.05, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4208, 6bgoW, 0.7909, 2.06, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4209, 6bgoU, 0.7909, 2.04, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4210, 6bgoT, 0.7909, 2.05, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4211, 6bgoS, 0.7909, 2.05, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4212, 6bgoR, 0.7909, 2.06, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4213, 6bgoQ, 0.7909, 2.06, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4214, 6bgoP, 0.7909, 2.06, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4215, 6bgoc, 0.7909, 2.06, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4216, 6bgob, 0.7909, 2.05, 0.181, 223, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4217, 6bgoa, 0.7909, 1.95, 0.192, 226, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4218, 6bglZ, 0.7909, 2.06, 0.181, 223, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4219, 6bglY, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4220, 6bglX, 0.7909, 2.07, 0.181, 223, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4221, 6bglW, 0.7909, 2.06, 0.181, 223, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4222, 6bglV, 0.7909, 2.05, 0.181, 234, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4223, 6bglU, 0.7909, 1.97, 0.192, 223, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4224, 6bglT, 0.7909, 2.85, 0.218, 244, 197, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4225, 6bglS, 0.7909, 2.06, 0.181, 223, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4226, 6bglR, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4227, 6bglQ, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4228, 6bglP, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4229, 6bglb, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4230, 6bgla, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4231, 5ts0H, 0.7909, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4232, 5lzpP, 0.7909, 2.07, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4233, 5lzpF, 0.7909, 2.07, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4234, 3mi02, 0.7909, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4235, 6epf7, 0.7908, 2.07, 0.181, 222, 193, GROUND STATE 26S PROTEASOME (GS1)
4236, 6bgoV, 0.7908, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4237, 6bglc, 0.7908, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4238, 5trya, 0.7908, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4239, 5trrL, 0.7908, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4240, 5lzpL, 0.7908, 2.07, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4241, 5lzpA, 0.7908, 2.07, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4242, 3mi0G, 0.7908, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4243, 5trrb, 0.7907, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4244, 5trra, 0.7907, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4245, 3mi0H, 0.7907, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4246, 5trrZ, 0.7906, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4247, 5trgX, 0.7906, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4248, 3mi0N, 0.7906, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4249, 5tryb, 0.7905, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4250, 5trrM, 0.7905, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4251, 3mi0P, 0.7905, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4252, 5tryY, 0.7904, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4253, 5trsL, 0.7904, 2.07, 0.181, 234, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4254, 5thoY, 0.7904, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4255, 5a0qY, 0.7904, 2.05, 0.181, 223, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4256, 5a0qK, 0.7904, 2.56, 0.039, 216, 203, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4257, 3mi0J, 0.7904, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4258, 3krdL, 0.7904, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4259, 5ts0L, 0.7903, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4260, 5trgW, 0.7903, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4261, 5trgV, 0.7903, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4262, 5thoN, 0.7903, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4263, 3mi0X, 0.7903, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4264, 3mi0T, 0.7903, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4265, 5ts0Z, 0.7902, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4266, 5tryL, 0.7902, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4267, 5trgM, 0.7902, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4268, 5t0iO, 0.7902, 2.06, 0.181, 222, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4269, 3mi0C, 0.7902, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4270, 3krdE, 0.7902, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4271, 3hfaR, 0.7902, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4272, 5ts0N, 0.7901, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4273, 5trsa, 0.7901, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4274, 5trgH, 0.7901, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4275, 3mkaZ, 0.7901, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4276, 3mi0V, 0.7901, 1.52, 0.235, 189, 187, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4277, 3hfaZ, 0.7901, 1.52, 0.235, 189, 187, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4278, 3hfaV, 0.7901, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4279, 3hfaL, 0.7901, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4280, 5ts0M, 0.7900, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4281, 5tryZ, 0.7900, 2.05, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4282, 5trsb, 0.7900, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4283, 5thoL, 0.7900, 2.05, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4284, 3mi0Z, 0.7900, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4285, 3hfaP, 0.7900, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4286, 3hfaN, 0.7900, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4287, 5trgL, 0.7899, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4288, 5thob, 0.7899, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4289, 5t0hR, 0.7899, 1.90, 0.181, 220, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4290, 3hfaX, 0.7899, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4291, 3hfaT, 0.7899, 2.04, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4292, 3hfaC, 0.7899, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4293, 3hfa2, 0.7899, 2.04, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4294, 5thoZ, 0.7898, 2.08, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4295, 3hfaJ, 0.7898, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4296, 5ts0Y, 0.7897, 2.22, 0.184, 245, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4297, 5trsZ, 0.7897, 2.06, 0.181, 239, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4298, 5trga, 0.7897, 2.07, 0.181, 224, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4299, 5thoa, 0.7897, 2.07, 0.181, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4300, 3hfaH, 0.7897, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4301, 3hfaG, 0.7897, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4302, 3hfaE, 0.7897, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4303, 5trrN, 0.7896, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4304, 5thoV, 0.7896, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4305, 5ts0V, 0.7895, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4306, 5tryM, 0.7895, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4307, 5t0gQ, 0.7895, 2.07, 0.181, 223, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4308, 5trrV, 0.7894, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4309, 5trrH, 0.7894, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4310, 5trgN, 0.7894, 1.94, 0.202, 201, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4311, 3krd2, 0.7894, 2.07, 0.181, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4312, 5trrJ, 0.7893, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4313, 5trgJ, 0.7893, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4314, 5trgb, 0.7893, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4315, 5thoM, 0.7893, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4316, 5fmgZ, 0.7893, 2.07, 0.181, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4317, 5fmgL, 0.7893, 2.07, 0.181, 223, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4318, 3mi0R, 0.7893, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4319, 5tryN, 0.7892, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4320, 5trsM, 0.7892, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4321, 5trsH, 0.7892, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4322, 5thoH, 0.7892, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4323, 5trsN, 0.7891, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4324, 5trgZ, 0.7891, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4325, 5tryX, 0.7890, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4326, 5trrX, 0.7890, 2.09, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4327, 3krdN, 0.7889, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4328, 5tryH, 0.7888, 2.16, 0.230, 199, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4329, 5t0jN, 0.7888, 2.08, 0.181, 223, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4330, 5wviFA, 0.7887, 2.08, 0.181, 222, 193, 
4331, 5trsJ, 0.7887, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4332, 3krdT, 0.7887, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4333, 3krdG, 0.7887, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4334, 5ts0J, 0.7886, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4335, 5ts0X, 0.7885, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4336, 5trsX, 0.7885, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4337, 3krdX, 0.7885, 1.53, 0.219, 189, 187, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4338, 3krdJ, 0.7885, 1.53, 0.219, 189, 187, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4339, 3krdC, 0.7885, 2.07, 0.181, 239, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4340, 5trsV, 0.7883, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4341, 3krdV, 0.7883, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4342, 3krdH, 0.7883, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4343, 5thoJ, 0.7882, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4344, 3krdP, 0.7882, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4345, 5thoK, 0.7881, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4346, 3krdR, 0.7881, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4347, 5thoX, 0.7880, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4348, 5tryJ, 0.7879, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4349, 3krdZ, 0.7879, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4350, 5tryV, 0.7878, 1.79, 0.236, 191, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4351, 5trrK, 0.7878, 1.96, 0.192, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4352, 1q5qN, 0.7876, 2.09, 0.181, 222, 193, THE RHODOCOCCUS 20S PROTEASOME
4353, 1q5qM, 0.7876, 2.07, 0.181, 222, 193, THE RHODOCOCCUS 20S PROTEASOME
4354, 1q5qL, 0.7876, 2.09, 0.181, 222, 193, THE RHODOCOCCUS 20S PROTEASOME
4355, 1q5qK, 0.7876, 2.08, 0.181, 222, 193, THE RHODOCOCCUS 20S PROTEASOME
4356, 1q5qJ, 0.7876, 2.10, 0.181, 222, 193, THE RHODOCOCCUS 20S PROTEASOME
4357, 1q5qI, 0.7876, 2.10, 0.181, 222, 193, THE RHODOCOCCUS 20S PROTEASOME
4358, 1q5qH, 0.7876, 2.09, 0.181, 222, 193, THE RHODOCOCCUS 20S PROTEASOME
4359, 5ts0K, 0.7873, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4360, 5fmgV, 0.7873, 2.09, 0.181, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4361, 5fmgH, 0.7873, 2.10, 0.181, 223, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4362, 5tryK, 0.7870, 2.08, 0.181, 229, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4363, 5wviC, 0.7869, 2.09, 0.181, 222, 193, 
4364, 5trsK, 0.7869, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4365, 2fhhR, 0.7867, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4366, 2fhhN, 0.7867, 2.10, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4367, 2fhhG, 0.7867, 2.08, 0.181, 229, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4368, 2fhhZ, 0.7866, 2.10, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4369, 2fhhX, 0.7866, 2.10, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4370, 2fhhT, 0.7866, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4371, 2fhhJ, 0.7866, 2.11, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4372, 2fhhH, 0.7866, 2.11, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4373, 2fhhC, 0.7865, 2.00, 0.207, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4374, 5t0iR, 0.7864, 2.00, 0.207, 224, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4375, 2fhhV, 0.7864, 2.00, 0.207, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4376, 2fhhP, 0.7864, 2.00, 0.207, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4377, 2fhhE, 0.7864, 2.00, 0.207, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4378, 2fhhL, 0.7863, 2.00, 0.207, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4379, 2fhh2, 0.7862, 2.00, 0.207, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4380, 2fhgG, 0.7847, 2.11, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4381, 2fhgZ, 0.7846, 1.72, 0.185, 191, 189, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4382, 2fhgN, 0.7846, 1.72, 0.185, 191, 189, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4383, 2fhgJ, 0.7846, 2.12, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4384, 2fhg2, 0.7846, 1.98, 0.192, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4385, 2fhgX, 0.7845, 2.12, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4386, 2fhgV, 0.7845, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4387, 2fhgT, 0.7845, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4388, 2fhgR, 0.7845, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4389, 2fhgC, 0.7845, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4390, 2fhgP, 0.7844, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4391, 2fhgL, 0.7844, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4392, 2fhgH, 0.7844, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4393, 2fhgE, 0.7843, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4394, 5t0hN, 0.7839, 2.11, 0.181, 222, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4395, 3mfeC, 0.7834, 2.02, 0.207, 201, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4396, 3mfeP, 0.7830, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4397, 5fmgN, 0.7824, 2.11, 0.181, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4398, 5fmgb, 0.7824, 2.11, 0.181, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4399, 3mfeH, 0.7809, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4400, 6epd3, 0.7792, 2.11, 0.181, 222, 193, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4401, 3sdiT, 0.7782, 2.13, 0.181, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4402, 4nnwF, 0.7781, 2.13, 0.181, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4403, 4r17F, 0.7780, 2.13, 0.181, 222, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4404, 4nnwT, 0.7780, 2.13, 0.181, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4405, 3dy3F, 0.7780, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4406, 4r17T, 0.7779, 2.13, 0.181, 222, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4407, 5t0jR, 0.7778, 2.13, 0.181, 222, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4408, 4y8gF, 0.7778, 2.13, 0.181, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4409, 4y84T, 0.7778, 2.13, 0.181, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4410, 4cr2G, 0.7778, 2.14, 0.181, 222, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4411, 3un8F, 0.7778, 2.14, 0.181, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4412, 3sdkF, 0.7778, 2.13, 0.181, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4413, 4y8gT, 0.7777, 2.14, 0.181, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4414, 3sdkT, 0.7777, 2.14, 0.181, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4415, 4zzgG, 0.7776, 1.88, 0.236, 191, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4416, 4x6zU, 0.7776, 2.10, 0.182, 221, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4417, 4intF, 0.7776, 2.11, 0.182, 221, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4418, 3un8T, 0.7776, 1.60, 0.177, 187, 186, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4419, 3d29T, 0.7776, 1.60, 0.177, 187, 186, PROTEASOME INHIBITION BY FELLUTAMIDE B
4420, 3d29F, 0.7776, 2.12, 0.182, 221, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
4421, 4x6zG, 0.7775, 2.33, 0.051, 205, 198, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4422, 4r02F, 0.7775, 2.93, 0.216, 242, 199, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4423, 4inrF, 0.7775, 3.04, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4424, 4inuT, 0.7774, 3.05, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4425, 5l5dT, 0.7772, 3.04, 0.215, 243, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4426, 5l5dF, 0.7772, 3.05, 0.215, 244, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4427, 4j70F, 0.7772, 3.05, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4428, 4intT, 0.7772, 2.25, 0.201, 201, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4429, 4inrT, 0.7772, 3.06, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4430, 3oevT, 0.7772, 3.07, 0.215, 243, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4431, 3gpjT, 0.7772, 2.99, 0.221, 245, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4432, 5mpag, 0.7771, 3.07, 0.210, 244, 200, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4433, 5fmgW, 0.7771, 2.95, 0.211, 236, 199, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4434, 5fmgI, 0.7771, 3.06, 0.215, 243, 200, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4435, 3nzjT, 0.7771, 2.92, 0.216, 236, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4436, 3nzjF, 0.7771, 2.98, 0.211, 244, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4437, 5l69F, 0.7770, 2.98, 0.216, 244, 199, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4438, 4qluF, 0.7770, 3.07, 0.210, 244, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4439, 3gpjF, 0.7770, 3.06, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4440, 2zcyT, 0.7770, 3.04, 0.210, 244, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4441, 2zcyF, 0.7770, 3.04, 0.210, 244, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4442, 5l69T, 0.7769, 3.00, 0.216, 244, 199, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4443, 4r18T, 0.7769, 2.97, 0.221, 243, 199, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4444, 4r18F, 0.7769, 3.07, 0.210, 244, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4445, 4no1T, 0.7769, 3.08, 0.210, 244, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4446, 4no1F, 0.7769, 2.94, 0.216, 243, 199, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4447, 4jsqT, 0.7769, 2.94, 0.216, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4448, 4jsqF, 0.7769, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4449, 3mg8T, 0.7769, 3.08, 0.210, 244, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4450, 4y8hF, 0.7768, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4451, 4qluT, 0.7768, 2.93, 0.221, 237, 199, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4452, 3oevF, 0.7768, 3.05, 0.210, 244, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4453, 3oeuT, 0.7768, 2.87, 0.217, 243, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4454, 3gpwF, 0.7768, 1.60, 0.189, 186, 185, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4455, 5laiF, 0.7767, 1.60, 0.189, 186, 185, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4456, 4y8hT, 0.7767, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4457, 4j70T, 0.7767, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4458, 3mfeG, 0.7767, 2.81, 0.217, 243, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4459, 3hyeF, 0.7767, 2.96, 0.221, 243, 199, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4460, 3gpwT, 0.7767, 3.05, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4461, 5laiT, 0.7766, 3.03, 0.220, 244, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4462, 4q1sF, 0.7766, 3.03, 0.220, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4463, 3hyeT, 0.7766, 2.81, 0.217, 243, 198, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4464, 1jd21, 0.7766, 2.83, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4465, 1g65T, 0.7766, 2.83, 0.217, 243, 198, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4466, 1g65F, 0.7766, 3.06, 0.215, 243, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4467, 5m2bT, 0.7765, 3.06, 0.215, 243, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4468, 5m2bF, 0.7765, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4469, 4qlvT, 0.7765, 3.08, 0.210, 244, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4470, 4qlvF, 0.7765, 2.81, 0.217, 237, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4471, 5l63T, 0.7764, 3.05, 0.220, 243, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4472, 5l63F, 0.7764, 2.96, 0.221, 243, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4473, 5l5sT, 0.7764, 2.96, 0.211, 237, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4474, 5l5sF, 0.7764, 2.93, 0.216, 237, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4475, 5l5jF, 0.7764, 3.06, 0.210, 244, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4476, 5bouT, 0.7764, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4477, 5bouF, 0.7764, 3.05, 0.220, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4478, 4zzgU, 0.7764, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4479, 4qz7F, 0.7764, 2.22, 0.181, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4480, 4qltF, 0.7764, 3.06, 0.210, 244, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4481, 3sdiF, 0.7764, 3.06, 0.210, 244, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4482, 3oeuF, 0.7764, 2.82, 0.217, 243, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4483, 3mg6F, 0.7764, 3.00, 0.211, 244, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4484, 3dy3T, 0.7764, 3.06, 0.210, 244, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4485, 3bdmT, 0.7764, 2.98, 0.211, 244, 199, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4486, 5l68T, 0.7763, 3.04, 0.215, 244, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4487, 5l68F, 0.7763, 3.04, 0.215, 244, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4488, 5l64F, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4489, 5l61T, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4490, 5l61F, 0.7763, 2.98, 0.216, 243, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4491, 5l60T, 0.7763, 2.98, 0.216, 243, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4492, 5l60F, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4493, 5l5yT, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4494, 5l5yF, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4495, 5l5wF, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4496, 5l5jT, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4497, 5l5iT, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4498, 5l5iF, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4499, 4y8tF, 0.7763, 2.74, 0.213, 244, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4500, 4qz7T, 0.7763, 2.83, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4501, 4qltT, 0.7763, 2.81, 0.222, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4502, 3mg8F, 0.7763, 2.77, 0.213, 242, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4503, 3mg7T, 0.7763, 2.97, 0.211, 237, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4504, 3bdmF, 0.7763, 2.96, 0.211, 237, 199, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4505, 5l65F, 0.7762, 2.81, 0.217, 244, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4506, 5l64T, 0.7762, 2.82, 0.212, 244, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4507, 5l62T, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4508, 5l62F, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4509, 5l5zT, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4510, 5l5zF, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4511, 5l5wT, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4512, 5l5tT, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4513, 5l5tF, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4514, 5l5hF, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4515, 4y8tT, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4516, 4y6vT, 0.7762, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4517, 4y6vF, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4518, 4rurT, 0.7762, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4519, 4rurF, 0.7762, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4520, 3mg7F, 0.7762, 2.80, 0.222, 243, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4521, 3mg6T, 0.7762, 2.83, 0.217, 243, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4522, 3mfeV, 0.7762, 2.81, 0.222, 243, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4523, 5t0jQ, 0.7761, 2.96, 0.211, 237, 199, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4524, 5l6cT, 0.7761, 2.82, 0.217, 237, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4525, 5l6cF, 0.7761, 2.82, 0.212, 244, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4526, 5l6aF, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4527, 5l65T, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4528, 5l5rT, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4529, 5l5rF, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4530, 5l5qF, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4531, 5l5pT, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4532, 5l5pF, 0.7761, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4533, 5l5hT, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4534, 5l54F, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4535, 5cz6F, 0.7761, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4536, 4y84F, 0.7761, 2.80, 0.222, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4537, 4r02T, 0.7761, 2.83, 0.217, 243, 198, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4538, 4qz1T, 0.7761, 2.83, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4539, 4qz1F, 0.7761, 2.83, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4540, 4qlsT, 0.7761, 2.83, 0.217, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4541, 4qlsF, 0.7761, 2.96, 0.211, 237, 199, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4542, 3nzxT, 0.7761, 2.82, 0.217, 237, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4543, 3nzxF, 0.7761, 2.19, 0.181, 224, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4544, 3dy4T, 0.7761, 2.23, 0.230, 199, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4545, 3dy4F, 0.7761, 2.83, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4546, 5mp9g, 0.7760, 2.83, 0.217, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4547, 5l6aT, 0.7760, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4548, 5l66T, 0.7760, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4549, 5l66F, 0.7760, 2.81, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4550, 5l5qT, 0.7760, 2.81, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4551, 5l54T, 0.7760, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4552, 5cz6T, 0.7760, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4553, 4y8oT, 0.7760, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4554, 4y8oF, 0.7760, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4555, 4qvyT, 0.7760, 2.82, 0.222, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4556, 4qvyF, 0.7760, 2.82, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4557, 4qlqT, 0.7760, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4558, 4qlqF, 0.7760, 2.99, 0.221, 243, 199, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4559, 4gk7T, 0.7760, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4560, 4gk7F, 0.7760, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4561, 5l5vT, 0.7759, 2.81, 0.222, 243, 198,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4562, 5l5vF, 0.7759, 2.81, 0.222, 243, 198,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4563, 5l5oT, 0.7759, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4564, 5l5oF, 0.7759, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4565, 5l5aT, 0.7759, 2.81, 0.217, 244, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4566, 5l5aF, 0.7759, 2.81, 0.217, 244, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4567, 4ya9F, 0.7759, 2.73, 0.213, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4568, 4ya5T, 0.7759, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4569, 4ya5F, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4570, 4y8sT, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4571, 4y8sF, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4572, 4y8nT, 0.7759, 2.82, 0.222, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4573, 4y8nF, 0.7759, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4574, 4y81T, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4575, 4y81F, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4576, 4y75T, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4577, 4y75F, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4578, 4qvmT, 0.7759, 2.82, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4579, 4qvmF, 0.7759, 2.82, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4580, 4no6T, 0.7759, 3.05, 0.215, 244, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4581, 4no6F, 0.7759, 3.05, 0.215, 244, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4582, 4inuF, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4583, 3mg4F, 0.7759, 2.84, 0.217, 243, 198, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4584, 1jd2F, 0.7759, 2.83, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4585, 5l67F, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4586, 5l5xT, 0.7758, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4587, 5l5xF, 0.7758, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4588, 5l5uT, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4589, 5l5uF, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4590, 5l5eT, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4591, 5l5eF, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4592, 5dkiT, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4593, 5dkiF, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4594, 5cghT, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4595, 5cghF, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4596, 4ya9T, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4597, 4y69T, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4598, 4y69F, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4599, 4hnpF, 0.7758, 2.84, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4600, 3okjF, 0.7758, 2.84, 0.217, 243, 198, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4601, 5l6bT, 0.7757, 2.99, 0.221, 243, 199, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4602, 5l6bF, 0.7757, 2.99, 0.221, 243, 199, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4603, 5l67T, 0.7757, 2.84, 0.212, 244, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4604, 5l5fT, 0.7757, 2.76, 0.213, 244, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4605, 5l5fF, 0.7757, 2.98, 0.211, 244, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4606, 5fghT, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4607, 5fghF, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4608, 5fggT, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4609, 5bxlT, 0.7757, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4610, 5bxlF, 0.7757, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4611, 4y74F, 0.7757, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4612, 4v7oOA, 0.7757, 2.84, 0.217, 243, 198, 
4613, 4v7oCB, 0.7757, 2.84, 0.217, 243, 198, 
4614, 4qz4F, 0.7757, 2.84, 0.217, 243, 198, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4615, 4qw4T, 0.7757, 2.83, 0.217, 243, 198, YCP IN COMPLEX WITH CARFILZOMIB
4616, 4qw4F, 0.7757, 2.83, 0.217, 243, 198, YCP IN COMPLEX WITH CARFILZOMIB
4617, 4qw3T, 0.7757, 2.83, 0.217, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4618, 4qw3F, 0.7757, 2.84, 0.217, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4619, 4qvlT, 0.7757, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH BORTEZOMIB
4620, 4qvlF, 0.7757, 2.88, 0.212, 244, 198, YCP IN COMPLEX WITH BORTEZOMIB
4621, 4qv6T, 0.7757, 3.06, 0.215, 244, 200, YCP BETA5-A49V MUTANT
4622, 4qv6F, 0.7757, 2.83, 0.217, 243, 198, YCP BETA5-A49V MUTANT
4623, 4quxT, 0.7757, 2.83, 0.217, 243, 198, YCP BETA5-A49T-MUTANT
4624, 4quxF, 0.7757, 2.83, 0.217, 243, 198, YCP BETA5-A49T-MUTANT
4625, 3mg0F, 0.7757, 2.83, 0.217, 243, 198, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4626, 5nifU, 0.7756, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4627, 5nifG, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4628, 5bxnT, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4629, 5bxnF, 0.7756, 2.94, 0.221, 243, 199, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4630, 4ya2T, 0.7756, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4631, 4ya2F, 0.7756, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4632, 4y9yF, 0.7756, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4633, 4y8iT, 0.7756, 2.74, 0.218, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4634, 4y8iF, 0.7756, 2.74, 0.218, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4635, 4y74T, 0.7756, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4636, 4y6zT, 0.7756, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4637, 4y6zF, 0.7756, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4638, 4y6aT, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4639, 4y6aF, 0.7756, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4640, 4v7oU, 0.7756, 2.82, 0.217, 243, 198, 
4641, 4qz4T, 0.7756, 2.82, 0.217, 243, 198, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4642, 4qvwT, 0.7756, 2.81, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4643, 4qvwF, 0.7756, 2.81, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4644, 5cz4T, 0.7755, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4645, 5cz4F, 0.7755, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4646, 4ya4T, 0.7755, 2.83, 0.212, 244, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4647, 4ya0T, 0.7755, 2.75, 0.213, 244, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4648, 4ya0F, 0.7755, 2.75, 0.213, 244, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4649, 4y9yT, 0.7755, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4650, 4y8kT, 0.7755, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4651, 4y8kF, 0.7755, 2.74, 0.218, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4652, 4y77T, 0.7755, 2.74, 0.218, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4653, 4y77F, 0.7755, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4654, 4qwxF, 0.7755, 2.85, 0.217, 243, 198, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4655, 4qwfF, 0.7755, 2.85, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4656, 4qvqT, 0.7755, 2.84, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4657, 4qvqF, 0.7755, 2.85, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4658, 4qvnT, 0.7755, 2.85, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4659, 4qvnF, 0.7755, 2.85, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4660, 5lttT, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4661, 5lttF, 0.7754, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4662, 5l5bT, 0.7754, 2.74, 0.213, 244, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4663, 5l5bF, 0.7754, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4664, 5dkjT, 0.7754, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4665, 5dkjF, 0.7754, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4666, 5cz7T, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4667, 5cz7F, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4668, 4ya4F, 0.7754, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4669, 4y8pT, 0.7754, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4670, 4y8pF, 0.7754, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4671, 4y8mT, 0.7754, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4672, 4y8mF, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4673, 4y7xT, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4674, 4y7xF, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4675, 4qwxT, 0.7754, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4676, 4qwkF, 0.7754, 2.84, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4677, 4qwfT, 0.7754, 2.84, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4678, 4qw0T, 0.7754, 2.84, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4679, 4qw0F, 0.7754, 2.84, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4680, 4no9T, 0.7754, 2.83, 0.217, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4681, 4no9F, 0.7754, 2.83, 0.217, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4682, 4g4sG, 0.7754, 2.84, 0.217, 243, 198, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4683, 3wxrG, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4684, 3shjT, 0.7754, 2.82, 0.217, 243, 198, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4685, 3shjF, 0.7754, 2.82, 0.217, 243, 198, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4686, 1rypU, 0.7754, 2.85, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4687, 5fgdT, 0.7753, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4688, 5fgdF, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4689, 5fg9T, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4690, 5fg9F, 0.7753, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4691, 5d0xF, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4692, 5d0vT, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4693, 5d0vF, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4694, 5ahjT, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4695, 5ahjF, 0.7753, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4696, 4ya7F, 0.7753, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4697, 4ya3T, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4698, 4ya3F, 0.7753, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4699, 4y9zT, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4700, 4y9zF, 0.7753, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4701, 4qwuT, 0.7753, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4702, 4qwuF, 0.7753, 2.82, 0.222, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4703, 4qwkT, 0.7753, 2.82, 0.222, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4704, 4ltcT, 0.7753, 2.59, 0.224, 246, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4705, 6gopT, 0.7752, 2.84, 0.212, 237, 198, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4706, 6gopF, 0.7752, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4707, 5fggF, 0.7752, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4708, 5fgeT, 0.7752, 2.79, 0.217, 244, 198, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4709, 5fgeF, 0.7752, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4710, 5d0xT, 0.7752, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4711, 5cz9T, 0.7752, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4712, 5cz9F, 0.7752, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4713, 4ya7T, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4714, 4y8uT, 0.7752, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4715, 4y8uF, 0.7752, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4716, 4y82T, 0.7752, 2.94, 0.221, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4717, 4y82F, 0.7752, 2.94, 0.221, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4718, 4v7oG, 0.7752, 2.83, 0.217, 243, 198, 
4719, 4qw6T, 0.7752, 2.86, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4720, 4qw6F, 0.7752, 2.86, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4721, 4qw1T, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4722, 4qw1F, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4723, 4qv1F, 0.7752, 2.83, 0.217, 243, 198, YCP BETA5-M45A MUTANT
4724, 4qv0T, 0.7752, 2.83, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4725, 4qv0F, 0.7752, 2.86, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4726, 4qbyT, 0.7752, 3.02, 0.211, 244, 199, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4727, 4qbyF, 0.7752, 2.82, 0.217, 243, 198, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4728, 3nzwF, 0.7752, 2.82, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4729, 2f16T, 0.7752, 2.83, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4730, 2f16F, 0.7752, 2.86, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4731, 5fgaF, 0.7751, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4732, 5d0wF, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4733, 5d0tT, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4734, 5d0tF, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4735, 5czaT, 0.7751, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4736, 5czaF, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4737, 4ya1T, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4738, 4ya1F, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4739, 4y70F, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4740, 4qzzF, 0.7751, 2.72, 0.218, 244, 197, YCP IN COMPLEX WITH OMURALIDE
4741, 4qw7T, 0.7751, 2.84, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4742, 4qw7F, 0.7751, 2.84, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4743, 4qv1T, 0.7751, 2.84, 0.217, 243, 198, YCP BETA5-M45A MUTANT
4744, 4quyT, 0.7751, 2.84, 0.217, 243, 198, YCP BETA5-A49S-MUTANT
4745, 4quyF, 0.7751, 2.83, 0.217, 243, 198, YCP BETA5-A49S-MUTANT
4746, 3nzwT, 0.7751, 2.84, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4747, 5t0hQ, 0.7750, 2.84, 0.217, 243, 198, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4748, 5l55T, 0.7750, 2.88, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4749, 5l55F, 0.7750, 2.88, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4750, 5fgiT, 0.7750, 2.83, 0.212, 244, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4751, 5fgiF, 0.7750, 3.07, 0.215, 244, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4752, 5fgaT, 0.7750, 3.07, 0.215, 244, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4753, 5cggT, 0.7750, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4754, 5cggF, 0.7750, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4755, 4y80T, 0.7750, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4756, 4y80F, 0.7750, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4757, 4y7wF, 0.7750, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4758, 4y70T, 0.7750, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4759, 4qz5T, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4760, 4qz5F, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4761, 4qz2F, 0.7750, 2.85, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4762, 4qz0T, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4763, 4qz0F, 0.7750, 2.85, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4764, 4qwiF, 0.7750, 2.85, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4765, 4qvpT, 0.7750, 2.83, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4766, 4qvpF, 0.7750, 2.83, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4767, 4qv8F, 0.7750, 2.83, 0.217, 243, 198, YCP BETA5-C52F MUTANT
4768, 4qv5T, 0.7750, 2.83, 0.212, 244, 198, YCP BETA5-M45I MUTANT
4769, 4qv5F, 0.7750, 2.35, 0.230, 199, 196, YCP BETA5-M45I MUTANT
4770, 4qv4T, 0.7750, 2.95, 0.221, 243, 199, YCP BETA5-M45T MUTANT
4771, 4qv4F, 0.7750, 2.95, 0.221, 243, 199, YCP BETA5-M45T MUTANT
4772, 4q1sT, 0.7750, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4773, 3mg4T, 0.7750, 2.86, 0.217, 243, 198, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4774, 1g0uF, 0.7750, 2.84, 0.217, 243, 198, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4775, 5jhsT, 0.7749, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4776, 5jhsF, 0.7749, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4777, 5jhrT, 0.7749, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4778, 5jhrF, 0.7749, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4779, 4y8lT, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4780, 4y8lF, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4781, 4y8jT, 0.7749, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4782, 4y8jF, 0.7749, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4783, 4y7wT, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4784, 4qz2T, 0.7749, 2.85, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4785, 4qwiT, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4786, 4qw5T, 0.7749, 2.86, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4787, 4qw5F, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4788, 4qv8T, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-C52F MUTANT
4789, 4qv7T, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT
4790, 4qv7F, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT
4791, 4hrdF, 0.7749, 2.83, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4792, 4hnpT, 0.7749, 2.84, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4793, 3mg0T, 0.7749, 2.84, 0.217, 243, 198, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4794, 3gptT, 0.7749, 2.80, 0.217, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4795, 3gptF, 0.7749, 2.87, 0.212, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4796, 1rypG, 0.7749, 2.83, 0.212, 242, 198, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4797, 5fgfT, 0.7748, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4798, 5fgfF, 0.7748, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4799, 5fg7T, 0.7748, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4800, 5fg7F, 0.7748, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4801, 4y8qT, 0.7748, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4802, 4y8qF, 0.7748, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4803, 4y78T, 0.7748, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4804, 4y78F, 0.7748, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4805, 4qzwT, 0.7748, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4806, 4qzwF, 0.7748, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4807, 4fzgT, 0.7748, 2.86, 0.217, 243, 198, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4808, 4fzgF, 0.7748, 2.85, 0.217, 243, 198, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4809, 5lajT, 0.7747, 2.85, 0.217, 243, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4810, 5lajF, 0.7747, 2.84, 0.217, 243, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4811, 5d0wT, 0.7747, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4812, 4z1lF, 0.7747, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4813, 4y8rT, 0.7747, 2.79, 0.213, 244, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4814, 4y8rF, 0.7747, 2.87, 0.212, 244, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4815, 4qwlF, 0.7747, 2.83, 0.212, 244, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4816, 4qvvT, 0.7747, 2.83, 0.212, 244, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4817, 4qvvF, 0.7747, 2.83, 0.212, 244, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4818, 4nnnT, 0.7747, 2.80, 0.217, 244, 198, YCP IN COMPLEX WITH MG132
4819, 4nnnF, 0.7747, 2.86, 0.217, 243, 198, YCP IN COMPLEX WITH MG132
4820, 5d0zF, 0.7746, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4821, 5d0sF, 0.7746, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4822, 5cgiT, 0.7746, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4823, 5cgiF, 0.7746, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4824, 5cgfT, 0.7746, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4825, 5cgfF, 0.7746, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4826, 4z1lT, 0.7746, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4827, 4r00T, 0.7746, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4828, 4r00F, 0.7746, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4829, 4qzzT, 0.7746, 2.85, 0.212, 244, 198, YCP IN COMPLEX WITH OMURALIDE
4830, 4qz6T, 0.7746, 2.85, 0.212, 244, 198, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4831, 4qz6F, 0.7746, 2.75, 0.223, 243, 197, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4832, 4qz3T, 0.7746, 2.75, 0.223, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4833, 4qz3F, 0.7746, 2.81, 0.222, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4834, 4qwlT, 0.7746, 2.85, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4835, 4qwgT, 0.7746, 2.81, 0.222, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4836, 4qwgF, 0.7746, 2.81, 0.222, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4837, 4no8T, 0.7746, 2.85, 0.217, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4838, 4no8F, 0.7746, 2.86, 0.217, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4839, 4eu2G, 0.7746, 2.86, 0.217, 243, 198, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4840, 1g0uT, 0.7746, 2.82, 0.222, 243, 198, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4841, 5mpaG, 0.7745, 2.82, 0.222, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4842, 5d0zT, 0.7745, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4843, 5d0sT, 0.7745, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4844, 5cz5T, 0.7745, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4845, 5cz5F, 0.7745, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4846, 4y7yT, 0.7745, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4847, 4y7yF, 0.7745, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4848, 4qwjF, 0.7745, 2.85, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4849, 4jsuT, 0.7745, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4850, 4jsuF, 0.7745, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4851, 4hrcT, 0.7745, 2.82, 0.222, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4852, 2fakT, 0.7745, 2.83, 0.222, 243, 198, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4853, 2fakF, 0.7745, 2.83, 0.222, 243, 198, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4854, 5mpcG, 0.7744, 2.83, 0.222, 243, 198, 
4855, 5l52F, 0.7744, 2.83, 0.222, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4856, 5fhsT, 0.7744, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4857, 5fhsF, 0.7744, 2.79, 0.218, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4858, 4qxjT, 0.7744, 2.79, 0.218, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4859, 4qxjF, 0.7744, 2.82, 0.222, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4860, 4qwjT, 0.7744, 2.82, 0.222, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4861, 4lqiF, 0.7744, 2.77, 0.218, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4862, 3okjT, 0.7744, 2.84, 0.212, 242, 198, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4863, 3e47T, 0.7744, 2.87, 0.212, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4864, 3e47F, 0.7744, 2.85, 0.217, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4865, 5l52T, 0.7743, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4866, 4ltcF, 0.7743, 2.87, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4867, 4lqiT, 0.7743, 2.87, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4868, 4jt0T, 0.7743, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4869, 4jt0F, 0.7743, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4870, 3un4T, 0.7743, 2.87, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4871, 3un4F, 0.7743, 2.84, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4872, 3tddF, 0.7743, 2.84, 0.212, 244, 198, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4873, 4qv3T, 0.7742, 2.86, 0.212, 244, 198, YCP BETA5-M45V MUTANT
4874, 4qv3F, 0.7742, 2.84, 0.217, 244, 198, YCP BETA5-M45V MUTANT
4875, 4cr44, 0.7742, 2.84, 0.217, 244, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4876, 3tddT, 0.7742, 2.89, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4877, 3mfeJ, 0.7742, 2.85, 0.217, 243, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4878, 5cz8T, 0.7741, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4879, 5cz8F, 0.7741, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4880, 4qzxT, 0.7741, 2.85, 0.222, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4881, 4qzxF, 0.7741, 2.85, 0.222, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4882, 5mp9G, 0.7740, 2.88, 0.217, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4883, 4fzcF, 0.7740, 2.82, 0.217, 244, 198, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4884, 3mfeX, 0.7740, 2.84, 0.212, 244, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4885, 4qv9T, 0.7739, 2.83, 0.217, 244, 198, YCP BETA5-C63F MUTANT
4886, 4qv9F, 0.7739, 2.83, 0.217, 244, 198, YCP BETA5-C63F MUTANT
4887, 4hrcF, 0.7739, 2.85, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4888, 4fzcT, 0.7739, 2.78, 0.213, 244, 197, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4889, 3mfeT, 0.7739, 2.82, 0.217, 244, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4890, 4qwsT, 0.7738, 2.85, 0.212, 244, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4891, 4qwsF, 0.7738, 2.85, 0.212, 244, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4892, 4qwrT, 0.7738, 2.85, 0.212, 244, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4893, 4qwrF, 0.7738, 2.85, 0.212, 244, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4894, 2gplT, 0.7738, 2.84, 0.212, 244, 198, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4895, 2gplF, 0.7738, 2.85, 0.217, 243, 198, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4896, 4hrdT, 0.7736, 2.85, 0.217, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4897, 3wxrU, 0.7735, 2.20, 0.223, 198, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4898, 3mfeL, 0.7733, 2.84, 0.212, 244, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4899, 4eu2U, 0.7731, 2.20, 0.182, 221, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4900, 3mfe2, 0.7731, 2.86, 0.217, 243, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4901, 4cr45, 0.7730, 2.86, 0.217, 243, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4902, 3mfeN, 0.7730, 2.87, 0.217, 243, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4903, 3mfeR, 0.7727, 2.87, 0.217, 243, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4904, 1z7qU, 0.7726, 2.74, 0.218, 243, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4905, 1z7qG, 0.7726, 2.86, 0.212, 244, 198, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4906, 3mfeE, 0.7723, 2.21, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4907, 5t0iQ, 0.7721, 2.81, 0.222, 243, 198, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4908, 5wvkBA, 0.7717, 2.81, 0.222, 243, 198, 
4909, 5mpbU, 0.7717, 2.80, 0.213, 244, 197, 
4910, 3mfeZ, 0.7715, 2.86, 0.212, 244, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4911, 6epf1, 0.7712, 2.21, 0.182, 221, 192, GROUND STATE 26S PROTEASOME (GS1)
4912, 3jcpPA, 0.7704, 2.80, 0.218, 243, 197, 
4913, 3jcpP, 0.7704, 2.80, 0.218, 243, 197, 
4914, 5mpcU, 0.7703, 2.79, 0.218, 243, 197, 
4915, 1fntG, 0.7703, 2.79, 0.218, 243, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4916, 1fntU, 0.7702, 2.83, 0.217, 244, 198, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4917, 5ln35, 0.7700, 2.83, 0.217, 244, 198, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4918, 4cr24, 0.7700, 2.78, 0.213, 244, 197, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4919, 5a5bG, 0.7694, 2.84, 0.212, 237, 198, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4920, 4cr3G, 0.7694, 2.23, 0.182, 221, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4921, 3dy4Q, 0.7684, 3.03, 0.211, 244, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4922, 3dy4C, 0.7683, 2.23, 0.182, 221, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4923, 3dy3Q, 0.7683, 2.21, 0.191, 212, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4924, 3dy3C, 0.7683, 2.22, 0.182, 221, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4925, 5wvkU, 0.7682, 2.22, 0.182, 221, 192, 
4926, 3gpjQ, 0.7682, 3.18, 0.215, 243, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4927, 5nifD, 0.7681, 3.18, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4928, 4inuQ, 0.7681, 2.23, 0.182, 221, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4929, 3gpjC, 0.7681, 2.32, 0.204, 199, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4930, 3bdmQ, 0.7681, 2.85, 0.218, 244, 197, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4931, 5a0qV, 0.7680, 2.97, 0.217, 243, 198, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4932, 5a0qH, 0.7680, 2.24, 0.182, 221, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4933, 3bdmC, 0.7680, 2.24, 0.078, 202, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4934, 6epc3, 0.7678, 3.02, 0.211, 244, 199, GROUND STATE 26S PROTEASOME (GS2)
4935, 4zzgD, 0.7678, 3.02, 0.211, 244, 199, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4936, 4inrQ, 0.7678, 3.02, 0.211, 244, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4937, 4inuC, 0.7677, 3.04, 0.216, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4938, 3un8Q, 0.7677, 2.91, 0.208, 240, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4939, 3d29Q, 0.7677, 2.91, 0.208, 240, 197, PROTEASOME INHIBITION BY FELLUTAMIDE B
4940, 2zcyQ, 0.7677, 2.36, 0.197, 195, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4941, 4inrC, 0.7676, 2.30, 0.223, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4942, 3d29C, 0.7676, 2.97, 0.217, 245, 198, PROTEASOME INHIBITION BY FELLUTAMIDE B
4943, 2zcyC, 0.7676, 2.97, 0.217, 245, 198, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4944, 4intQ, 0.7675, 2.89, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4945, 3un8C, 0.7675, 2.89, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4946, 4gk7Q, 0.7674, 2.89, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4947, 4gk7C, 0.7674, 2.89, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4948, 3un4Q, 0.7674, 2.90, 0.213, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4949, 3un4C, 0.7674, 2.82, 0.205, 241, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4950, 3okjQ, 0.7674, 2.85, 0.205, 241, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4951, 3gptQ, 0.7674, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4952, 1g65Q, 0.7674, 2.82, 0.205, 241, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4953, 4jsqC, 0.7673, 2.88, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4954, 4fzgQ, 0.7673, 1.58, 0.240, 183, 183, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4955, 3okjC, 0.7673, 1.58, 0.240, 183, 183, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4956, 3gptC, 0.7673, 2.88, 0.204, 241, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4957, 1g65C, 0.7673, 2.50, 0.045, 205, 199, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4958, 4jsqQ, 0.7672, 2.92, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4959, 4fzgC, 0.7672, 2.84, 0.205, 241, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4960, 3nzxQ, 0.7672, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4961, 3nzxC, 0.7672, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4962, 4q1sQ, 0.7671, 2.83, 0.205, 241, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4963, 4intC, 0.7671, 2.90, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4964, 3nzjQ, 0.7671, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4965, 3nzjC, 0.7671, 2.83, 0.205, 241, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4966, 4jsuQ, 0.7670, 2.90, 0.204, 241, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4967, 4jsuC, 0.7670, 2.85, 0.205, 241, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4968, 3mg0Q, 0.7669, 2.85, 0.205, 241, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4969, 1rypR, 0.7669, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4970, 4eu2R, 0.7668, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4971, 3tddQ, 0.7668, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4972, 3tddC, 0.7668, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4973, 3shjQ, 0.7668, 2.83, 0.205, 241, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4974, 3hyeC, 0.7668, 2.83, 0.205, 241, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4975, 4jt0Q, 0.7667, 2.81, 0.210, 241, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4976, 4jt0C, 0.7667, 2.85, 0.205, 241, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4977, 4fzcQ, 0.7667, 2.85, 0.205, 241, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4978, 4fzcC, 0.7667, 2.83, 0.205, 241, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4979, 4cr4G, 0.7667, 2.83, 0.205, 241, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4980, 3shjC, 0.7667, 2.81, 0.210, 241, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4981, 3sdiQ, 0.7667, 2.85, 0.205, 241, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4982, 3hyeQ, 0.7667, 2.85, 0.205, 241, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4983, 1rypD, 0.7667, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4984, 4lqiQ, 0.7666, 2.84, 0.205, 241, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4985, 4lqiC, 0.7666, 2.85, 0.205, 241, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4986, 3nzwQ, 0.7666, 2.92, 0.204, 241, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4987, 3nzwC, 0.7666, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4988, 1g0uQ, 0.7666, 2.84, 0.205, 241, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4989, 5mpbG, 0.7665, 2.84, 0.205, 241, 195, 
4990, 3sdiC, 0.7665, 2.84, 0.205, 241, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4991, 3mg7Q, 0.7665, 2.86, 0.205, 241, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4992, 2fakQ, 0.7665, 2.93, 0.204, 241, 196, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4993, 2fakC, 0.7665, 2.95, 0.204, 241, 196, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4994, 3gpwQ, 0.7664, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4995, 3gpwC, 0.7664, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4996, 2f16Q, 0.7664, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4997, 2f16C, 0.7664, 2.84, 0.205, 241, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4998, 1g0uC, 0.7664, 2.84, 0.205, 241, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4999, 5l5uQ, 0.7663, 2.84, 0.205, 241, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
5000, 5l5uC, 0.7663, 2.87, 0.205, 241, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
